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Abstract 
Enteroaggregative Escherichia coli (EAEC) are a major cause of diarrhoeal illness in 
children, travellers, and the immunocompromised, and associated with foodborne 
outbreaks worldwide. However, EAEC is a heterogeneous pathotype with frequent 
asymptomatic carriage and a diversity of virulence factors. Previous studies have 
been unsuccessful in identifying genetic virulence markers. In this study, two 
complimentary approaches were applied using intestinal infection models to 
investigate bacterial factors contributing to EAEC pathogenesis in the human gut. 
Firstly, the influence of intestinal environmental signals on the expression of 
putative EAEC virulence genes was evaluated using a vertical diffusion chamber 
(VDC). Aerobic oxygen levels increased expression of the adhesins aggregative 
adherence fimbriae II (AAF/II) and E. coli common pilus, the colonisation factor 
dispersin, and the global transcriptional activator AggR in prototype strain 042. 
Furthermore, adherence to polarised T84 intestinal epithelial cells significantly 
enhanced the expression of adherence factors (AAFs and dispersin), toxins (HlyE, 
EAST-1, Pet) and the Pic mucinase. This induction required host cell binding and was 
independent of AggR regulation. Based on these findings, it is proposed that EAEC 
adherence factors are induced by proximity to the oxygen diffusion gradient across 
the gut epithelium, while epithelial cell contact activates expression of further 
virulence factors. 
As an alternative approach to identify EAEC pathogenicity markers, virulence-
associated phenotypes and genotypic profiles were determined for EAEC sequence 
types associated with disease (ST40) or carriage (ST31). ST40 isolates exhibited 
significantly higher biofilm formation and adherence to T84 cells and human colonic 
biopsies. The genotype comparison identified differences in virulence genes 
associated with epithelial colonisation and induction of host inflammatory 
responses between both sequence types. 
Overall, this project has revealed that EAEC virulence gene expression is modulated 
by intestinal environmental signals and identified phenotypic and genotypic traits 
specific for EAEC sequence types associated with disease or carriage. 
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Chapter 1 Introduction 
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INTRODUCTION 
  
20 
 
1.1: Enteroaggregative Escherichia coli 
In the field of microbiology, Escherichia coli are a paradigm for the versatility of a 
bacterial species. E. coli are the most abundant facultative anaerobes in the human 
gastrointestinal tract (GIT) and the majority of strains are harmless commensals 
(Kaper et al., 2004). It is estimated that individuals are colonised by an average of 
five E. coli strains within their intestinal microbiota, where they participate in 
nutrient processing and scavenging oxygen in symbiosis with strictly anaerobic 
species (Maltby et al., 2013, Apperloo-Renkema et al., 1990). Commensal E. coli 
also contribute to resistance against enteric pathogens, through diverse 
mechanisms including adherence exclusion, restriction of nutrients such as carbon 
sources and iron, and secretion of antimicrobial compounds (Sassone-Corsi and 
Raffatellu, 2015). In addition to a beneficial role in the human microflora, E. coli 
strains have long held a unique importance as the predominant bacterial model and 
tool for molecular biology, to the extent that the laboratory strain E. coli K12 was 
amongst the first published full genomes (Blattner et al., 1997, Luo et al., 2011). 
However, a minority of E. coli strains have acquired virulence genes during 
evolution which confer the ability to cause disease in a human host. Such 
pathogenic strains are diverse in genetics and colonisation niches and have been 
categorised on emergence into groups termed pathotypes (Figure 1.1) (Croxen et 
al., 2013, Kaper et al., 2004). The first identified pathogenic E. coli strains were 
isolated from cases of infant diarrhoea in the United Kingdom (UK) in the 1940s and 
represented what was later recognised as the pathotype enteropathogenic E. coli 
(EPEC) (Bray, 1945). Other diarrheagenic E. coli (DEC) pathotypes which colonise the 
human GIT are: enterohaemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC), 
enteroinvasive E. coli (EIEC, which includes Shigella), enterotoxigenic E. coli (ETEC), 
and diffusely-adherent E. coli (DAEC). A further enteric pathotype is adherent-
invasive E. coli (AIEC), although this group has been implicated in inflammatory 
bowel disease rather than diarrhoeal illness specifically. E. coli virulence is not 
restricted to the gut, with the two major extraintestinal pathotypes being 
uropathogenic E. coli (UPEC), associated with bladder and urinary tract infections, 
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and neonatal meningitis-associated E. coli (NMEC), which colonises the 
cardiovascular system and brain.  
 
Figure 1.1 Colonisation sites of E. coli pathotypes. Modified from (Croxen and Finlay, 2010) 
  
DEC are highly genetically diverse global pathogens. For example, one study of 1196 
clinical DEC isolates using Multi-Locus Sequence Typing (a typing method discussed 
in detail in Chapter 1.3.4), identified 579 distinct sequence types grouped into 27 
clonal complexes (Yu et al., 2018). The population structure is also diverse, with 
some sequence type groups restricted to specific pathotypes while others are 
highly heterogeneous for different pathotypes (Figure 1.2). Genetic diversity has 
also been demonstrated using pulsed-field gel electrophoresis, such as a collection 
of DEC from human, animal and environmental sources in India which contained 52 
unique pulsotypes for 59 recovered DEC pathotype samples (Dhaka et al., 2016). 
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Figure 1.2 Diversity of diarrheagenic E. coli. Minimum spanning tree analysis of 1196 
human isolates by multi-locus sequence typing. Connecting lines indicate six (thick lines), 
five (thin), four (dashed) or three to one (dotted) shared alleles, out of seven (Yu et al., 
2018).  
 
EAEC is a relatively recent pathotype, only reported as a distinct group since the 
late 1980s (Nataro et al., 1987). However, it has been increasingly recognised as an 
important emerging enteric pathogen, associated with diarrhoeal illness in 
populations worldwide and frequently the most common bacterial pathogen 
identified in diarrhoeal stool samples during epidemiological studies (Croxen et al., 
2013, Huang et al., 2006b). Although improvements in sanitation, nutrition, and 
medical care have seen global deaths due to diarrhoea decrease by an estimated 
20% between 2005 and 2015, there remains an annual 1.31 million deaths, 
including approximately 500,000 children under the age of five years, due to a 
largely preventable disease (Troeger et al., 2017). Additionally, repeated or chronic 
enteric infections are associated with long-term clinical disadvantages, including 
malnutrition, a weakened immune system, and impaired growth and development 
(Guerrant et al., 2008). The EAEC pathotype has been specifically associated with 
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persistent diarrhoeal illness in children and the immunocompromised, representing 
a major health burden (Lima et al., 2017b, Rogawski et al., 2017).  
Many aspects of EAEC pathogenesis remain unclear, and the pathotype has not 
been as well characterised as other DEC such as EPEC and EHEC. This is largely due 
to the genetic heterogeneity of EAEC as a whole, which includes significant 
variability between strains in pathogenicity and putative virulence genes 
(Hebbelstrup Jensen et al., 2014). This chapter will provide an overview of the 
current understanding of EAEC infection biology, including clinical epidemiology, 
reported virulence mechanisms, and the strengths and limitations of available 
infection model systems for this pathotype.      
 
1.2: Emergence 
The classical definition of EAEC is based on the ability to form the characteristic 
“stacked-brick” aggregative adherence (AA) phenotype on cultured HEp-2 cells, 
with this pattern playing an important role in the original determination of the 
pathotype (Villaseca et al., 2005, Lacroix, 2008). The initial observations of distinct 
phenotypes of HEp-2 cell adherence by enteropathogenic serotypes of E. coli date 
back to research by Cravioto et al. in 1979, with some EPEC forming microcolonies 
described as localised adherence (LA) (Cravioto et al., 1979). However, other E. coli 
strains also adhered to HEp-2 cells with a phenotype described as diffuse adherence 
(DA), which was subsequently further subdivided into separate AA and true diffuse 
categories (Figure 1.3) (Nataro et al., 1987, Nataro and Kaper, 1998). It was a result 
of these findings that enteropathogenic strains displaying AA were suggested as a 
new category of DEC. The original name ‘enteroadherent-aggregative E. coli’ was 
eventually shortened to enteroaggregative E. coli, with the abbreviations EAggEC or 
EAEC alternatively used in the literature. 
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Figure 1.3 Adherence patterns of diarrhoeagenic E. coli on HEp-2 cells. The EAEC 
pathotype is characterised by the aggregative adherence (AA) phenotype on cultured HEp-
2 cells, distinct from the localised adherence (LA) pattern of microcolonies associated with 
EPEC and the diffuse adherence (DA) phenotype of DAEC. Adapted from (Polotsky et al., 
1997) 
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An evolutionary relationship has been determined for certain DEC pathotypes. An 
example is the strong evidence that EHEC emerged from an EPEC background. Both 
groups share virulence features such as the formation of attaching/effacing (A/E) 
lesions on intestinal epithelial cells and the locus of enterocyte effacement (LEE) 
pathogenicity island of virulence genes associated with the A/E phenotype (Mellies 
et al., 2007). EHEC strains have evolved from EPEC by the gain of additional 
virulence factors, most notably the acquisition of phage-encoded Shiga toxin genes 
(Reid et al., 2000). The evolutionary history of EAEC is less well-defined. 
Phylogenetic analysis of EAEC populations has determined that the characteristic 
AA is a convergent phenotype, arising independently in multiple lineages and 
selected by survival advantages in the human host environment. While certain 
lineages are prevalent in multiple global locations, indicative of clonal expansion, 
the heterogeneity of EAEC is linked to the parallel evolution of the AA phenotype in 
lineages with diverse genotypes and virulence (Chattaway et al., 2014b, Okeke et 
al., 2010).  
 
1.3: Epidemiology  
It is extremely difficult to accurately determine the incidence of any enteric 
pathogen due to the challenges of determining causative agents of gastrointestinal 
illness and the under-reporting of such disease in the community (Flint et al., 2005). 
However, since its description as a separate DEC pathotype it has been increasingly 
recognised that EAEC is a major contributor to the global burden of diarrhoeal 
disease (Huang et al., 2006a, Walker et al., 2013). Epidemiological studies in diverse 
geographical locations have consistently identified EAEC as one of the most 
common causes of diarrhoeal illness in children and travellers worldwide, in many 
cases being isolated more frequently than any other DEC (Rajendran et al., 2010, 
González et al., 1997, Sarantuya et al., 2004). In addition, the overall impact of EAEC 
disease may be greatly underestimated, as it is associated with persistent diarrhoea 
which is a risk factor for malnutrition and compromised immunity (Roche et al., 
2010). The global incidence of EAEC is unclear, as it is not commonly screened for in 
global disease burden studies unlike established pathogens such as Rotavirus, 
26 
 
Shigella, Campylobacter, and Salmonella species. However, the epidemiological 
prevalence of EAEC strains associated with gastrointestinal illness suggests a major 
contribution to the annual estimate of 2.39 billion global episodes of diarrhoea 
(Troeger et al., 2017) 
 
1.3.1: Association with disease in global populations  
The importance of EAEC as an enteric pathogen was originally not well recognised. 
Following the identification of EAEC as a separate DEC pathotype, epidemiological 
studies resulted in initial uncertainty on the true pathogenicity of such strains. 
While some early case studies failed to show a significant association between EAEC 
infection and diarrhoea (Gomes et al., 1989), others concluded that EAEC was likely 
an enteric pathogen playing a causal role for diarrhoea in children (Paul et al., 1994, 
Bhatnagar et al., 1993). A stronger association was eventually established by Nataro 
et al. when a volunteer study was conducted where the prototype strain 042 
elicited diarrhoea in adults. However, three other strains also isolated from infant 
diarrhoeal cases failed to induce any disease response, showing the heterogeneity 
of EAEC pathogenicity (Nataro et al., 1995). 
Over the last 20 years, many case-control and cohort studies have increasingly 
shown both the prevalence of EAEC carriage and an association with diarrhoea. For 
example, a case-control study performed between 2003 and 2006 in children in 
South India found that EAEC was the most common pathotype of DEC detected in 
both clinical cases and control groups, although isolates expressing 3 specific 
virulence markers (aap, aggR, and aat) were significantly associated with diarrhoea 
(Rajendran et al., 2010). In 2006, Huang et al. published a meta-analysis examining 
the existing data. This confirmed that EAEC was significantly associated with acute 
diarrhoeal illness in many subpopulations including: children and adults in 
developing regions, children in industrialised regions, international travellers to 
developing regions, and adults with human immunodeficiency virus infection 
residing in developing regions (Huang et al., 2006b). As such, although the 
pathotype is highly heterogeneous, EAEC can be considered an important causal 
agent of diarrhoeal disease. 
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Many of the epidemiological surveys in the existing literature focus on the level of 
EAEC infection in developing countries. EAEC has repeatedly been demonstrated as 
a significant contributor to diarrhoeal illnesses in diverse geographical locations. For 
example, a study of 513 infant patients between 1993 and 1995 in Caracas, 
Venezuela found that EAEC was the second-most commonly isolated 
enteropathogen (26.9% of patients) after Rotavirus (González et al., 1997). A case-
control study of 587 children with diarrhoea and 249 age-matched healthy controls 
in Vietnam identified EAEC as the predominant bacterial pathogen (although again 
less frequent than Rotavirus) and most associated with disease in infants below two 
years of age (Vu Nguyen et al., 2006). More recently, the malnutrition and enteric 
disease (MAL-ED) longitudinal study screened stools from over 2092 infants from 
eight global low-income regions during the first two years of life. EAEC was isolated 
at least once from 94.8% of the cohort, and was associated with intestinal 
inflammation and growth reduction (Rogawski et al., 2017). Often studies have 
shown a particularly significant association between EAEC and chronic or persistent 
diarrhoea, usually defined as lasting more than 14 days (Lima et al., 1992, Bhan et 
al., 1989). While therapies for acute diarrhoea continue to improve in developing 
countries, persistent illness remains a great concern, especially in infants (Fang et 
al., 1995, Troeger et al., 2017, Kotloff et al., 2013). In general, EAEC appears to be 
an important emerging threat in paediatric diarrhoea. This is evident in the results 
of the meta-analysis by Huang et al., which estimated EAEC to be the cause of acute 
diarrhoeal illness in children for 4% of cases in industrialised nations, and 15 % in 
developing countries (Huang et al., 2006b, Huang et al., 2006a). 
EAEC is also being increasingly recognised as a prevalent enteropathogen in 
industrialised nations. An early case-control study established that this pathotype 
was both more prevalent and more strongly associated with diarrhoea than EPEC in 
Scandinavia (Bhatnagar et al., 1993). Since then, similar results have been obtained 
in many developed countries, including the UK, Austria and Japan (Knutton et al., 
2001, Presterl et al., 1999, Itoh et al., 1997). As in lower income regions, EAEC is 
most commonly associated with acute and persistent diarrhoea in infants and 
children (Itoh et al., 1997, Knutton et al., 2001, Tobias et al., 2015, Chan et al., 
1994). However, EAEC cases in adult patients are also significant as demonstrated 
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by a Swedish study which identified EAEC as the second-most frequently isolated 
DEC (after ETEC) in cases of adult diarrhoea (Svenungsson et al., 2000). 
Another population associated with EAEC-induced diarrhoea are travellers from 
industrialised countries to developing regions (Jiang et al., 2002, Adachi et al., 
2002a). This was established in a large study by Adachi et al., which found that 
EAEC was isolated from 26% of travellers’ diarrhoea cases studied in areas of 
Mexico, Jamaica, and India. This made it second only to ETEC in prevalence, and it 
was proposed that EAEC may account for a large proportion of the previously 
recorded cases with an unknown pathogen that still responded well to 
antimicrobial therapy (Adachi et al., 2001). In a study of travellers returning to 
Finland from subtropical destinations, EAEC colonisation was significantly 
associated with ongoing travellers’ diarrhoeal symptoms (Laaveri et al., 2016). EAEC 
has also been reported as prevalent in traveller's diarrhoea cases in children 
(Pouletty et al., 2018). 
A further group which may be affected by EAEC infection are immunocompromised 
patients. Wanke et al. previously investigated EAEC prevalence in human 
immunodeficiency virus (HIV)–infected adults with diarrhoea, as compared to 
healthy controls. This study found EAEC to be significantly associated with 
diarrhoeal illness in this population, and interestingly EAEC infection was strongly 
linked to the stage of HIV disease progression and corresponding lower CD4 cell 
counts (Wanke et al., 1998). Although further studies are needed, EAEC has been 
previously associated with higher isolation frequency and greater symptomatic 
severity in acquired immunodeficiency syndrome patients, as compared to the 
healthy adult population (Rossit et al., 2009). 
 
1.3.2: Transmission and reservoirs  
EAEC is primarily transmitted via the faecal-oral route (Hebbelstrup Jensen et al., 
2014, Kaur et al., 2010). Therefore, most cases likely arise from consumption of 
either contaminated food products or drinking water. A number of investigations 
have shown that EAEC can remain viable for long periods in various conditions 
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outside the human host, thereby increasing their danger as food or drink-related 
pathogens. For example, viable EAEC were recovered from inoculated bottles of 
mineral or spring water after more than 60 days (Vasudevan et al., 2003). Studies 
have also found EAEC to be prevalent in standing water, both in developing and 
industrialised regions (Sidhu et al., 2013, Akter et al., 2013). Additionally, a recent 
publication identified the EAEC virulence marker aggR in as many as 69% of 
samples taken from rivers in South Africa (Ndlovu et al., 2015). 
As with many enteropathogens, food handling is believed to be a major source of 
EAEC infections. This is supported by findings in adult volunteer studies where a 
relatively high inoculum (approximately 1010 bacteria) was required for prototype 
strain 042 to cause diarrhoea, which makes food and water consumption more 
likely modes of transmission than environmental exposure (Nataro et al., 1995, 
Huang et al., 2006a, Huang and DuPont, 2004). While the infectious dose has been 
well-characterised for EPEC and EHEC (108-1010 and less than 100 bacteria, 
respectively), this has not been defined for EAEC strains in general due to the 
heterogeneity of virulence for clinical isolates (Mellies et al., 2007). A number of 
known outbreaks of diarrhoeal illness associated with virulent EAEC strains have 
been linked to contaminated food and water sources. These include a restaurant 
serving unpasteurised cheese in Italy, villagers drinking from an open well in South 
India, and a large outbreak affecting 2,697 children in Japan at 16 schools all using 
the same supplier of cooked lunches (Scavia et al., 2008, Pai et al., 1997, Itoh et al., 
1997). In addition, the most publicised EAEC outbreak so far, the 2011 O104:H4 
outbreak in Germany, likely originated from contaminated fenugreek sprouts often 
consumed raw in salads (Beutin and Martin, 2012). 
Contaminated food and water sources are also suggested to cause many cases of 
EAEC-induced travellers’ diarrhoea. For example, a cross-sectional study of table 
sauces in Guadalajara, Mexico, and Houston, Texas found a significantly higher 
prevalence of viable E. coli at the former location, of which EAEC was the most 
common pathotype of DEC identified (Adachi et al., 2002b). A recent study in South 
Africa investigated the prevalence of DEC in diverse sources including milk, 
irrigation water, vegetables, and street food. This determined that EAEC was the 
most abundant pathotype, and the authors suggested that it may represent the 
30 
 
leading cause of DEC-associated food and water-borne enteric infection in the 
country (Aijuka et al., 2018). Another consideration is the role of asymptomatic 
human carriers. A study of food handlers at Kenyan hotels concluded that they 
represented a risk for transmitting EAEC to traveller via shedding and food 
contamination (Oundo et al., 2008).  
The main reservoir of pathogenic EAEC is generally accepted to be humans 
(Hebbelstrup Jensen et al., 2014, Okeke, 2009). Animal reservoirs have been 
established for some pathogenic E. coli subtypes, including the carriage of EHEC by 
cattle and other ruminant livestock, yet have not been conclusively demonstrated 
for EAEC (Ferens and Hovde, 2011). Large studies of farmed animals including 
ruminants have failed to show any association with EAEC carriage (Cassar et al., 
2004, Orden et al., 2017). Low levels of EAEC have been isolated from an abattoir 
setting in South Africa, yet no EAEC were identified amongst 10,618 E. coli isolates 
screened from slaughterhouse effluents in France (Tanih et al., 2015, Bibbal et al., 
2014). A recent study of DEC prevalence in humans, food, and livestock in Japan 
determined that the EAEC marker aggR was only associated with humans, 
supporting a predominantly human reservoir for the pathotype (Wang et al., 2017). 
Similarly, aggR-positive E. coli were associated with humans but not farmed 
chickens in South Vietnam (Trung et al., 2016). EAEC strains previously isolated 
from animal faeces often displayed major genetic differences to typical human 
pathogenic strains, although the possibility of animal-related strains becoming 
further adapted for human infection cannot be discounted (Uber et al., 2006). 
Plants can also act as reservoirs of human pathogenic enterobacteria, often with a 
direct link to harvested produce entering the food chain (Holden et al., 2009). 
Although it is unknown if this is a common transmission route for EAEC, studies 
have shown that several clinical strains are able to bind crops such as spinach and 
salad leaves using established adherence factors (Berger et al., 2009, Nagy et al., 
2016). The prevalence of EAEC in standing water and irrigation sources also 
supports agricultural contamination as a contributory factor in faecal-oral 
transmission of pathogenic EAEC (Ndlovu et al., 2015, Sidhu et al., 2013, Aijuka et 
al., 2018). 
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1.3.3: Recent developments and hybrid strains 
The heterogeneity of EAEC has been recognised from an early stage, associated 
with the theory that diverse factors confer the shared AA phenotype in different 
strains (Nataro and Kaper, 1998, Nataro et al., 1995). One distinction commonly 
used in the literature is the classification of EAEC strains as typical or atypical EAEC 
based on the presence or absence of the AggR regulator or pAA plasmid 
(Hebbelstrup Jensen et al., 2014). Some case studies have found a positive 
association between typical strains of EAEC and pathogenic effects, suggesting that 
they represent the most clinically relevant class of EAEC (Dudley et al., 2006a, Jiang 
et al., 2002). However, human disease is also caused by some atypical strains, and 
the prevalence of virulence factors is often different from typical EAEC (Andrade et 
al., 2017, Elias et al., 2002). The use of typical EAEC markers including AggR for 
general EAEC identification also introduces bias towards the association of typical 
strains with virulence (Jenkins et al., 2006). This distinction between typical and 
atypical EAEC is therefore too simplistic to account for the heterogeneity of the 
pathotype. More recently, the advances in sequencing and bioinformatic 
approaches for studying pathogen populations have been predicted to allow a 
clearer definition of pathogenic and non-pathogenic subpopulations within EAEC in 
the future (Robins-Browne et al., 2016). 
Another aspect of EAEC research that has become more prominent in the last 
decade is the evolution of hybrid-pathotype strains. This interest has been largely 
driven by the E. coli O104:H4 outbreak in 2011 (Figure 1.4). During the late spring of 
that year, a large-scale outbreak of enteric disease occurred in central Europe, 
primarily in regions of Germany. This led to over 3800 reported cases of 
gastrointestinal illness, but the situation was complicated by an unusually high 
number of patients developing haemolytic uraemic syndrome (HUS), a disease most 
commonly associated with the Shiga toxin of EHEC. This syndrome is characterised 
by a combination of haemolytic anaemia, thrombocytopenia (platelet loss), and 
subsequent acute renal failure, and can cause up to 10% mortality (Corrigan and 
Boineau, 2001). While HUS is predominantly associated with infants, adults were 
mostly affected in this outbreak with approximately 850 recorded cases of HUS and 
54 deaths (Hebbelstrup Jensen et al., 2014, Karch et al., 2012). This incident was 
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notable for both the overall scale and high mortality rate, especially for developed 
nations, and received major media coverage.  
 
 
 
Figure 1.4 Timeline of 2011 E. coli O104:H4 outbreak. (Karch et al., 2012) 
 
Within weeks of the first cases, microbiological laboratories began to complete 
work on sequencing and typing the causative pathogen. Serotyping classified the 
isolated strains as O104:H4 E. coli (Mellmann et al., 2011, Bielaszewska et al., 2011). 
This serotype had been identified in at least 8 previous infections in Europe and 
Korea, which had formerly been attributed to EHEC strains (Karch et al., 2012). 
However, investigators subsequently determined that the German outbreak strain 
was negative for intimin (encoded by eae), a key virulence factor in typical EHEC 
involved in intimate attachment and the formation of A/E lesions (Donnenberg et 
al., 1993). Records in Germany between 1996 and 2010 showed that less than 4% 
of previous HUS cases were caused by eae-negative isolates, demonstrating that 
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the 2011 outbreak strain represented an uncommon E. coli pathogen (Karch et al., 
2012). 
By early June, full sequencing results were available and indicated that the outbreak 
was the result of an EHEC-EAEC hybrid. Whilst lacking eae, the strain contained the 
stx2 gene encoding Shiga toxin 2 (Stx2), as well as additional EHEC associated genes 
such as the adhesin iha (Bielaszewska et al., 2011). However, a range of molecular 
markers for typical EAEC strains were also present, including the aggregative 
adherence fimbriae AAF/I, the global regulator AggR, a mucinase Pic, dispersin, and 
the enterotoxin ShET1 (Muniesa et al., 2012, Bielaszewska et al., 2011). A picture 
therefore developed of a pathogen with an EAEC origin which had acquired stx2 
and other EHEC virulence genes via horizontal gene transfer. 
Although rare, other incidents of Stx-producing EAEC hybrids have been described, 
albeit on a smaller scale than the 2011 outbreak. For example, an outbreak in 
France in 1992 resulted in 10 cases of HUS in children caused by an Stx2-positive 
EAEC strain of serotype O111:H2 (Morabito et al., 1998). More recently, an isolated 
case of HUS in Northern Ireland in 2012 was attributed to an Stx-producing EAEC 
O111:H21 strain (Dallman et al., 2012). Research into the evolutionary history of 
the 2011 O104:H4 strain identified a similar O104:H4 case in 2001, but lacking a 
plasmid conferring ceftazidime resistance (Karch et al., 2012). Interestingly, the 
outbreak strain had 99.8% nucleotide sequence similarity to a Shiga toxin–negative 
EAEC O104:H4 strain (55989) isolated in 1995 from an HIV-positive patient with 
diarrhoea in Central Africa; therefore giving a rough time window for the 
acquisition of the prophage encoding Stx2 (Beutin and Martin, 2012).  
The 2011 O104:H4 strain caused the largest outbreak of Stx-producing E. coli ever 
recorded, and was one of the most serious microbiological incidents in the modern 
era of Western medicine (Muniesa et al., 2012). The virulence of this strain is a 
likely result of the unusual combination of the pAA plasmid mediating AA and the 
Stx2-encoding phage linked to kidney damage and HUS. It has been proposed that 
EAEC virulence mechanisms contributed to epithelial barrier disruption, and 
therefore greater penetration of the Stx2 toxin (Boisen et al., 2015).  
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This outbreak demonstrates that combinations of existing pathotypes, utilising the 
exceptional ability of virulence genes to spread between E. coli strains, may cause 
the rise of new pathogens. The scale of this incident has resulted in renewed 
interest in EAEC research (Beutin and Martin, 2012). Furthermore, the example of 
the 2011 outbreak shows how the acquisition of certain genetic elements can make 
EAEC a much greater threat for adults in developed countries, a population in which 
EAEC is less frequently considered.      
 
1.3.4: EAEC typing 
While increasingly considered outdated, E. coli research has traditionally used 
serotyping as a standard practise for characterisation of strains. This uses a 
numerical scheme assigned to specific surface antigens: the O antigen of the 
lipopolysaccharide (LPS) layer, H antigen of flagellin, and also the K antigen of 
capsular polysaccharide (Orskov and Orskov, 1992). However, as fewer reference 
laboratories had the capabilities for K antigen typing, the O:H serotype has 
historically been the gold standard in E. coli typing (Fratamico et al., 2016). While 
developed in the 1940s, serotyping has remained popular as a technique applicable 
across all E. coli species which allows sufficient discrimination for differentiating 
taxonomic groups and tracking pathogenic outbreaks (Jenkins, 2015, Kauffmann, 
1947). It has been effective for determining virulent lineages in the study of DEC. A 
prominent example is the serotype O157:H7 which has been identified as the major 
EHEC group associated with diarrhoeal illness (Nguyen and Sperandio, 2012, 
Weintraub, 2007). Unfortunately, serotyping has proven less useful in the study of 
EAEC as no O:H group dominates or specifically associates with disease; therefore it 
has been limited to specific outbreak identification (Scavia et al., 2008, Hebbelstrup 
Jensen et al., 2014). This is partly the result of the genetic heterogeneity of the 
pathotype, with one major UK epidemiological study identifying 47 distinct EAEC 
serotypes (Jenkins et al., 2006). The issue is compounded by the highly aggregative 
phenotype of EAEC as auto-agglutination causes a high proportion of strains to be 
classed as non-typeable (Weintraub, 2007).  
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E. coli have also been previously analysed by phylogroup (A, B1, B2, C, D, E, F), 
where isolates can be assigned by triplex PCR (Clermont et al., 2013). Some 
subgroups of E. coli are highly associated with phylogroups, such as extraintestinal 
pathogenic E. coli with groups B2 and D, or commensal E. coli with group A (Croxen 
et al., 2013). However, EAEC have been found to be widely distributed across these 
phylogroups, a further indicator of the phylogenetic diversity of the pathotype and 
parallel evolution of the aggregative adherence phenotype (Escobar-  ramo et al., 
2004, Hebbelstrup Jensen et al., 2014)  
Another common typing scheme in bacterial epidemiology is Multi-Locus Sequence 
Typing (MLST), which was developed for Neisseria meningitidis in the 1990s but is 
now applied to various pathogens including E. coli (Maiden et al., 1998, Larsen et 
al., 2012). An allelic profile of core gene sequences, amplified by polymerase chain 
reaction (PCR), is used to type strains against defined sequence types (STs). The 
standard E. coli MLST scheme uses 7 loci: adk, fumC, gyrB, icd, mdh, purA and recA 
(Chattaway et al., 2014b). MLST can be particularly effective for investigating 
population genetics and discriminating between lineages in larger data sets (Okeke 
et al., 2010). 
Both serotyping and sequence typing have benefited from the advances in genome 
sequencing technologies. For serotyping, determining antigen alleles from genetic 
sequences circumvents the practical limitations of maintaining at least 188 O and 
53 H antisera and specialised facilities for traditional antigen testing (Jenkins, 2015, 
Joensen et al., 2015, Ingle et al., 2016). Similarly, in silico MLST has become 
increasingly efficient with the improving cost-effectiveness of whole-genome 
sequencing (WGS), as opposed to traditional PCR amplification (Larsen et al., 2012). 
WGS is also allowing the development of new typing approaches, such as core 
genome MLST. This technique performs genome-wide gene-by-gene allele 
comparisons for typically 1500 to 4000 genes conserved within a species, allowing 
enhanced resolution versus conventional MLST schemes (Kimura, 2018).  
The standard typing methods for epidemiology have been effective for identifying 
EAEC outbreaks and lineages, but the heterogeneity of the pathotype is a challenge 
for determining pathogenic subgroups. However, ongoing advances using WGS in 
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combination with typing techniques may improve discriminatory power for future 
studies and allow pathogenic and non-pathogenic EAEC strains to be distinguished 
(Robins-Browne et al., 2016, Chattaway et al., 2013).  
 
1.4: Pathology 
1.4.1: Diagnosis of EAEC 
The characteristic AA phenotype of bacteria incubated with cultured HEp-2 cells 
was the original defining feature for classification of EAEC as a separate pathotype 
and remains the nominal gold-standard for EAEC diagnosis. The main feature of this 
phenotype is the stacked-brick adherence pattern, with bacteria binding not only to 
the HEp-2 cells, but also to the surface of the culture dish (Figure 1.5) (Cennimo et 
al., 2007). However, the HEp-2 adherence assay has drawbacks due to the 
necessary time, practical expertise, and cell culture facility requirements 
(Weintraub, 2007). It has been demonstrated that formalin-fixed HEp-2 cells can be 
used for many weeks with a similar sensitivity and specificity to the standard assay, 
which offers extra practicality and reduces the risk of contamination, but this has 
not been widely adopted (Miqdady et al., 2002). In practice, epidemiological 
identification of EAEC is now typically performed by molecular biology techniques. 
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Figure 1.5 Aggregative adherence phenotype of EAEC on HEp-2 cells. The EAEC aggregate 
in a “stacked-brick” pattern on both the cultured epithelial cells and the underlying abiotic 
surface. (Boisen et al., 2013) 
 
The use of PCR assays for diagnosis of infective disease agents is well established 
and has advantages for rapid detection of microbes (Yang and Rothman, 2004). 
However, the use of PCR with EAEC has been complicated by the genetic 
heterogeneity of the pathotype. Many studies have used the DNA probe CVD432, 
targeting the aatA gene sequence (encoding a membrane transporter of the 
dispersin protein). This which was originally developed by Baudry et al. for Southern 
blotting based on a specific fragment of the 042 pAA (Baudry et al., 1990). Although 
the CVD432 probe has been widely used for its high specificity, its sensitivity is 
highly variable (15% to 89%) (Cennimo et al., 2007). Other studies have used a 
range of potential target genes as markers for EAEC, including virulence genes such 
as aap, astA, and aaiA, and the transcriptional regulator gene aggR (Jenkins et al., 
2006, Andrade et al., 2014). However, as many putative virulence genes are poorly 
conserved amongst all EAEC and also found in other pathotypes, it is difficult to 
design a specific assay using PCR alone (Weintraub, 2007). Despite this, PCR 
approaches are widely used due to their cost-effectiveness especially when 
screening large sample collections. Multiplex PCR against multiple EAEC-associated 
genes is often used to improve the sensitivity of EAEC identification, whilst real-
time PCR can allow a more rapid detection of the bacteria (Bischoff et al., 2005, 
Bouzari et al., 2005, Cerna et al., 2003). 
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Other basic diagnostic options have been proposed based on EAEC-associated 
phenotypes. One simple method for detection is a “clump-formation” test, based 
on the visible auto-agglutination of EAEC in culture broths. While crude, it has a 
reported sensitivity and specificity of approximately 90% and was recommended as 
a potential EAEC detection tool following a study in Japan (Iwanaga et al., 2002). A 
quantitative biofilm assay has also been described, utilising optical density to 
identify rapid bacterial aggregation in a microtiter plate, and may be useful as a 
quick initial screening tool in regions lacking more specialised facilities (Wakimoto 
et al., 2004).  
For now, the HEp-2 adherence assay remains the nominal gold standard for reliable 
confirmation of EAEC, although many reference laboratories mostly use PCR 
techniques for efficiency of identification. The development of improved molecular 
diagnostic tools could improve future research of this pathotype, particularly for 
specific epidemiological analysis of pathogenic EAEC strains, but will require further 
understanding of the key factors in EAEC pathogenesis (Hebbelstrup Jensen et al., 
2014).   
 
1.4.2: Clinical symptoms of EAEC infection 
The heterogeneity of EAEC strains results in great variation in the clinical symptoms 
of infection, including frequent asymptomatic carriage. This diversity in disease has 
been proposed to also depend on factors such as host genetic susceptibility and 
immune response, as well as the number of bacteria initially ingested (Kaur et al., 
2010). Two major infectious intestinal disease studies in the UK (IID1 and IID2) 
reported that a quarter of EAEC-positive individuals were asymptomatic (Chattaway 
et al., 2013). This was also observed in traveller’s diarrhoea, where a study of 382 
travellers to the tropics identified EAEC in 50% of diarrhoeal samples but also in 
28% of asymptomatic controls (Laaveri et al., 2016).   
Gastrointestinal illness caused by EAEC can present with a range of symptoms 
(Table 1.1), although watery diarrhoea (less frequently containing mucus and/or 
blood) is most prevalent. Accompanying symptoms can include dehydration, 
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abdominal pain, vomiting, nausea, and low-grade fever (Kaur et al., 2010, Kahali et 
al., 2004, Nataro et al., 2006). However, many studies focus on EAEC strains 
isolated from hospitalised patients. As EAEC is not typically screened for in 
community health services, especially in developing countries, infections with 
milder symptoms are likely to be underreported (Okeke, 2009). Onset of diarrhoea 
following ingestion of the pathogen may be rapid, with a human volunteer study by 
Nataro et al. reporting an average incubation period of 14 hours for affected 
subjects (Nataro et al., 1995). However, some typical EAEC-associated foodborne 
outbreaks have reported longer incubation times of 33-50 hours before symptoms, 
while the 2011 O104:H4 outbreak had an estimated median incubation time of 8 
days (Scavia et al., 2008, Itoh et al., 1997, Frank et al., 2011). 
 
 
Table 1.1 Clinical characteristics of EAEC infections in India (Kahali et al., 2004) 
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EAEC infections can cause both acute and chronic diarrhoeal illness. Persistent EAEC 
diarrhoea has mostly been associated with children, especially in developing 
countries (Fang et al., 1995, Cravioto et al., 1991, Henry et al., 1992). However, 
further epidemiological studies have disputed this, with only low rates of persistent 
diarrhoea (> 14 days) reported for EAEC infections (Lima et al., 2013b, Pabst et al., 
2003). A specific role of chronic diarrhoea as an important disease trait for EAEC 
infection compared to other DEC may have been overestimated by earlier studies of 
the pathotype (Hebbelstrup Jensen et al., 2014). Chronic infection by enteric 
pathogens such as EAEC has been linked to malnutrition in children, both as a risk 
factor for initial infection due to mucosal damage, and also as a resulting effect of 
persistent diarrhoeal illness (Nataro and Kaper, 1998, Roche et al., 2010). Children 
under 60 months of age in Kenya with clinical wasting (defined as mid-upper arm 
circumference </= 125 mm) had a significantly greater rate of EAEC infection and 
more severe disease and dehydration (Tickell et al., 2017). EAEC was one of 
multiple pathogens associated with infant malnutrition in a case-control study in 
Bangladesh, after adjusting for sociodemographic factors, and EAEC infections were 
more prevalent in malnourished children in North-eastern Brazil (Platts-Mills et al., 
2017, Lima et al., 2017a). While EAEC is suggested to mostly cause acute illness in 
otherwise healthy adults, immunocompromised individuals such as HIV-positive 
patients also have a significant association with chronic diarrhoea (Wanke et al., 
1998, Samie et al., 2007).  
Aside from the initial gastrointestinal symptoms of infection, EAEC has been linked 
to additional long-term effects. Studies have shown an association between the 
presence of EAEC in stools of children and a subsequent impairment of growth. This 
also occurs in children colonised without symptomatic illness, suggesting EAEC-
induced malnutrition is at last partially independent of diarrhoea (Steiner et al., 
1998, Guerrant et al., 2008). The MAL-ED study associated EAEC infections with 
reduced body length by 2 years of age, and proposed that maintained intestinal 
inflammation may stunt growth without diarrhoea (Rogawski et al., 2017). A similar 
observation of growth shortfalls and under-nutrition induced by EAEC has been 
demonstrated in a murine model (Roche et al., 2010). Sobieszczaoska et al. have 
suggested an additional link between EAEC and irritable bowel syndrome (IBS) 
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(Sobieszczaoska et al., 2007). They determined a highly significant increase in EAEC 
isolates in IBS patients, and theorised that a persistent infection of this pathotype 
could contribute to IBS development through induced mucosal inflammation. 
However, there is currently insufficient evidence to indicate any causative 
correlation. 
Although EAEC is primarily a foodborne enteric pathogen, some strains have shown 
an ability to cause extraintestinal infection. The most common causative agent of 
urinary tract infections has long been established as uropathogenic E. coli (UPEC). 
However, while UPEC dominates in community-acquired cases, hospital-acquired 
infections can be caused by E. coli strains normally associated with intestinal 
colonisation, including EAEC (Toval et al., 2014). An increase in such observations, 
including an outbreak of EAEC-associated urinary tract infections in Copenhagen, 
has led some researchers to suggest that a UPEC/EAEC hybrid pathotype may be an 
evolving clonal group specialised for this extraintestinal niche (Chattaway et al., 
2014a, Olesen et al., 2012). 
While most cases of EAEC infection do not result in life-threatening illness, some 
strains have been able to cause more serious complications. Most notable is the 
association between certain EAEC strains and the development of haemolytic-
uraemic syndrome (HUS). HUS has been historically linked to EHEC, with the 
pathogenesis dependent on the expression of Shiga toxins (Melton-Celsa and 
O'Brien, 2014). However, there have been multiple examples of HUS associated 
with EAEC strains that have acquired Shiga toxins, including cases in HIV-positive 
patients in the Central African Republic, and minor outbreaks in France and Japan in 
1996 and 1999, respectively (Mossoro et al., 2002, Chattaway et al., 2013). 
However, the risk of Shiga toxin-producing EAEC received greater recognition in the 
wake of the major 2011 O104:H4 outbreak in Europe, as previously described in 
Chapter 1.3.3.  
 
 
 
42 
 
1.4.3: Clinical therapy 
In the majority of cases of EAEC-associated diarrhoea, the infection is self-limiting 
(Huang et al., 2004). As a result, oral rehydration therapy is commonly applied, 
although the link between EAEC and chronic disease can make this less suitable 
alone in cases with persistent symptoms (Kaur et al., 2010). Antimicrobial therapy is 
frequently given empirically for severe diarrheal illness before pathogen 
identification and is likely for EAEC infection due to the aforementioned limitations 
in diagnosis. Certain classes of antibiotics have proven effective against most EAEC 
strains, with a susceptibility to fluoroquinolones often highlighted (Glandt et al., 
1999, Cennimo et al., 2007). Evidence from two clinical trials, using ciprofloxacin 
and rifaximin, showed a significant reduction in post-treatment diarrhoea duration 
in comparison to placebo controls (Infante et al., 2004, Glandt et al., 1999). 
However, antibiotics are not recommended for treatment of infections caused by 
Stx-producing EAEC. Many of the antibiotics available for use against 
gastrointestinal infections, such as mitomycin C or quinolones, can induce bacterial 
SOS responses and trigger additional Stx expression and therefore an enhanced risk 
of HUS (Karch et al., 2012, Kimmitt et al., 1999). The O104:H4 outbreak strain 
demonstrates increased Stx2 production in response to ciprofloxacin (Bielaszewska 
et al., 2012). While supportive rehydration therapy is currently used for confirmed 
infections by Stx-producing E. coli, new therapeutics in development include 
monoclonal antibodies against the toxin itself (Melton-Celsa and O'Brien, 2014).   
However, as with most bacterial pathogens the issue of developing antibiotic 
resistance must be considered. While susceptibility patterns naturally vary by 
geographic region, high levels of resistance in EAEC have been reported for a 
number of major antibiotics including ampicillin, tetracycline and chloramphenicol 
(Huang et al., 2006a). Multi-drug resistance is also on the rise in certain areas. For 
example, a study in rural South India found over 75% of isolated EAEC strains were 
resistant to more than 3 of a panel of common antimicrobial agents tested (Raju 
and Ballal, 2009). Recent screening of all DEC pathotypes (of which EAEC was most 
prevalent) isolated from children with diarrhoea in Nairobi, Kenya, found more than 
50% resistance to the following antibiotics: ampicillin, 
trimethoprim/sulfamethoxazole, streptomycin, gentamicin, kanamycin, 
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ciprofloxacin, chloramphenicol, and tetracycline (Nyanga et al., 2017). Antimicrobial 
resistance is also observed in asymptomatic carriage, with 56% of EAEC isolates 
from a healthy elderly population in China being positive for extended spectrum 
beta-lactamases (Wang et al., 2015). It has been proposed that resistance has 
grown most rapidly in enteric pathogens in areas such as South and South-East Asia 
due to poorer control of antimicrobial use. The availability of antibiotics for self-
treatment for symptoms such as diarrhoea without a prescription or medical 
consultation is likely a driving factor (Nguyen et al., 2005). 
Some research has been performed into alternative therapies for EAEC infection. 
Some of the most interesting findings have been reported for the effect of the 
antimicrobial protein lactoferrin. In general, lactoferrin exhibits antibacterial 
activity by sequestering iron to inhibit the growth of microorganisms, as well as 
disrupting the outer membrane of Gram-negative bacteria by inducing the release 
of LPS (González-Chávez et al., 2009). In vitro, lactoferrin has been shown to inhibit 
EAEC adherence to HEp-2 cells and biofilm formation, via disruption of AAF binding 
(Ochoa et al., 2006). In addition, a clinical trial of Japanese children given lactoferrin 
supplements found a significant reduction in vomiting and diarrhoeal illness 
without any effect on Rotavirus incidence, suggesting a protective effect against 
bacterial enteric pathogens in general (Egashira et al., 2007). The inclusion of 
recombinant human lactoferrin and lysozyme in oral rehydration therapy during a 
study of Peruvian children caused a significant decrease in diarrhoea duration and 
relapse (Zavaleta et al., 2007). It is unclear if supplements such as lactoferrin could 
be viable alternatives in antimicrobial therapy against virulent EAEC, but growing 
evidence suggests a beneficial effect during enteric disease.  
Bacteriophage therapy has been proposed as an alternative to antibiotic usage. 
Such treatments are currently applied in areas of Eastern Europe and Russia, yet 
their effectiveness remains unconfirmed in the wider medical community 
(Sulakvelidze et al., 2001). Bacteriophages specific for an EAEC strain reduced 
biofilm formation on abiotic surfaces and were able to infect bacterial aggregates 
on epithelial cells and persist in murine intestines (Maura et al., 2012). It has also 
been proposed that candidate bacteriophages could be selected rapidly from 
existing libraries as a response to outbreaks such as the 2011 O104:H4 event 
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(Merabishvili et al., 2012). Research is expanding for phage therapy to target E. coli 
pathogens, although in vivo animal studies and clinical trials for intestinal infections 
have demonstrated only modest effects (Bolocan et al., 2016). Bacteriophages able 
to lyse EHEC O157:H7 in vitro improved clearance of the bacteria in a murine 
model, but caused only a limited reduction of colonisation in cattle and no effect in 
sheep (Sheng et al., 2006). Furthermore, a randomised clinical trial of phage 
therapy (including a commercial Russian coliphage product) for microbiologically 
diagnosed E. coli diarrhoea, mostly ETEC and EAEC, observed no improvement in 
clinical outcomes including diarrhoea duration, stool frequency, and vomiting 
(Sarker et al., 2016). As such, the applicability of bacteriophage therapy for clinical 
EAEC cases remains undetermined. 
The heterogeneity of DEC has hindered the development of effective vaccines. 
However, recent progress has been made using major colonisation factors as 
antigens which could confer protection against the majority of virulent ETEC strains 
(von Mentzer et al., 2014). Although EAEC has a particularly high degree of 
heterogeneity, it has been proposed that similar approaches could also be effective 
for this pathotype. One potential option is exploiting the adhesins specific to EAEC, 
as incorporating all of the AAF family adhesins as antigens could be successful 
against many (but not all) virulent strains (Boisen et al., 2008). The dispersin protein 
involved in epithelial dispersal of adhesins is also highly immunogenic and well 
conserved, and has therefore been suggested as a possible vaccine candidate 
(Nataro et al., 1995, Huang et al., 2006a, Karam et al., 2017). Other research has 
identified protective antigens from the core E. coli genome, such as the outer-
membrane protein YncE, which could be used in combination with pathotype-
specific antigens for future vaccine development against DEC (Moriel et al., 2016).     
 
1.5: Mechanisms of EAEC virulence 
The pathogenesis of EAEC is likely variable, reflecting the heterogeneity of the 
pathotype. However, the generally accepted course of infection can be summarised 
by the following stages: Adherence to the intestinal epithelium, colony expansion 
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and biofilm formation, toxin-induced epithelial damage and host inflammatory 
response (Figure 1.6).  
Due to the exceptional aggregative properties of EAEC, it is proposed that initial 
epithelial adherence is enhanced by auto-aggregation of bacteria in the gut lumen 
which benefits initial colony establishment (Hebbelstrup Jensen et al., 2014). 
Aggregative adherence at the mucosal surface is multi-factorial and includes a 
number of adhesins and other putative virulence factors. Once EAEC colonisation is 
established, the secretion of bacterial toxins and other serine protease 
autotransporters of Enterobacteriaceae (SPATEs) induces tissue damage and 
immunological host responses (Kaur et al., 2010). Inflammation is also a key factor 
of symptomatic infection and is triggered by host-pathogen interactions including 
toxins and flagella (Kong et al., 2015, Harrington et al., 2005). In chronic infections 
associated with EAEC, it is suggested that dense biofilm formation contributes to 
the resistance to clearance by the immune system and subsequent persistent 
diarrhoea (Weintraub, 2007).  
 
 
Figure 1.6 Stages of EAEC pathogenesis. 1. Agglutination of bacteria in the lumen. 2. 
Aggregative adherence to the mucosal surface. 3. Colony expansion and biofilm formation. 
4. Release of toxins causing tissue damage and inflammation, resulting in diarrhoeal 
symptoms. 5. In persistent cases, establishment of additional biofilm and resistance to 
clearing by immune responses (Hebbelstrup Jensen et al., 2014). 
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Many putative virulence factors have been described for pathogenic EAEC. A key 
feature of “typical” EAEC strains is the aggregative adherence plasmid (pAA) which 
encodes many of the virulence factors associated with the AA phenotype including 
the aggR transcriptional activator gene (Johnson and Nolan, 2009). The archetype 
of this virulence plasmid is that of prototype strain 042 (pAA2), but the pAA varies 
greatly between different EAEC strains in size (72-120 Kb) and genetic composition 
(Chaudhuri et al., 2010, Jonsson et al., 2017b). The AggR regulon (Figure 1.7) 
includes a set of virulence genes linked with EAEC pathogenesis, such as genes 
encoding AAFs, dispersin, and the toxin Pet (Dudley et al., 2006a, Cerna et al., 
2003). Most of the regulon is located on the pAA plasmid, although AggR also 
regulates genes located on chromosomal islands, such as pic (Morin et al., 2013). 
Some studies have found a positive association between AggR and acute diarrhoea 
and inflammation caused by EAEC (Jiang et al., 2002, Hebbelstrup Jensen et al., 
2017). 
 
Figure 1.7 AggR regulon on the pAA2 of EAEC 042. (Morin et al., 2013) 
 
While several virulence factors have been reported, many of these are only found in 
a minority of EAEC isolates. In this section, the proposed mechanisms for different 
aspects of EAEC pathogenesis will be reviewed, along with the associated virulence 
genes at each stage.      
 
1.5.1: Epithelial adherence 
One of the defining aspects of EAEC is the AA phenotype, as originally identified on 
cultured HEp-2 cells. This adherence is key for the initial colonisation of the 
intestinal mucosa and has been associated with a number of expressed adhesins. 
The major virulence factors responsible for AA are the aggregative adherence 
fimbriae (AAF) (Figure 1.8). These bundle-forming fimbriae were first identified in 
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the prototype strain 17-2; with this variant now termed AAF/I. Introduction of AAF/I 
into E. coli K12 strains successfully conferred an AA phenotype, demonstrating the 
importance of these fimbriae for EAEC adherence (Nataro et al., 1992). The 
frequently used prototype strain 042 was later found to express a distinct allele, 
AAF/II, which while functionally similar, includes a major pilin subunit with less than 
25% amino acid identity with that of AAF/I (Nataro et al., 1995, Harrington et al., 
2006). Subsequent research has increased the number of known AAF alleles to at 
least five, with a large degree of variation between the pilin subunits, but each 
EAEC strain typically only possesses a single allele (Dallman et al., 2014). Protein 
interaction studies have identified a number of potential host cell receptors for AAF 
attachment, which include fibronectin, laminin, collagen IV, and cytokeratin 8 
(Izquierdo et al., 2014b).  
The AAFs are related to the Dr family of fimbrial adhesins, which are important in 
UPEC and DAEC. Both groups of adhesins utilise usher and chaperone proteins with 
a high level of sequence conservation (Harrington et al., 2006). The AAF adhesins 
are encoded on the EAEC virulence plasmid pAA. However, while AAFs are 
important facilitators of the AA phenotype, many clinical EAEC isolates do not 
possess any known AAF alleles (Jonsson et al., 2015). In addition, a study using a 
rabbit infection model refuted that the pAA is absolutely required for in vivo 
colonisation by virulent EAEC, although this conclusion was based on tissue 
homogenates rather than direct evaluation of intestinal adherence (Munera et al., 
2014). While it is possible that further uncharacterized AAFs may be involved, other 
adhesins are also thought to play a role in EAEC adherence.  
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Figure 1.8 Electron micrograph of Aggregative Adherence Fimbriae connecting EAEC 
bacteria. The image shows EAEC strain 042, which expresses AAF/II. (Sheikh et al., 2002)  
 
A common adhesin in various pathogenic and commensal E. coli is the E. 
coli common pilus (ECP), associated with enhanced bacterial adherence to cultured 
epithelial cells in vitro (Rendón et al., 2007). ECP is conserved in the majority of 
EAEC strains, with a study of 130 EAEC isolates determining the ecpA gene to be 
present in 96% of strains. The same study demonstrated that loss of ecpA 
significantly reduced adherence in AAF-negative but not AAF-positive EAEC strains, 
such as 042 (Avelino et al., 2010). It has therefore been suggested that ECP could be 
an important mediator of AA in some of the many EAEC strains lacking AAF 
adhesins. 
Another common adhesin in Enterobacteriaceae is the type I fimbria (TIF), which 
plays an important role in the adherence of many commensal and pathogenic E. coli 
subtypes. It is encoded by the fim operon present in the majority of clinical EAEC 
isolates (Regua-Mangia et al., 2009). TIF knockouts and anti-TIF serum can inhibit 
the AA phenotype in vitro, suggesting TIF contribute to the adherence of EAEC 
strains (Moreira et al., 2003).  
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Alongside adhesins themselves, EAEC also express an additional virulence factor 
from the pAA plasmid which supports adherence. This is a 10.2-kDa protein termed 
anti-aggregation protein (Aap), now more commonly referred to as dispersin 
(Sheikh et al., 2002). Dispersin is non-covalently attached to the bacterial surface 
and associated with a greater dispersal of EAEC on epithelial surfaces. Structural 
studies suggest the protein binds to outer membrane LPS to mask its strong 
negative charge, allowing positively charged adhesins such as AAFs to effectively 
bind more distant sites and mediate the hyper-aggregative properties of EAEC, thus 
regulating the AA phenotype for optimal colonisation (Harrington et al., 2006, 
Velarde et al., 2007). Dispersin is exported to the bacterial surface by a specialized 
ABC transporter, encoded by the aat cluster also located on pAA (Nishi et al., 2003). 
Both dispersin and aat are well conserved in typical EAEC and have been used as 
markers for PCR-based identification of the pathotype (Jenkins et al., 2006). 
Agglutinins have also been described for EAEC, with the heat-resistant agglutinin 
(encoded by hra1) characterised in 042. While Hra1 conferred enhanced auto-
agglutination, biofilm formation and AA when expressed by laboratory E. coli 
strains, no effects were observed in 042 hra1 deletion mutants. As such, Hra1 has 
been described as an auto-adhesion factor as well as a putative accessory adhesin 
(Bhargava et al., 2009). Recently, a study demonstrated that a hyper-aggregative 
phenotype exhibited by dispersin mutants was due to an unmasking of Hra1, not 
AAF. However, all three factors were important for colonisation of a Caenorhabditis 
elegans infection model, highlighting the interplay of multiple factors in EAEC 
adherence (Blanton et al., 2018).  
While AAFs are specifically associated with EAEC and the AA phenotype, they are 
not expressed by all strains. It is apparent that AA is multi-factorial, which is 
connected to the genetic diversity of EAEC. In addition, many of the factors 
important for initial adherence also contribute to the development of biofilm. 
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1.5.2: Biofilm formation 
Following the establishment of aggregative adherence to the intestinal epithelium, 
the next stage of EAEC pathogenesis is the formation of a biofilm. It is well 
established that biofilms confer a number of advantages to colonising bacteria, 
such as resistance to antimicrobial agents including antibiotics and host factors 
(Costerton et al., 1999, Xu et al., 2000). Furthermore, the ability of EAEC to form 
thick, aggregating biofilms likely contributes to persistent infection and prolonged 
diarrhoea often seen in clinical cases, especially in infants (Kaur et al., 2010, Nataro 
and Kaper, 1998).  
Biofilm formation is a complex, multi-factorial process, but some factors have been 
identified as important for EAEC biofilms. In addition to their central role in 
aggregative adherence, AAF adhesins are also implicated in biofilm development 
(Berry et al., 2014). Biofilm formation by prototype strains 042 and 17-2 require 
expression of AAF (AAF/II and AAF/I, respectively), and non-pathogenic E. 
coli strains harbouring pAA constructs (containing AAF genes) are able to form 
biofilms (Sheikh et al., 2001). 
AAF expression is regulated by the transcriptional activator AggR, yet there is some 
disagreement as to the overall importance of AggR in biofilm formation. While 
some studies have observed no significant correlation between AggR and biofilms 
(Sheikh et al., 2002), others have suggested that AggR is strongly associated with 
the phenotype (Mohamed et al., 2007b). However, AAF can be regulated by other 
factors including Fis, a nucleoid-associated protein involved in growth-phase 
dependent regulation of EAEC genes (Morin et al., 2010, Rossiter et al., 2011). 
Deletion of fis results in loss of biofilm formation and disruption of AggR and AAF 
expression, which are restored by fis complementation. It has therefore been 
suggested that Fis mediates biofilm formation via AggR regulation of AAF biogenesis 
(Sheikh et al., 2001). Although less well characterised than fis, a similar role has 
been detected for the yafK gene (Kaur et al., 2010). Mutations in yafK significantly 
reduced expression of AAF genes, adherence, and generation of biofilms (Sheikh et 
al., 2001). 
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However, as with the AA phenotype, many EAEC isolates form biofilms without 
possessing AAF alleles, suggesting that other factors play important roles. One 
candidate gene is shf, first described on the pAA2 plasmid of prototype strain 042. 
Mutations of shf resulted in  significant disruption of biofilm formation, yet the 
bacteria retained an aggregative phenotype in liquid phase (Fujiyama et al., 2008). 
While the function of Shf is undetermined, the closest characterised homologue is 
the IcaB protein of pathogenic Staphylococcus epidermidis. IcaB mediates 
modifications of exopolysaccharides and promotes intercellular adhesion in 
bacterial biofilms (Vuong et al., 2004). The ECP adhesin, which has been proposed 
to contribute to AA in AAF-negative EAEC strains, is also a common factor 
associated with biofilm development by E. coli pathogens and commensals alike 
(Garnett et al., 2012).   
Other putative regulators of biofilm formation are related to a type III secretion 
system (T3SS) designated ETT2, encoded at the glyU locus on the chromosome of 
EAEC strain 042, with potential effectors reported at the selC locus. These include 
EilA, a homologue of a transcriptional regulator HilA from Salmonella enterica, and 
Air, a homologue of invasin from Yersinia. Mutations in either eilA or air reduced 
epithelial adherence and biofilm abundance (Sheikh et al., 2006). It is suggested 
that EilA regulates the co-expression of ETT2 and air, while air is predicted to 
encode an outer membrane protein with roles as an agglutinin and possible 
accessory adhesin contributing to biofilm formation (Kaur et al., 2010, Sheikh et al., 
2006).    
A further example of AggR-independent biofilm-promoting factors are type IV pili, 
which contribute to bacterial adherence and twitch-motility in Gram-negative 
pathogens (Donnenberg et al., 1992). Dudley et al. have previously described a 
clinical EAEC isolate lacking the AggR regulon and containing a plasmid-encoded 
type IV pilus, which mediated both adherence and biofilm formation (Dudley et al., 
2006a). Interestingly, up to 10 % of EAEC strains possessed similar pilus genes 
suggesting that type IV pili may be as prevalent as some AAF alleles. 
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1.5.3: Toxins and Serine Protease Autotransporters of 
Enterobacteriaceae (SPATEs) 
The clinical manifestations of EAEC infection are varied but usually include watery 
diarrhoea, occasionally with blood and mucus components, resulting from 
expression of enterotoxins and cytotoxins (Figure 1.9) (Harrington et al., 2006). 
While the 2011 German outbreak isolate gained notoriety due to the association 
between the acquired Shiga toxin and risk of HUS, the pathogenesis of typical EAEC 
strains involves other virulence factors (Karch et al., 2012). 
One enterotoxin that was discovered in EAEC strains is the plasmid-encoded toxin 
(Pet). It was originally isolated from the supernatant of outbreak strains in Mexico, 
and subsequently linked to cytotoxic effects on the mucosa of infected rats (Eslava 
et al., 1998). Moreover, infection of human colonic explants with prototype strain 
042 resulted in mucosal abnormalities such as crypt dilation and cell rounding, 
which were Pet-dependent (Henderson et al., 1999b). Pet is a class I SPATE, a family 
of extracellular proteases consisting of a C-terminal domain required for 
translocation through the outer membrane and an N-terminal functional domain 
with enzymatic activity (Dautin, 2010). The SPATE family appears to be important in 
EAEC, with two studies respectively reporting 94.5% and 80% of typical strains 
contained genes for at least one SPATE (Boisen et al., 2009, Andrade et al., 2017). 
Studies suggest that following export by the autotransporter pathway, Pet is 
internalised by epithelial cells and degrades the structural protein fodrin (Boisen et 
al., 2009, Canizalez-Roman and Navarro-García, 2003). This causes cytoskeletal 
disruption, resulting in detachment, rounding and/or cell death (Betancourt-
Sanchez and Navarro-Garcia, 2009). Expression of Pet is regulated by AggR, and 
there is also evidence that the transcriptional factors CRP and Fis act as co-
activators for the toxin (Rossiter et al., 2011). While the activity of Pet is likely a 
contributing factor to EAEC pathogenesis, it is only found in a minority of strains, 
with studies reporting prevalence rates between 4.3% and 19.2%  (Harrington et al., 
2006, Andrade et al., 2017, Vila et al., 2000, Boisen et al., 2009).  
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Figure 1.9 Targets of EAEC toxins and SPATEs contributing to tissue damage and 
inflammation (Estrada-Garcia et al., 2014) 
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Another SPATE cytotoxin linked to EAEC pathogenesis is the secreted 
autotransporter toxin (Sat), originally described in UPEC. Similar to Pet, Sat is only 
present in some EAEC strains, but has been detected in isolates from children with 
diarrhoea (Mendez-Arancibia et al., 2008). While it is absent in 042, Sat is one of 
the toxins expressed by the prototype strain 17-2 (Boisen et al., 2009). It has been 
proposed that Sat and Pet are functionally homologous, with similar proteolytic 
specificity for spectrin-like proteins and the epithelial cytoskeleton (Maroncle et al., 
2006, Lievin-Le Moal et al., 2011). Other putative SPATE cytotoxins identified in a 
smaller proportion of EAEC strains, such as SigA and EspP, are typically associated 
with virulence of EHEC and Shigella flexneri (Boisen et al., 2009, In et al., 2013, Al-
Hasani et al., 2009). 
The EAEC heat-stable toxin 1 (EAST-1) was originally identified as a distinct EAEC 
virulence factor but has subsequently been detected frequently in other DEC 
pathotypes and Salmonella species (Savarino et al., 1996, Paiva de Sousa and 
Dubreuil, 2001). As with most EAEC-associated virulence factors, EAST-1 is not 
conserved in all strains, but is a common toxin and present in both 042 and 17-2 
(Savarino et al., 1996, Nataro et al., 1995). Encoded by the astA gene, EAST-1 has 
been significantly associated with diarrhoea in case studies (Zamboni et al., 2004, 
Pereira et al., 2007). EAST-1 has similarities to the heat-stable enterotoxin STa of 
ETEC, and is proposed to function in a comparable way via interference of cyclic 
GMP signalling resulting in anion secretion and disrupted fluid homeostasis across 
the gut epithelium (Menard et al., 2004, Harrington et al., 2006). Although 
inconclusive in a mouse model, purified EAST-1 toxin causes sustained anion 
secretion from T84 cells and a secretory response in a rabbit ileal mucosa model 
(Savarino et al., 1991, Veilleux et al., 2008). 
Some other putative virulence factors of EAEC are more commonly associated with 
other DEC. These include haemolysins, pore-forming cytotoxins associated with 
epithelial cell death in culture (Chaudhuri et al., 2010). One of these is α-
haemolysin which is normally found in UPEC, but has been identified in some EAEC 
strains including 17-2 (Suzart et al., 2001). Prototype strain 042 expresses 
haemolysin E (encoded by hlyE), also known as cytolysin A (Chaudhuri et al., 2010). 
A role for HlyE in EAEC pathogenesis has not yet been determined, but the protein 
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forms a dodecameric transmembrane pore and is cytotoxic to cultured mammalian 
cells (Mueller et al., 2009). HlyE is prevalent in DEC but also found in non-
pathogenic bacteria, so its importance for disease is uncertain (Navarro-Garcia and 
Elias, 2011). It is also unclear whether cytolethal distending toxin (Cdt) is a virulence 
factor of EAEC. While it is an important inducer of epithelial apoptosis for some DEC 
types such as EPEC, Cdt has only rarely been found in EAEC isolates (Albert et al., 
1996, Mendez-Arancibia et al., 2008). Some studies have identified no Cdt-positive 
strains at all from clinical EAEC collections, suggesting that it is more important in 
EPEC than EAEC (Suzart et al., 2001, Patzi-Vargas et al., 2015). 
Many EAEC strains possess a pair of virulence factors originating from Shigella 
flexneri. The first of these is a putative oligomeric toxin referred to as Shigella 
enterotoxin 1 (ShET1), which has been found in a range of EAEC isolates including 
042 (Zamboni et al., 2004, Villaseca et al., 2005, Chaudhuri et al., 2010). ShET1 has 
been previously associated with intestinal fluid secretion using a rabbit model and 
is a possible contributor to the watery diarrhoea phenotype (Fasano et al., 1997, 
Schroeder and Hilbi, 2008). The mechanism for this effect is unclear as the 
enterotoxin does not affect predicted secretion mediators such as cAMP, cGMP and 
Ca2+. However, a role in nitric oxide signalling has been suggested (Fasano et al., 
1997, Harrington et al., 2006, Andrade et al., 2017). 
The genes for ShET1 (setA and setB) are part of the same locus as another virulence 
factor, named ‘protein involved in colonization’ ( ic). Unusually, ShET1 is encoded 
completely within the pic gene on the opposite strand, so both factors are always 
present together. While not considered a cytotoxin, Pic has been characterised as a 
SPATE with potentially diverse biological functions (Henderson et al., 1999a). Pic 
exhibits mucinolytic activity which might promote penetration of the mucus layer 
and bacterial colonisation  (Harrington et al., 2009). A putative role in resistance to 
complement proteins via Pic protease activity has also been proposed, but has not 
been well characterised (Henderson et al., 1999a). More recently, an additional 
secretagogue activity has been reported, as Pic was shown to induce intestinal 
mucus hypersecretion which may contribute to biofilm production and mucoid 
diarrhoea (Navarro-Garcia et al., 2010). Pic is relatively well conserved in EAEC, with 
a recent study determining it to be the most prevalent SPATE (present in 47% of 
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strains) in a clinical EAEC collection (Andrade et al., 2017). In a study of children in 
Peru, Pic was the only virulence factor out of 18 examined, which was statistically 
associated with diarrhoea (both acute and persistent), suggesting this SPATE is 
important for EAEC infection (Durand et al., 2016).  
 
1.5.4: Inflammation   
Intestinal inflammation is implicated as a contributory factor in EAEC diarrhoea, and 
case studies have frequently identified pro-inflammatory markers in patient stools, 
including lactoferrin and the cytokines interleukin (IL)-8 and IL-1β (Greenberg et al., 
2002, Steiner et al., 1998). This effect can also be replicated in vitro, with EAEC 
strains inducing IL-8 release from Caco-2 cells. This was reported as the first 
example of an adherent, non-invasive pathogen causing cytokine release from 
intestinal epithelial cells (Steiner et al., 1998). The flagellin of EAEC strain 042 has 
been shown to stimulate IL-8 secretion via binding of Toll-like receptor 5 and 
activation of mitogen-activated protein kinases such as ERK-1/2, JNK and p38MAPK 
(Steiner et al., 2000, Khan et al., 2010).  
In addition to flagellin, AAF/II induces IL-8 release from T84 intestinal epithelial cells 
infected with EAEC 042 (Harrington et al., 2005). This further highlights the central 
role of AAFs throughout EAEC pathogenesis, including adhesion, biofilm formation 
and pro-inflammatory response (Boll et al., 2012, Harrington et al., 2005). The 
inflammatory response characterised by IL-8 release leads to transepithelial 
migration of polymorphonuclear neutrophils as demonstrated by experiments in 
vitro and using a human intestinal xenograft mouse model  (Boll et al., 2012). The 
AAF adhesins have also been implicated in inducing epithelial barrier dysfunction 
through disruption of tight junction components such as occludin and claudin-1 
(Strauman et al., 2010). This may aid the translocation of neutrophils, with resulting 
epithelial damage from innate immune response activity or induced apoptosis 
suggested to contribute to diarrhoeal illness in some EAEC cases (Boll et al., 2012). 
In addition, studies using an EAEC mouse model observed an increased goblet cell 
concentration and mucus depletion following infection (Roche et al., 2010). This 
suggests an interaction between EAEC and goblet cells during the local response to 
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the pathogen, and may contribute to the manifestation of mucoid diarrhoea of 
some clinical cases (Hebbelstrup Jensen et al., 2014).  
As well as inflammatory infectious diarrhoea during symptomatic infection, EAEC 
has been associated with prolonged subclinical inflammation. For example, in the 
MAL-ED study of over 2000 infants in low-resource settings, EAEC infection was 
associated with intestinal inflammation but not diarrhoeal symptoms (Rogawski et 
al., 2017). A recent study of enteric dysfunction in slum-dwelling children in 
Bangladesh determined that EAEC infection causes enhanced faecal levels of 
myeloperoxidase, a marker for intestinal inflammation and permeability (Fahim et 
al., 2018). It is possible that even in the absence of diarrhoea, EAEC colonisation can 
induce an inflammatory response with negative clinical outcomes such as 
malnutrition.  
 
1.6: Influence of oxygen on bacterial virulence 
Many enteric pathogens use different chemical signals in the intestinal 
environment to regulate virulence gene expression. Oxygen concentration has been 
shown to modulate the virulence of many bacterial pathogens in the GIT (Marteyn 
et al., 2011). The availability of oxygen varies greatly throughout the gut, with 
intestinal bacteria exposed to fluctuating conditions (Figure 1.10). Overall, there is a 
decreasing oxygen gradient along the length of the GIT as oxygen consumed with 
air during swallowing is diffused into the mucosal tissue or depleted by bacterial 
respiration. Non-invasive measurements in a live murine model determined a 
transition from approximately 7% oxygen in the stomach, to less than 0.5% in the 
distal colon (He et al., 1999).  
However, there is also a radial oxygen gradient within the GIT. Due to oxygen 
diffusion from capillary blood supply across the intestinal epithelium, there is a 
steep increase in oxygen concentration relative to proximity to the mucosal surface 
(Albenberg et al., 2014). This is greatest in the small intestine, which has a superior 
mesenteric arterial blood supply than the colon. While the central lumen can be 
near to anoxic (< 0.1% oxygen), oxygen levels at the base of the villi are as high as 
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10-13% In the colon, the oxygen concentration at the mucosal surface is 
approximately 4-5% (Espey, 2013). 
 
Figure 1.10 Environmental gradients in the human gastrointestinal tract. Adapted from 
(Pereira and Berry, 2017)  
 
 
59 
 
These differences in oxygen microenvironment have implications for the 
segregation of the intestinal microbiota. For example, the luminal gradient may act 
as a signal for aerotaxis of oxygen-tolerant bacteria into the mucus later, and an 
increase in oxygen diffusion during inflammation has been implicated in the bloom 
of potentially harmful facultative anaerobes associated with inflammatory bowel 
disease (Albenberg et al., 2014, Winter et al., 2013). The ability to adapt to 
fluctuations in oxygen availability is important for E. coli colonisation of the 
intestine. E. coli colonisation in mouse models requires both functional aerobic (AE) 
and anaerobic (AN) respiration, reflecting the variable oxygen levels encountered in 
the GIT of mammals (Jones et al., 2007). Oxygen gradients also modulate the 
direction of E. coli motility, and trigger fast nonmotile to motile transitions, with 
motility often associated with bacterial virulence (Douarche et al., 2009, Josenhans 
and Suerbaum, 2002) 
Oxygen availability has been recognised as an important environmental signal for 
the modulation of virulence in several enteric pathogens. For example, Salmonella 
Typhimurium demonstrates increased host cell adherence and invasion at low 
oxygen concentrations (Marteyn et al., 2011). In addition, the FNR transcriptional 
regulator (involved in sensing of low oxygen environments) is required for full 
virulence of Salmonella in a murine model, and modifies expression of a T3SS 
required for pathogenesis (Fink et al., 2007). Microaerobic (MA) and AN growth 
of Vibrio cholerae enhances biofilm formation and expression of the Toxin co-
regulated pilus virulence factor important for adherence (Marrero et al., 2009). A 
paper from 2010 elegantly described an oxygen-dependant virulence regulation 
system in Shigella flexneri: While an AN environment similar to that of the intestinal 
lumen enhances expression of a T3SS essential for cell invasion and virulence, it 
also causes an FNR-regulated suppression of effector protein secretion. Therefore, 
effector proteins accumulate within the bacterial cell until the suppression is 
removed by the oxygen gradient encountered in proximity to the mucosal surface, 
thereby restricting full T3SS activity to the precise site of action (Marteyn et al., 
2010). 
A similar role for oxygen sensing has been demonstrated in EHEC, where MA 
conditions enhanced maturation of the T3SS and adherence to polarized human 
60 
 
colon carcinoma cells (Ando et al., 2007, Schüller and Phillips, 2010, Carlson-
Banning and Sperandio, 2016). The expression of Sfp adhesion fimbriae by sorbitol-
fermenting EHEC O157:NM strains is also dependent on low oxygen tension 
(Müsken et al., 2008). However, there is currently a lack of research regarding the 
influence of oxygen on EAEC virulence. 
 
1.7: Model systems for studying EAEC pathogenesis 
1.7.1: EAEC prototype strains 
Due to the great variety of EAEC, it is difficult to perform experimental studies 
which are representative of the whole pathotype. As a result, a few prototype 
strains have been frequently used in previous EAEC research as examples of typical 
EAEC. The most common prototype strain is 042, which was isolated from a case of 
infant diarrhoea in Lima, Peru in 1983 (Nataro et al., 1985). A major reason for the 
popularity of 042 was the adult volunteer study performed by Nataro et al. in 1995 
where volunteers were fed 1010 colony forming units (CFU) of different EAEC 
isolates. While strains 17-2, JM221, and 34b failed to elicit any symptomatic 
response, strain 042 caused diarrhoea in 3 out of 5 adults, including one case of 
persistent diarrhoea over 7 days (Nataro et al., 1995). As a result of this, 042 
subsequently became established as the major prototype strain for studying EAEC 
pathogenesis (Chaudhuri et al., 2010). However, the small size of the study groups 
(5 individuals per strain) limits the conclusions that can safely be made from this 
result. Additionally, the volunteers were given a gastric neutralisation treatment 
before inoculation to promote live bacteria reaching the gut, which in combination 
with the relatively large dose introduces further uncertainty regarding the true 
virulence of 042 (Nataro et al., 1995). It is possible that the focus on 042 may have 
caused a bias for subsequent attempts to identify different host factors important 
for EAEC-induced disease, as genes present in this strain have received greater 
research interest (Hebbelstrup Jensen et al., 2014). 
Many EAEC virulence factors have been first identified in 042 including the 
archetypical pAA plasmid encoding AggR and dispersin (Sheikh et al., 2002, Morin et 
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al., 2013, Dudley et al., 2006b),the SPATEs Pic and Pet (Eslava et al., 1998, 
Henderson et al., 1999a), and the AAF/II fimbriae (Jonsson et al., 2017a, Czeczulin 
et al., 1997). In addition, the complete genome sequence of 042 was the first 
published for an EAEC strain (Chaudhuri et al., 2010). 
Another EAEC prototype strain is 17-2 which was isolated during a study of infants 
with diarrhoea in Santiago, Chile in 1988 (Vial et al., 1988). Notably, it was in 17-2 
that the first AAF variant (AAF/I) was identified in 1992. In that same study, 17-2 
was given to 19 adult volunteers, of which only one subject experienced diarrhoea 
(Nataro et al., 1992). The same dose was used as in the 1995 volunteer study, 
where 17-2 caused no diarrhoea in a group of 5 subjects (Nataro et al., 1995). In 
this project, both 042 and 17-2 have been used as EAEC prototype strains. This 
allows the interpretation of the results in the context of previous findings with two 
common reference strains expressing AAF/I and AAF/II  
 
1.7.2: In vitro models 
Cell culture has been used extensively for the study of virulence mechanisms in 
gastrointestinal pathogens including DEC (Langerholc et al., 2011). An important 
cell type within EAEC research is the HEp-2 cell line, due to the importance of the 
AA phenotype on HEp-2 cells as the gold standard for identification of the 
pathotype (Cravioto et al., 1991). However, HEp-2 cells were originally established 
from an epidermoid carcinoma of the larynx, but have since been contaminated by 
the cervical carcinoma cell line HeLa  (Lacroix, 2008). Therefore, they are not an 
ideal model for the intestinal epithelium and the specific study of host-pathogen 
interactions, aside from assays of general adherence and aggregation properties.  
Two commonly used cell lines in this field are T84 and Caco-2. Both are derived 
from human colon carcinomas, yet display key differences in structure and function 
(Devriese et al., 2017). Caco-2 cells undergo spontaneous differentiation upon 
confluency to gain features reminiscent of small intestinal enterocytes. These 
include an apical brush border of microvilli comparable to that of  small bowel 
epithelium (Figure 1.11), and increased expression of enterocyte-specific surface 
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enzymes (including sucrase, maltase, lactase, alkaline phosphatase, gamma-
glutamyltransferase, aminopeptidase N, and dipeptidyl-dipeptidase IV) (Jumarie 
and Malo, 1991). In contrast, differentiated T84 cells resemble colonocytes, 
including a brush border of shorter irregular microvilli. T84 cells also express 
colonocyte-specific differentiation markers such as monocarboxylate transporter 1, 
and demonstrate a dose-dependent response to butyrate indicative of the 
colonocyte cell type (Devriese et al., 2017). In this project, T84 and Caco-2 cells 
have been utilised as in vitro models of the colonic and small intestinal epithelium, 
respectively. 
 
 
Figure 1.11 Brush border microvilli of T84 and Caco-2 cells. Transmission electron 
microscopy reveals that Caco-2 cells express longer microvilli on the apical cell surface. 
(Devriese et al., 2017)  
 
Both Caco-2 and T84 have been used in previous EAEC research. For example, 
Nataro et al. demonstrated that T84 cells are a suitable model for EAEC 
pathogenesis due to a strong adherence of prototype strain 042 and observations 
of cytotoxicity induced by infection, which agreed with findings from ex vivo 
infections of human intestinal biopsies (Nataro et al., 1996). Caco-2 cells have been 
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used as model for intestinal colonisation by EAEC strains including 17-2, as well as 
demonstrating the induction of IL-8 release by epithelial cells in response to EAEC 
infection (Couto et al., 2007, Steiner et al., 1998, Steiner et al., 2000). Other human 
intestinal epithelial cell lines have been utilised in studies of EAEC pathogenesis. For 
example, HT29, a colon adenocarcinoma cell line, has been used to investigate 
EAEC adherence factors and the cytoskeletal effects of the Pet toxin (Navarro-
García et al., 1999, Dudley et al., 2006a). Induction of IL-8 secretion by EAEC 
infection was demonstrated using cultured INT-407 cells, which were derived from 
an embryonic intestinal epithelium but, as with HEp-2, is now understood to be a 
HeLa-contaminated cell line (Khan et al., 2010).  
In order to model the epithelial barrier, intestinal carcinoma cells can be cultured in 
conditions which promote cell polarisation. This allows the establishment of tight 
junctions which separate the apical and basolateral membrane, and results in a 
difference in membrane protein distribution between the two sides. Polarised cell 
culture can be performed using Transwell or Snapwell inserts, whereby intestinal 
epithelial cells are seeded onto a permeable membrane (often pre-coated with 
collagen for enhanced cell attachment) suspended in culture plate wells. When 
maintained at high cell density with frequent exchanges of culture media, the 
monolayers develop a columnar morphology and demonstrate high epithelial 
barrier function. Polarised T84 cells have been frequently used to study bacterial 
adherence, IL-8 release, and tight junction integrity during EAEC infection 
(Strauman et al., 2010, Harrington et al., 2005, Farfan et al., 2008). Polarised Caco-2 
cells have been used along with T84 cells to compare adherence properties of 
prototype 042 to clinical EAEC isolates (Abe et al., 2001).   
An in vitro model system called the vertical diffusion chamber (VDC) can be used in 
combination with polarised intestinal epithelial cells to simulate separate apical and 
basal conditions (Figure 1.12). The VDC is a dual compartment system similar to an 
Ussing chamber, with each side connected to independent gas flow inputs. By 
perfusing with either AE or AN gas mixture, cell culture media can be maintained in 
AE or MA conditions, respectively. When a polarised monolayer of intestinal 
epithelial cells is inserted between the compartments, an AE basal side can support 
the eukaryotic cells (mimicking oxygen supply from the blood) while the apical side 
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is inoculated with bacteria under the experimental conditions of interest. This 
allows for bacterial infection assays including control of conditions such as oxygen 
concentration which is not possible with standard in vitro cell culture models 
(Schüller and Phillips, 2010).  
 
 
Figure 1.12 Vertical diffusion chamber apparatus. The two half chambers can be separated 
by a polarised intestinal epithelial cell monolayer for infections (A) or connected as one 
chamber for incubations of bacteria only (B). (C) Experimental setup of 12 independent 
chambers attached to a gas supply and mounted onto heating blocks. A and B adapted 
from (Tran et al., 2014)  
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The VDC system has been previously used to study interactions of EHEC with 
polarised T84 cells, and has demonstrated that MA conditions enhance EHEC T3S, 
adherence, and Shiga toxin translocation across the epithelium  (Schüller and 
Phillips, 2010, Tran et al., 2014, Tran et al., 2018). The VDC system was first 
developed using polarised Caco-2 cells to study Helicobacter pylori infection under 
low oxygen conditions (Cottet et al., 2002). It has also been used to demonstrate 
enhanced Campylobacter jejuni invasion of polarised Caco-2 cells during MA 
incubation (Mills et al., 2012). Clostridioides difficile strains induce an enhanced 
cytokine response from polarised T84 cells under AN VDC conditions (Jafari et al., 
2016, Anonye et al., 2018). However, to my knowledge the VDC model system has 
not previously been applied for the study of EAEC virulence mechanisms. 
 
1.7.3: Ex vivo models 
In vitro experiments with intestinal epithelial cells can be a practical and effective 
model for studying host-pathogen interactions. However, this approach has 
limitations such as that the monoculture of a single cell type does not replicate the 
complex structure of intestinal mucosal tissue and lacks important physiological 
features such as the mucus layer. Also, most cell lines are derived from cancer cells 
which exhibit a different metabolism and gene expression pattern compared to 
healthy tissue (Rajan et al., 2018). Therefore, primary cells and tissues are being 
increasingly used to study host-microbe interactions. 
Recent emerging models are the human intestinal organoid, derived from 
embryonic or pluripotent stem cells, and colonoids or enteroids, generated from 
adult stem cells by isolating intestinal crypts (from the colon and small intestine, 
respectively) (Hill and Spence, 2017). Using growth-factor enriched media, it is 
possible to grow three-dimensional “mini-intestines” with an epithelial layer 
containing all major intestinal cell types (enterocytes, goblet cells, Paneth cells and 
endocrine cells)  (Poole et al., 2018, Sato et al., 2011). These have been proposed as 
a promising new model for host-pathogen interaction studies, and have been used 
for research with pathogens including Salmonella species, Clostridioides difficile, 
and Rotavirus (Sun, 2017, Forbester et al., 2015, Zachos et al., 2016). Infection of 
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human colonoids with EHEC resulted in actin network remodelling and tight 
junction disruption which was mediated by the serine protease EspP (In et al., 
2014).  
In addition, EAEC adherence (prototypical strain 042 and clinical isolates from 
diarrheal cases) has been examined in human enteroids derived from different 
regions of the human intestine, showing colonisation of duodenal, ileal and colonic 
tissue, but very little adherence to jejunal enteroids. This suggests that EAEC strains 
may have adapted for greater adherence to specific niches in the GIT. Donor-
dependent differences were also reported, suggesting that host susceptibility is an 
important factor in EAEC colonisation (Rajan et al., 2018). While the technology is 
still developing, intestinal organoids may be a useful model for future study of EAEC 
and other enteric pathogens. 
An ex vivo model which has a longer history of use for studying EAEC pathogenesis 
is in vitro organ culture (IVOC) of endoscopic mucosal intestinal biopsy samples. In 
brief, intestinal epithelial biopsies are obtained from consenting donors undergoing 
endoscopy procedures. These samples can then be maintained in a specific IVOC 
medium for infection assays with bacteria, which contains both cell culture (DMEM) 
and tissue culture (NCTC-135) media and newborn calf serum to support tissue 
survival in vitro (Figure 1.13) (Fang et al., 2013).  
IVOC studies with EAEC have previously revealed novel details regarding infection 
of the human GIT by the pathotype. One such finding is an apparent intestinal 
tissue tropism of greater colonisation of the colon than the small intestine by 
prototype EAEC strains. For example, 042 has previously demonstrated a greater 
than ten-fold higher colonisation of colonic than small bowel mucosa, as 
enumerated by scanning electron microscopy analysis (Nataro et al., 1996). Higher 
levels of adherence to colonic biopsies compared to the ileum and jejunum have 
also been reported for prototype strains 17-2 and JM221 and EAEC isolates from 
infant diarrhoea cases (Hicks et al., 1996). Another IVOC study of 44 clinical EAEC 
isolates observed consistent colonisation to colonic tissue for all strains, which was 
absent for experiments with duodenal biopsies (Knutton et al., 1992).  
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IVOC of duodenal biopsies inoculated with clinical EAEC isolates from paediatric 
diarrhoeal cases in India demonstrated a significant IL-8 response mediated by toll-
like receptor-5 activation (Gupta et al., 2016). This is evidence to support previous 
results from cell culture assays (Steiner et al., 2000), representing a pro-
inflammatory response to EAEC by ex vivo epithelial tissue as well as cells in 
monoculture. EAEC has also been associated with an induction of mucus secretion 
by the intestinal epithelium, including experiments with an in vivo Rat model where 
mucus hypersecretion was dependent on the Pic protein (Navarro-Garcia et al., 
2010). This is supported by IVOC findings where mucus accumulation and emptying 
of goblet cells were observed following EAEC infection (Nataro et al., 1996, Hicks et 
al., 1996). 
Previous studies have also investigated potential cytotoxic effects of EAEC infection 
using IVOC, although findings are inconsistent. Some studies report no mucosal 
abnormalities following infection, in comparison to non-infected control tissue 
(Knutton et al., 1992). However, others have observed indicators of tissue 
pathology including dilated crypt openings and increased cell rounding and 
extrusion (Nataro et al., 1996, Hicks et al., 1996) or possible microvillous 
effacement (Andrade et al., 2011). Such changes in tissue structure have been 
proposed as evidence of cytotoxicity linked to known EAEC toxins such as EAST1 
and HlyE, yet this has not been demonstrated experimentally (Hicks et al., 1996). 
The uncertainty between different IVOC studies may be linked to the heterogeneity 
of the different EAEC clinical and prototype strains that were used, or aspects of 
host susceptibility in different donor populations. A further confounding factor may 
be inconsistency in the definition of “abnormal” tissue appearance between 
investigators performing qualitative microscopical analysis. 
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Figure 1.13 In vitro organ culture. (A) Experimental set-up for the incubation of a biopsy 
tissue sample with EAEC in a culture plate well. (B) Representative image of a colonic crypt 
(blue) with adherent EAEC (red) using the IVOC model. (False-coloured scanning electron 
micrograph; generated in this study) 
 
As human tissue is difficult to obtain, IVOC has also been performed using animal 
tissue. For example, Braga et al. demonstrated that EAEC isolates from infant 
diarrhoeal cases in Brazil displayed greater adherence to rabbit colonic mucosa 
than ileal mucosa (Braga et al., 2017). Previous studies have also used rabbit ileal 
tissue in combination with an Ussing chamber to elucidate the enterotoxigenic 
effect of the EAST-1 toxin (Savarino et al., 1991, Savarino et al., 1993). Similarly, the 
cytotoxicity of the EAEC Pet toxin has been demonstrated using rat jejunal tissue 
mounted in a Ussing chamber (Henderson et al., 1999b). 
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IVOC is a powerful experimental model as it allows the study of host-pathogen 
interactions using native intestinal tissue with representative structure and 
complexity (Fang et al., 2013). However, there are practical limitations to the 
model, not least the availability of human tissue samples and variability of results 
due to different donor backgrounds. Furthermore, maintenance of tissue samples 
requires high oxygenation to delay ischemia and cell death, thereby preventing 
studies of EAEC infection under physiologically relevant low oxygen tension. Even 
under high oxygen pressure, the tissue can only be cultured for a limited time 
without deterioration (typically 4 to 24 hours), preventing investigation of long-
term pathogenic effects (Benam et al., 2015, Law et al., 2013, Schüller et al., 2004).  
 
1.7.4: Animal models 
In vivo model systems are required to study enteric pathogenesis in a complex 
intestinal environment by taking into account the influence of an active immune 
system, interactions with the host microbiota, and the specific physical and 
chemical environment of the gut (Law et al., 2013). Animal models also allow to 
study  long-term effects of bacterial infection, which is especially important for 
pathogens associated with chronic disease and outcomes such as malnutrition 
(Weintraub, 2007). However, in vivo studies are time and labour-intensive, 
alongside disadvantages regarding cost and the difficulties of biological 
containment of live animals for research with pathogenic strains. The complexity of 
animal models also limits the study of specific host-pathogen interactions (Benam 
et al., 2015). Another major obstacle is that pathogens adapted to the human host, 
such as EAEC and EPEC, often do not produce disease in animals (Law et al., 2013, 
Philipson et al., 2013).  
Some of the earliest in vivo experiments of EAEC infection used a ligated intestinal 
loop model (Figure 1.14). This allows the incubation of bacteria within a confined 
intestinal section in a live animal, and the surgical removal of the affected tissue 
and fluids for analysis. Injection of rabbit and rat ileal loops with EAEC produced 
adherent colonies, as well as limb paralysis and fatal complications in some rabbits 
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suggesting toxin production by EAEC and contributing to the characterisation of the 
Pet cytotoxin (Vial et al., 1988, Navarro-García et al., 1999).  
 
 
Figure 1.14 Ligated ileal loop model. Ligated ileal segments are injected with live bacteria 
or purified toxin for different time periods, before excision and analysis of tissue pathology. 
These are representative images of the model, in this case showing how the activity of the 
cholera toxin secreted by Vibrio cholerae (not EAEC) causes increasing fluid accumulation 
within murine ileal segments over time. Adapted from (Sawasvirojwong et al., 2013). 
 
As EAEC is strongly associated with disease in infant and paediatric populations, 
neonatal and weanling mouse models have been developed. These also have a 
limited microbiota providing less colonisation resistance and immature immune 
systems, so are more susceptible to infection by pathogens (Roche et al., 2010). 
Neonatal mice challenged with EAEC displayed growth shortfalls dependent on 
bacterial dose, as well as stool shedding and histological tissue changes such as 
inflammatory damage and increased goblet cell density. However, infected adult 
mice did not demonstrate sustained stool shedding or weight loss, suggesting that 
the murine model replicates the increased vulnerability of infants to EAEC infection 
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reported in human epidemiological studies (Huang et al., 2006b). Interestingly, 
when a protein-poor diet was fed to weaned mice, EAEC-infected animals displayed 
impaired growth and increased stool shedding, which correlates with previous 
associations of clinical EAEC disease with malnourishment (Rogawski et al., 2017). 
However, a limitation of this model is a lack of symptomatic disease including 
diarrhoea.  
Other murine models use microbiota depletion or genetic immunodeficiency to 
increase susceptibility of adult mice to bacterial infection. Adult mice treated with 
streptomycin for 48 hours prior to challenge were reliably colonised with EAEC at 
higher levels than untreated controls. Gastric neutralisation was also performed 
before oral inoculation to increase viable bacteria reaching the intestines. This 
model was used for in vivo competition assays which demonstrated the importance 
of dispersin and Pic for EAEC colonisation (Harrington et al., 2009). A similar murine 
model was utilised to investigate the role of the transcriptional regulators AggR and 
Fis in EAEC infection (Morin et al., 2010). However, while this model allows EAEC 
colonisation in adult mice, the infection does not induce clinical symptoms or 
histopathological abnormalities, and therefore poorly reflects human inflammation 
and disease (Philipson et al., 2013).  
In addition, human intestinal xenografts in mice have been used to study EAEC 
infection. Human foetal intestinal tissue was implanted in severe-combined 
immunodeficient mice, and EAEC were inoculated intraluminally. Evaluation of 
tissue damage and transepithelial migration of polymorphonuclear neutrophils 
following infection with wild-type or mutant strains revealed that both depended 
on functional AAF expression (Boll et al., 2012). However, this approach is limited 
by the availability of foetal tissue samples as well as an inherently abnormal 
immune response. 
Currently one of the best animal models reflecting EAEC infection in humans are 
gnotobiotic piglets. Germ-free 24-hour-old piglets challenged with EAEC 
demonstrated AA to the intestinal epithelium, severe diarrhoea and even mortality 
in some cases (Tzipori et al., 1992). However, the piglet model is limited by the cost 
and poor scalability compared to rodent models, as well as a lack of large animal 
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biosafety level 2 research facilities and genetic manipulation tools in pigs. As such, 
the gnotobiotic piglet model has not been widely used in EAEC research despite the 
promising initial studies. More recently, germ-free piglets were used to compare 
the virulence of the O104:H4 German outbreak strain against EHEC O157:H7, with 
the former strain unexpectedly causing only mild symptoms and no systemic 
disease (Wöchtl et al., 2017). This contrasts with the severe disease outcomes in 
humans during the 2011 outbreak, demonstrating the difference in EAEC virulence 
even in an animal model with a well-established similarity in gastrointestinal 
physiology and the immune system (Philipson et al., 2013). 
Animal models are important for understanding pathogenesis in a complete 
intestinal system, yet are currently lacking for EAEC research due to limitations in 
replicating human symptomatic disease and immunological responses for a host-
specific pathotype. The development of new in vivo models, or the refinement of 
existing approaches, may be necessary for the study of EAEC virulence in the future. 
 
1.8: Summary 
EAEC is an important global enteric pathogen, particularly associated with children, 
travellers, and the immunocompromised. It is also a causative agent of foodborne 
outbreaks worldwide and highly prevalent in diarrhoeal cases. Epithelial 
colonisation is mediated by AA, which remains the gold standard phenotype for 
EAEC diagnosis, although in practice PCR is now almost exclusively used for 
identification. However, AA is a multi-factorial phenotype, and EAEC strains are 
highly heterogenous in genetic background and virulence.  Many putative virulence 
factors characterised to date are only present in a minority of strains and their 
importance in EAEC pathogenesis remains uncertain. Additional research using 
physiologically relevant infection models is needed to identify the factors and 
mechanisms which define EAEC pathogenesis and lead to the identification of 
reliable markers for the pathogenic subpopulations of this heterogenous E. coli 
pathotype. 
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1.9: Aim, hypotheses and objectives of this study 
The overarching aim of this PhD project was to determine the underlying factors of 
EAEC pathogenicity in humans. The hypotheses underlying this work were that: 
 Intestinal environmental signals such as oxygen concentration and host 
epithelial interactions modulate expression of EAEC virulence factors. 
 Different subgroups of EAEC demonstrate phenotypic and genotypic differences 
which relate to differences in pathogenicity. 
These have been investigated by addressing the following objectives: 
A. Establish relevant human intestinal model systems to investigate EAEC 
virulence.  
B. Determine the influence of intestinal environmental factors (low oxygen levels 
and host cell adherence) on the expression of putative EAEC virulence genes. 
C. Compare phenotypic virulence traits (adherence and biofilm formation) and 
virulence gene profiles of EAEC isolates from sequence types associated with 
disease (ST40) and asymptomatic carriage (ST31). 
Objectives A and B are addressed in Chapter 3, and objective C in Chapter 4. 
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Chapter 2 Materials & Methods 
 
CHAPTER TWO 
MATERIALS AND METHODS 
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2.1: Bacterial strains and growth conditions 
A full list of the wild-type E. coli strains used for this study is provided in Table 2.1. 
In addition, two 042 mutant strains were obtained from Douglas Browning 
(University of Birmingham): a knockout mutant of aggR and a re-complemented 
strain with aggR expressed on a pBAD30 plasmid (Sheikh et al., 2002, Sheikh et al., 
2001). All experimental handling of viable EAEC strains was performed at 
containment level 2 throughout the project.  
Frozen bacterial stocks were prepared by dilution of 700 μL of overnight cultures 
(ONC; in Luria Bertani Lennox (LB) broth at 37 °C) with 300 μL sterile 50% glycerol 
(Thermo Fisher Scientific) in distilled deionised water (ddH2O) and stored in 
cryotubes (Sarstedt) at -80 °C. Bacteria from glycerol stocks were subsequently 
streaked out with a sterile pipette tip on LB-agar plates, incubated overnight at 37 
°C, and stored for up to 1 month at 4 °C. Bacteria were passaged no more than 3 
times before reversion to glycerol stocks to prevent accumulation of mutations. For 
infections, bacteria were inoculated from agar plates and grown as standing ONC in 
2 mL LB broth at 37 °C. Antibiotic selection was used for culture of mutant strains. 
ONC of 042 ΔaggR contained 50 μg/mL kanamycin, while 042 ΔaggR pBAD30::aggR 
was selected with a combination of 50 μg/mL kanamycin and 100 μg/mL ampicillin. 
 
Strain Disease case or 
asymptomatic 
control 
MLST  
Sequence 
Type 
Clinical 
Source 
Year Country 
Prototypes (a)      
042 Case 31 N/A 1985 Peru 
17-2 Case 10 N/A 1994 Chile 
Clinical 
isolates (b) 
     
E099975 Control 31 IID1 1994 UK 
E103617 Case 31 IID1 1994 UK 
E104931 Control 31 IID1 1994 UK 
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E104940 Control 31 IID1 1994 UK 
E104946 Case 31 IID1 1994 UK 
E104967 Case 31 IID1 1994 UK 
E104969 Control 31 IID1 1994 UK 
E107526 Case 31 IID1 1994 UK 
E107759 Control 40 IID1 1995 UK 
E109907 Control 40 IID1 1995 UK 
1091 Case 40 IID2 2008 UK 
1337 Case 40 IID2 2008 UK 
146052 Case 40 Sporadic 2015 UK 
153145 Case 40 Sporadic 2015 UK 
221654 Case 40 Sporadic 2016 UK 
232736 Case 40 Sporadic 2016 UK 
Table 2.1 EAEC Strains used in this study. The prototype strains were originally isolated in 
previous studies (Nataro et al., 1985, Vial et al., 1988). The clinical isolate collection 
contains strains from two previous UK infectious intestinal disease studies (IID1 and IID2) 
and sporadic cases collected through Public Health England surveillance (Chattaway et al., 
2014b). 
 
2.2: Cell culture 
2.2.1: Resurrection of cell lines 
Cell line stocks prepared in cell culture medium containing 5% dimethyl sulfoxide 
(Sigma) were kept in liquid nitrogen storage (vapour phase, -190 °C) for long term 
preservation. To initiate cultures from frozen stocks, cells were rapidly thawed by 
partial submersion of the cryotube in warm water. The cell suspension was 
transferred into 5 mL of pre-warmed cell culture medium, and centrifuged at 100 x 
g for 7 min (Eppendorf 5810-R) to remove residual dimethyl sulphoxide. The 
supernatant was discarded, and cell pellet resuspended in 7 mL culture medium 
and transferred to a 25 cm2 culture flask.  
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2.2.2: Culture conditions and passaging of cell lines 
The human colon carcinoma cell line Caco-2 (ATCC HTB-37) and cervix 
carcinoma/HeLa contaminated cell line HEp-2 (ATCC CCL-23) were grown in 
Dulbecco’s Modified Eagle’s Medium with high glucose (DMEM; Sigma D5671) 
supplemented with 1x non-essential amino acids, 10% foetal bovine serum and 4 
mM L- glutamine (Sigma). The human colon carcinoma cell line T84 (ATCC CCL-248) 
was cultured in DMEM/F-12 (Sigma D4621), supplemented with 10% foetal bovine 
serum and 2.5 mM L-glutamine.  
Cells were grown in 25 cm2 culture flasks (Sarstedt) and maintained at 37 °C in a 5% 
CO2 atmosphere. All media used for routine cell culture was warmed to 37 °C prior 
to use. Cells were used for experiments within a window of approximately 15-20 
passages before culture was restarted from liquid nitrogen stocks. Cells were 
routinely grown to confluence before passage and/or seeding for experiments. 
When confluent, the cell culture medium was removed from the flask and the cell 
layer washed once with sterile phosphate buffered saline (PBS), and once with 
approximately 0.5 mL of 0.25% trypsin-0.02% ethylenediaminetetraacetic acid 
(EDTA) solution (Sigma). A further 0.5 mL of the trypsin solution was applied, and 
the cells incubated at 37 °C until cell detachment from the flask was observed. An 
incubation time of 5-10 min was required for detachment of Caco-2 and Hep-2 
cells, and 15-30 min was required for T84 cell detachment. The cells were 
vigorously resuspended in 4.5 mL of culture medium to deactivate the trypsin, and 
then transferred to new culture flasks at a suitable dilution ratio. To maintain a 
passage approximately every 7 days, standard dilution ratios used were: 1:10 for 
Caco-2, 1:5 for T84, 1:10 for Hep-2 (relative to concentration before passage). 
 
2.2.3: Determination of cell counts and seeding for infection assays 
Cells were seeded for experimental use during the passaging process. Following 
trypsinisation and thorough resuspension of detached cells, 50 μL of cell suspension 
was diluted 1:1 with trypan blue solution (Sigma) and loaded into a Neubauer 
haemocytometer (Hawksley; depth 0.1 mm) for cell counting. Viable cells 
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(distinguishable by exclusion of blue stain) were counted under an inverted light 
microscope (Zeiss Invertoskop ID03), with the cell concentration (cell per mL) 
determined as the average count of two haemocytometer fields multiplied by 104. 
The volume of cell suspension required for seeding was calculated as: 
Seeding volume (mL) = total number of cells required / cell concentration (cells per mL) 
This volume was then diluted to the required volume of culture medium for 
seeding. 
For standard infection experiments in 24-well plates (Sarstedt), cells were seeded 
onto sterile circular coverslips (13 mm diameter, Academy Science Products) for 
staining and microscopy, or directly onto well surfaces for all other infection assays. 
To achieve confluence in 7 days, cells were seeded at a density of 1.5 x 105 cells/mL 
for T84, 1.2 x 105 cells/mL for Caco-2, and 1.0 x 105 cells/mL for HEp-2 cells. Well 
plates were cultured at 37 °C in a 5% CO2 atmosphere until confluency, and the 
culture medium was exchanged the day before infection. 
 
2.2.4: Simulated Intestinal Media 
Simulated ileal environment medium (SIEM) and simulated colonic environment 
medium (SCEM) were prepared according to previously published compositions 
(Table 2.2) (Polzin et al., 2013, Müsken et al., 2008). The media were autoclaved to 
ensure sterility, except for the D-glucose which was added from a 20x stock solution 
using filter-sterilisation. Media were adjusted to pH 7.0 using a Corning-240 pH 
meter. For SIEM, pancreatin from porcine pancreas (Sigma) instead of the individual 
specified digestive enzymes (α-amylase, lipase, trypsin, and chymotrypsin) was 
added to SIEM aliquots immediately before use to prevent loss of enzymatic activity 
during storage of stock solutions. 
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Simulated ileal environment medium Simulated colonic environment medium 
Bacto tryptone 5.7 g/L Bacto tryptone  6.25 g/L 
D-glucose 2.4 g/L D-glucose  2.6g/L 
NaCl 6.14 g/L NaCl 0.88 g/L 
KH2PO4 0.68 g/L KH2PO4 0.43 g/L 
NaHCO3 1.01 g/L NaHCO3 1.7 g/L 
NaH2PO4 0.3 g/L KHCO3   2.7 g/L 
Bile salts #3 (cholic and 
deoxycholic acid) 
5.6 g/L Bile salts #3 (cholic and 
deoxycholic acid) 
4.0 g/L 
Pancreatin (8 x USP) 1% (w/v)   
Table 2.2 Composition of simulated intestinal media Adapted from (Polzin et al., 2013, 
Müsken et al., 2008). 
 
2.2.5: Determination of cell viability  
The viability of T84 or Caco-2 cells following exposure to different culture 
conditions was evaluated using Trypan Blue staining (Sigma). Cells were washed 
with PBS, and a 50% solution of Trypan Blue stain in PBS was added. The cells were 
examined under an inverted light microscope (Zeiss Invertoskop ID03). Cell viability 
was assessed by evaluating dye exclusion, with the amount of non-stained (viable) 
cells compared to stained (dead) cells.  
 
2.2.6: Culture of polarised cells in Transwells and Snapwells 
For infection assays requiring a polarised cell monolayer, cells were seeded onto 
either Transwell or Snapwell permeable filter inserts (12 mm diameter, 0.4 μm pore 
polyester membrane; Corning Costar) at a density of 5 x 105 cells/insert for T84 and 
2 x 105 cells/insert for Caco-2 cells. Prior to seeding, the inserts were collagen 
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coated to aid cell polarisation. Lyophilized rat tail collagen type I (Sigma) was 
dissolved in 0.1 M acetic acid and used to prepare a working solution of 50 μg/mL 
collagen in 60% ethanol in ddH2O. 200 μL were added to each insert and left under 
sterile condition until all liquid had evaporated.   
From day 4 after seeding, the culture medium was exchanged every 2 days to 
prevent acidification. At each medium exchange, the transepithelial electrical 
resistance (TEER) of the cell monolayers was measured to monitor polarisation. 
TEER was determined using an EVOM2 resistance meter with an STX2 electrode 
applied for Transwells, and an Endohm-24SNAP electrode for Snapwells (WPI). A 
stable TEER of greater than 1000 Ω × cm2 for T84 and 500 Ω × cm
2
 for Caco-2 cells 
indicated full differentiation and was typically reached after 10-14 days of growth. 
To reduce the risk of contamination during repeated medium changes and TEER 
measurements, the culture medium for Transwells and Snapwells was 
supplemented with 100U/mL penicillin and 0.1 mg/mL streptomycin (Sigma). 
Antibiotics were removed the day before infection.   
 
2.3: Vertical diffusion chamber 
Snapwells inserts with polarised monolayers of T84 cells were inserted between the 
apical and basal compartments of a vertical diffusion chamber (VDC) (Figure 2.1; 
Harvard Apparatus). Each compartment was filled with 4 mL of pre-warmed non-
supplemented DMEM/F-12, and chambers were mounted in a heating block pre-
warmed to 37 °C by a circulating water bath (Grant Instruments). Each half-
chamber was connected to a gas manifold supplying AE (5% CO2 in air) or AN (5% 
CO2, 5% H2, 90% N2) gas mixture; perfusion providing an AE or MA culture medium 
condition. After a 30 min equilibration period, the apical compartment was 
inoculated with 1x107 EAEC, and incubated for 2-6 hours. At the end of the assay, 
apical media and T84 monolayers were harvested for further analysis. The 
disassembled chambers were sterilised between experiments by submersion in 
Presept Effervescent Disinfectant (Advanced Sterilization Products) for at least 1 
hour. 
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Figure 2.1 Diagram of vertical diffusion chamber incorporating a polarised T84 cell 
monolayer. Image modified from (Tran et al., 2014). 
 
For assays without T84 cells, an empty Snapwell insert (filter removed) was used to 
connect both compartments of the chamber, and apical and basal compartments 
were gassed with the same AE or AN gas mixture (Figure 2.2). The total volume of 8 
ml of culture medium was inoculated with 2x107 EAEC. 
 
 
Figure 2.2 Diagram of vertical diffusion chamber with connected compartments without 
T84 cells. Image modified from (Tran et al., 2014). 
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The concentration of oxygen over time within the VDC was evaluated using an ISO2 
isolated dissolved oxygen meter and oxygen electrode (WPI) inserted into the 
media. Bacterial growth within chambers was measured by determining optical 
density at 600 nm of 500 µL aliquots of media using a spectrophotometer (Uvikon 
XS, NorthStar Scientific Ltd.). 
 
2.4: Quantification of bacterial adherence  
Confluent monolayers of T84 or Caco-2 cells were grown in a 24-well plate, and 
wells were inoculated with 10 µL (≈1x107 CFU) ONC of EAEC isolates. The plate was 
incubated at 37 °C in a 5% CO2 atmosphere for 2-5 hours. At the end of infection, 
the cell layer was washed with sterile PBS three times to remove non-adherent 
bacteria. Cells were lysed in 1% Triton X-100 in PBS for 10 min, and serial dilutions 
of lysates in sterile PBS were plated on LB agar plates. In addition, serial dilutions of 
the inoculum were plated. Agar plates were incubated at 37 °C overnight, and CFU 
were counted the following day. Counts of bacterial adherence were normalised 
against the inoculum concentration. 
Adherence assays were also performed using the VDC system. Infection of polarised 
T84 cells was set up as previously described (section 2.3). A two-stage incubation 
was used, whereby chambers were incubated for either 2 hours, or 4 hours with 
media exchanged after 2 hours to reduce bacterial density. After removal from the 
chambers, the Snapwells were washed three times with PBS and bacterial 
adherence was determined as described above.  
 
2.5: Transwell assay for cell contact dependence  
An experiment was designed to determine if the influence of T84 cells on EAEC 
virulence gene expression required physical contact or proximity to secreted 
factors. T84 cells were grown to confluence in a 12-well culture plate. Infection 
assays were performed with 10 µL (≈1x107 CFU) EAEC inoculated from ONC in 3 
conditions: directly into wells with a confluent T84 monolayer, into Transwell 
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inserts in wells containing only DMEM/F-12 media, or into Transwell inserts 
separated from a T84 monolayer by the permeable membrane (Figure 2.3). The 
plate was incubated for 3 hours at 37 °C in a 5% CO2 atmosphere, and bacteria were 
then harvested for gene expression analysis.  
 
 
Figure 2.3 Diagram of conditions used for cell contact dependence assay. (A) EAEC were 
incubated for 3 hours in culture wells with confluent T84 cells, and adherent and non-
adherent bacteria were harvested separately. (B) EAEC were harvested after incubation 
within a Transwell insert without T84 cells. (C) EAEC were harvested after incubation within 
a Transwell insert in wells containing confluent T84 cells. 
 
2.6: In vitro organ culture of human intestinal biopsy tissue 
2.6.1: Ethical approval and sample collection 
This study was performed under ethical approval from the University of East Anglia 
Faculty of Medicine and Health ethics committee (ref 2010/11-030), with biopsies 
collected through the Norwich Biorepository (National Ethics Service approval; ref 
08/h0304/85+5). All samples were obtained from patients recruited via the 
Gastroenterology Department of the Norfolk and Norwich University Hospital. 
Patients were undergoing routine colonoscopy for investigation of GI related 
symptoms or as part of the NHS bowel cancer screening programme. Informed 
written consent was obtained prior to donation of samples, using The Norwich 
Biorepository Consent Form v.15 (Appendix 2). Patients were excluded from the 
study if they met any of the following criteria: diagnosis of inflammatory bowel 
disease, infection with Human Immunodeficiency Virus or Hepatitis B virus, 
medication with blood thinning drugs. 
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Up to 8 biopsies were collected from an individual patient, with the tissue removed 
using an endoscope grasp capture forceps operated by a medically trained 
endoscopist. Biopsies were only collected from regions without macroscopic 
pathologies. Samples were collected from the second part of the duodenum (upper 
endoscopy) or from the terminal ileum, transverse colon, or sigmoid colon 
(colonoscopy). Upon removal, samples were immediately transferred into IVOC 
medium, transported to the laboratory, and processed within an hour. 
 
2.6.2: Culture and infection of biopsies 
Biopsies were cultured in IVOC medium, prepared from a solution of NCTC-135 
(0.94 g), sodium bicarbonate (0.22 g), and D-(+)-mannose (1 g) in 90 mL ddH2O (all 
Sigma). This solution was filter sterilised with a 0.45 μm syringe filter (Sartorius 
Stedim), and added to 90 mL DMEM and 20 mL newborn calf serum (Sigma) in a 
sterile glass bottle. IVOC medium was stored at 4 °C, and small aliquots in plastic 
bijoux (Ramboldi) taken to the hospital for transport of collected samples. 
IVOC of intestinal biopsies was performed as previously by Knutton et al. (Knutton 
et al., 1987), with some modifications. Biopsies were initially examined for size and 
quality under a dissecting microscope (Zeiss Stem SV8), and where necessary 
dissected into pieces of approximately 5 mm2 surface area. Samples were 
orientated with the mucosal side facing upwards onto foam supports (Simport) in a 
12-well culture plate (Figure 2.4). Approximately 700 µL of IVOC medium was 
added to each well, and adjusted to saturate the foam support and allow only a thin 
film of medium to cover the biopsy without full submersion. Subsequently, 25 μL of 
EAEC ONC (2.5x107 CFU) or LB medium were applied directly to the mucosal surface 
of the biopsy. Samples were incubated on a rocking platform at 37 °C in a 5% CO2 
atmosphere for up to 8 hours. Media were exchanged at 4 and 6 hours post-
inoculation to prevent bacterial overgrowth and maintain the pH. Following 
infection, biopsies were transferred into PBS, washed twice by vigorous shaking to 
remove mucus and non-adherent bacteria, and processed for microscopic analysis.  
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Figure 2.4 In vitro organ culture (IVOC)  
 
2.7: Scanning Electron Microscopy 
2.7.1: Sample preparation 
Biopsy samples were fixed in 2.5% glutaraldehyde (Agar Scientific) in PBS overnight 
at 4 °C, washed twice in PBS, and dehydrated by sequential incubations in 30%, 
50%, 70%, 90%, and 100% (twice) acetone in ddH2O for 15 min on a rocker. The 
specimens were dried by a 10 min incubation in tetramethylsilane (Sigma) on a 
rocker and air-dried until evaporation of all residual liquid.  
Processed samples were mounted onto aluminium stubs (TAAB Laboratory 
Equipment Ltd.) using conducive silver paint (Agar Scientific). Biopsies were 
orientated under a dissecting microscope with the mucosal surface facing upwards. 
The samples were then transported to the Environmental Analysis Laboratory of 
the UEA School of Environmental Sciences, where they were sputter-coated with 
gold (Polaron SC7640, Quorum Technologies) and imaged with a JSM 4900 LV 
scanning electron microscope (JEOL). 
 
2.7.2: Semi-quantitative analysis of biopsy colonisation      
Bacterial colonisation of biopsies during IVOC was scored against a relative scale 
based on frequency and size of adhering EAEC colonies observed by SEM. Colony 
size and frequency were both scored on a scale of 0-4, and the additive value used 
as an overall colonisation score for each biopsy. A score of 0 indicated no observed 
adherent bacteria.  
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For colony size:  
1 = isolated bacteria or very small aggregates, < 10 bacteria 
2 = small defined colonies, approx. 10-100 bacteria 
3 = medium to large defined colonies, approx. 100-1000 
4 = very large colonies, approx. >1000 bacteria 
For colony frequency: 
1 = approx. <10 % colonised crypts 
2 = approx. 25 % colonised crypts 
3 = approx. 50 % colonised crypts 
4 = approx. >50 % colonised crypts 
 
2.8: Immunofluorescence staining 
Samples were fixed for immunostaining with 3.7% formaldehyde in PBS for 10-20 
min at RT (Acros Organics) or by incubation in ice-cold ethanol for 15 min. For 
occludin staining, samples were pre-extracted in ice-cold 0.05% Triton X-100 in PBS 
for 2 min (Sigma) before fixation. 
Fixed samples were blocked and permeabilised with 0.1% Triton X-100 and 0.5% 
bovine serum albumin (BSA) in PBS for 20 min (Sigma). Samples were incubated 
with primary antibodies (Table 2.3) diluted in 0.5% BSA in PBS for 1 hour at RT. The 
samples were washed in PBS for 10 min on a rocking platform, and subsequently 
incubated in Alexa Fluor 488 or 568-conjugated IgG (Life Technologies) for 30 min at 
RT in the dark. When a counterstain was required, DNA and filamentous actin were 
labelled with 4’,6-diamidino-2-phenylindole (DAPI; 1:5000, Roche) and fluorescein 
isothiocyanate-conjugated phalloidin (1:200, Sigma), respectively, for 20 min at RT. 
Samples were washed in PBS for a minimum of 30 min following the final antibody 
incubation, and mounted on glass microscopy slides (R & L Slaughter) in Vectashield 
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mountant (Vector Laboratories) to reduce photo-bleaching. Slides were stored at 4 
°C in the dark, and imaged with an Axio Imager 2 microscope (Zeiss). 
When performing immunofluorescence staining for bacteria from liquid culture, 10 
µL of sample was pipetted onto lysin-coated microscopy slides (Agar Scientific) 
inside an area encircled by liquid repellent slide-marker PAP pen (Sigma), and 
allowed to air dry. Samples were fixed and stained as described above. 
 
Primary 
antibody 
Animal 
source 
Dilution 
factor 
Incubation 
temperature 
Supplier 
Anti-E. coli  Goat 1:200 RT Abcam 
Anti-occludin Rabbit 1:10 On ice Life Technologies 
Table 2.3 Primary antibodies used for immunofluorescence staining 
 
2.9 Giemsa Staining 
Coverslips were washed with PBS and fixed using a 15 min incubation in 70% 
methanol at room temperature (RT). The samples were stained using 10% Giemsa 
Modified Solution (Sigma) in PBS for 20-30 min at RT.  The Giemsa solution was 
removed, and samples washed with dH2O to remove excess stain. Coverslips were 
air-dried and mounted onto slides using Depex mounting medium (VWR) or clear 
nail varnish. Samples were observed under bright field or phase-contrast 
illumination as appropriate (Axio Imager 2 microscope, Zeiss). 
 
2.10: Analysis of gene expression using quantitative reverse 
transcription PCR (qPCR) 
All following protocols for analysis of RNA and cDNA were performed using 
RNase/DNase-free tubes, pipette tips and reagents.   
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2.10.1: RNA stabilisation and differential lysis 
A 10% phenol-EtOH solution was prepared on ice (Sigma). Non-adherent bacteria in 
apical media were harvested and immediately mixed with phenol-EtOH solution to 
a 2% phenol final concentration, to deactivate biochemical reactions and preserve 
RNA. The samples were incubated for 30 min on ice, and centrifuged at 13000 rpm 
for 10 min at 4 °C (Eppendorf 5810-R). The supernatant was discarded, and cell 
pellets were snap-frozen on dry ice and stored at -80 °C. 
For RNA stabilisation of bacteria adhered to T84 cells in culture-plate wells or on 
Snapwell filters, cells were washed with DMEM/F-12 medium and incubated on ice 
with 2% phenol / 20% ethanol / 3% Triton X-100 in DNase/RNase free water for 30 
min to stabilise RNA and lyse the eukaryotic cells. Cells were detached by scraping 
with a pipette tip, and lysates were transferred to Eppendorf tubes. Bacterial 
pellets were collected by centrifugation (13000 rpm for 10 min at 4 °C), and snap-
frozen on dry ice and stored at -80 °C. 
 
2.10.2: RNA extraction 
Total RNA was extracted from bacterial samples using the RNeasy Mini Kit (Qiagen). 
Samples were thawed on ice and bacterial pellets resuspended in 50 mg/mL 
lysozyme in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and vortexed for 30 sec 
initially, followed by 10 sec of vortexing every min for 5 min. Samples were treated 
with 350 µL of RLT buffer supplemented with 3.5 µL β-mercaptoethanol (Sigma) 
and briefly vortexed, followed by the addition of 250 µL of ethanol. After transfer to 
a Qiagen spin column, RNA was isolated according to the manufacturer’s 
instructions for bacterial samples. Genomic DNA was removed by on-column 
digestion with RNase-free DNase I, following the manufacturer’s protocol (Qiagen). 
RNA was eluted in 30 µL of RNase-free water and stored at -20 °C prior to analysis 
and further processing.   
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2.10.3: Analysis of RNA quality and quantity 
RNA samples were evaluated using a NanoDrop spectrophotometer (ND-1000 & 
2000, Thermo Scientific). RNA concentration was determined from absorbance at 
260 nm. The absorbance ratios at 260/280 nm and 260/230 nm were used to assess 
protein and salt contamination, respectively.  
RNA integrity was evaluated using agarose gel electrophoresis (Figure 2.5). RNA 
samples were run on a 1.5% agarose gel in TBE buffer (10.8 g/L Tris, 5.5 g/L boric 
acid, 2 mM EDTA, pH 8.0, in dH2O; Sigma). Electrophoresis was performed at 100 V 
constant for 20 min, and the gel was stained with ethidium bromide solution (0.01% 
in dH2O) for 15 min on a rocking platform. RNA was visualised under UV light with a 
U:Genius gel imager (Syngene), and distinct bands for bacterial 16S and 23S 
ribosomal RNA were taken as an indicator for RNA integrity. 
 
 
Figure 2.5 Agarose gel electrophoresis of isolated bacterial RNA. Each column represents 
an individual sample.  
 
2.10.4: cDNA synthesis 
Sample RNA was converted to complementary DNA (cDNA) using qScript cDNA 
supermix (Quanta Biosciences). The reaction mix consisted of 4 µL of the supermix 
and a concentration-dependent volume containing 1 µg of RNA, made up to a total 
volume of 20 µL with RNase-free water. Synthesis of cDNA was performed 
according to the manufacturer’s instructions using a thermal cycler (Biometra 
Professional Trio). The cycling program was set as: 5 min at 25 °C, 30 min at 42 °C, 5 
min at 85 °C. The obtained cDNA sample was diluted with 20 µL sterile nanopure 
water and kept at 4 °C for short-term use or at -20 °C for long-term storage. 
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2.10.5: Primer design 
All primers used in this study were designed using publicly available EAEC gene 
sequences published on the NCBI GenBank database. The primer oligonucleotides 
were supplied by Sigma Genosys. The primers were designed using both the 
Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) and PrimerBLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) software, with accepted 
sequences requiring both software outputs to meet the following parameters: 
 Primer sequence length: 15-25 base pairs 
 Melting temperature (Tm): 58-63 °C 
 GC content: 20-80% 
 Self-complementarity score: < 8 
 Amplicon length: 60-150 base pairs 
 Amplicon GC content: < 60% 
 
Additionally, the primers were also evaluated for predicted formation of primer 
dimers or secondary structures. For each gene target, the Tm of forward and reverse 
primers did not differ more than 1 °C. The primers used in this study are detailed in 
Table 2.4. The lyophilised oligonucleotides were resuspended in RNase-free water 
at a stock concentration of 100 µM, aliquoted and stored at -20 °C. Working 
solutions for use in qPCR were prepared from 5 µL of both the forward and reverse 
primer 100 µM stock solutions in 90 µL sterile nanopure water. 
 
Gene Primer sequence (5’-3’) Tm (°C) GC % 
gyrA 
(housekeeper) 
CCGAAGTTACCCTGACCGTC 60.11 60 
GGTGACTCGGCGGTTTATGA 60.11 55 
mdoG 
(housekeeper) 
AATGCGTTGGTTGAGTGCTG 59.69 50 
CCCGGCTAAGGATTGAGCTT 59.82 55 
gapA 
(housekeeper) 
GGCTCCGCTGGCTAAAGTTA 60.11 55 
CCGCGCCAGTCTTTATGAGA 60.18 55 
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rpoB 
(housekeeper) 
GTGGTGAAACCGCATCTTTT 60 45 
CGATGTACTCAACCGGGACT 60 55 
aggR AATTCGGACAACTACAAGCATCT 58.42 39.13 
CAACAGCAAATCCATTTATCGCA 58.58 39.13 
pic AATGCCCTGTCACTTCCCAG 59.96 55 
TCGCTGAAAGACGCTGACTT 59.97 50 
hlyE GGCTATCTAACGCCAGCAGT 59.89 55 
GCATCCGCCCAGAAAGACAT 60.75 55 
aap CGGGTCCACATTATCTGCGT 60.18 55 
TGGCATCTTGGGTATCAGCC 59.82 55 
aafA ACACCGGCTACAAATCGTGA 59.68 50 
TTGACCGTGATTGCCTTCCC 60.61 55 
aggA GACAATCCGCCTCACCGTTA 60.11 55 
AGACCCTTGCACCGCTTTTA 59.89 50 
pet TGAACTCGATGGCCTTGACC 60.04 55 
CCGGACTCAAACATGGCAGA 60.32 55 
astA GACGGCTTTGTAGTCCTTCCA 60.00 52.38 
GAAGGCCCGCATCCAGTTAT 60.18 55 
cyoA CCAGACCACAGCTTCCACTT 59.82 50 
TTCCCGCAATCTTGATGGCT 59.75 55 
cydB ACACTGGTCTGTTTCGCACT 59.82 50 
GTGGGTTAGAGGCTGCGTAA 59.75 55 
Table 2.4 Primers designed and used in this study  
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2.10.6: qPCR  
The reaction for qPCR was prepared by mixing 1 µL of cDNA with 3 µL RNase-free 
water, 0.1 µL internal reference dye, 5 µL SYBR Green Jumpstart Taq ReadyMix 
(Sigma), and 1 µL of primer pair working solution (final primer concentration of 1 
µM). Two control samples were also prepared: A non-template control (NTC) with 
the cDNA replaced by water, and a reverse-transcription control (RTC) replacing 
cDNA with the equivalent amount of RNA had reverse-transcription not been 
performed (equivalent to 1/40 * volume containing 1 µg RNA). Samples were 
loaded in duplicate in a 96-well PCR plate (semi-skirt, Sarstedt) on ice, separated by 
a layer of cling film to prevent contact of the plate exterior with water or other 
contaminants. Plates were sealed with transparent sealing film (Sarstedt) and 
briefly centrifuged to ensure all reagents were collected at the well base (4000 rpm, 
1 min, Eppendorf 5810-R).  
The qPCR reaction was performed using the ABI 7500 real-time PCR system 
(Applied Biosystems), with the following cycling parameters: 
 
1. 1 cycle:  
a. 95 °C, 2 min – initial denaturation 
2. 40 cycles: 
a. 95 °C, 30 sec – denaturation  
b. 60 °C, 30 sec – annealing 
c. 72 °C, 35 sec – elongation (and SYBR signal data collection) 
3. 1 cycle: 
a. 72 °C, 5 min – extended elongation (if higher quantity of amplicons 
required for further analysis such as gel electrophoresis) 
4. 1 cycle: - dissociation curve analysis 
a. 95 °C, 15 sec 
b. 65 °C, 60 sec 
c. 95 °C, 15 sec 
d. 60 °C, 15 sec 
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At the end of the qPCR run, Taqman 7500 SDS software was used to set the 
absorbance value for the cycle threshold (CT) and to generate dissociation curves. 
 
2.10.7: Primer validation 
The amplification efficiency of the designed primer pairs was determined by 
amplifying a two-fold serial dilution of cDNA from samples known to be positive for 
the gene target. The CT values were log transformed and plotted against the 
dilution factor as a scatter graph. The gradient for each primer pair was used to 
calculate the primer efficiency according to the formula: 
Amplification efficiency (%) = (10(-1/gradient)) * 100 
The efficiency of each primer pair was evaluated, with minimal variation between 
primer pairs and proximity to 100% considered optimal. 
Primer specificity was confirmed by dissociation curve analysis during the qPCR run, 
with a single peak indicating a single amplification product. In addition, agarose gel 
electrophoresis confirmed the expected amplicon sizes. 
 
2.10.8: Relative quantification of gene expression (ΔΔCT method) 
Relative gene expression changes were calculated from q CR data using the ΔΔCT 
method (Livak and Schmittgen, 2001). CT values for each sample were normalised 
for total cDNA concentration by subtraction of the geometric mean CT value of two 
E. coli reference genes, glucans biosynthesis protein G (mdoG) and DNA gyrase 
(gyrA), to determine a normalised value referred to as ΔCT. The fold-expression 
change between two samples of interest can then be calculated from the difference 
in ΔCT between the treated sample and non-treated control sample, a value termed 
ΔΔCT, by the following formula: 
Fold-expression = 2-ΔΔCT 
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For quality control, the CT values for the RTC and NTC controls were assessed, and a 
CT difference of greater than 5 compared to cDNA sample values (equivalent to a 
32-fold difference in transcript abundance) was considered acceptable.    
 
2.11: Western Blot 
For quantification of protein expression, non-adherent bacteria were pelleted by 
centrifugation of culture media (4000 rpm, 10 min, Eppendorf 5810-R), whilst 
bacteria adherent to T84 cells were harvested by incubation of the cell monolayer 
for 20 min in ice-cold lysis buffer (50 mM HEPES pH 7.4, 50 mM NaCl, 1% Triton X-
100) containing protease inhibitor cocktail (1:200, Sigma). Non-adherent bacterial 
pellets were resuspended in 1x reducing sample buffer (RSB), while 5x RSB was 
added to lysates for a 1x final concentration (Table 2.5). Samples were heat 
denatured at 100 °C for 5 min and electrophoresed in 15% SDS-polyacrylamide gels 
in 1x running buffer using a Mini-PROTEAN Tetra Cell device (Bio-Rad) for 60 min at 
200 V, 50 mA, 10 W (Tables 2.5 & 2.6). Proteins were transferred to Polyvinylidene 
difluoride membranes (VWR) by wet-blotting at 100V constant for 60 min in 
blotting buffer (Table 2.5).  
All following incubations were performed on a rocking platform unless otherwise 
stated. The membranes were blocked in 5% skimmed milk powder in TBS/0.05% 
Tween-20 (TBST), at RT for 60 min. After a 10 min wash in TBST, membranes were 
incubated with primary antibody diluted in TBST overnight at 4 °C. Primary 
antibodies were rabbit anti-dispersin (1:5000; provided by Christopher Icke, 
University of Birmingham) and rabbit anti-AAF/I (1:2000, provided by Ulrich 
Dobrindt, University of Münster). After a TBST wash, blots were incubated with 
horseradish peroxidase-conjugated goat anti-rabbit IgG (1:200,000, Sigma) for 45 
min. A final 30 min wash with TBST was used to remove non-bound antibody. The 
membranes were developed using enhanced chemiluminescence reagents 
(Immobilon Western, Millipore) and imaged with a FluorChem E Imager 
(ProteinSimple). ImageJ Fiji software was used for densitometric analysis of imaged 
blots. 
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Reducing Sample Buffer (RSB)  
Glycerol  2.5 mL 
Sodium dodecyl sulphate (SDS) 0.5 g 
2M Tris pH 6.8  625 μL 
Dithiothreitol  0.39 g 
Bromophenol blue  5 mg 
dH2O  1.9 mL 
4x Stacking Gel Buffer (SGB) pH 6.8  
0.5M Tris 60.5 g/L 
SDS 0.4% 
4x Running Gel Buffer (RGB) pH 8.8  
1.5M Tris 181.6 g/L 
SDS 
 
0.4% 
10x Running Buffer pH 8.3  
0.25M Tris 30.3 g/L 
2M Glycine 144.0 g/L 
SDS 1% 
Blotting Buffer pH 8.8  
200mM Glycine  14.4 g/L 
25mM Tris 3.0 g/L 
TBS Tween 0.05%  
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5M NaCl 30 mL/L 
1M Tris pH 8.0 10 mL/L 
Tween-20 0.5 mL/L 
Table 2.5 Reagents for SDS-PAGE and Western Blotting 
 
 
Reagent Running gel (15%) Stacking gel (3%) 
4x RGB/SGB 2.5 mL 1.25 mL 
40% acrylamide/bis-aa 5.0 mL 500 µL 
dH2O 2.5 mL 3.2 mL 
10% Ammonium persulfate 50 µL 50 µL 
TEMED 10 µL 5 µL 
Table 2.6 Components for 15% SDS-polyacrylamide gel  
 
2.12: Biofilm formation assay 
EAEC ONCs in LB were diluted 1:100 in DMEM, mixed by vortexing, and 100 µL of 
culture was added to the wells of a 96-well microplate (Sigma). The plate was 
incubated at 37 °C in a 5% CO2 atmosphere for 48 hours. After removal of the 
medium, wells were washed twice with sterile water and stained with 0.1% crystal 
violet in water for 10 min (Sigma). Excess stain was removed with two washes in 
sterile water. Plates were left to air-dry, before 30% acetic acid in water was added 
to each well to solubilise the stain. The absorbance at 595 nm was measured using 
a Benchmark Plus microplate spectrophotometer, normalised against a blank well 
control (Bio-Rad).  
For imaging biofilm density, 10 µL of EAEC ONC was added to wells of a 24-well 
culture plate (Sigma) containing 1 mL DMEM and a sterile circular coverslip (13 mm 
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diameter, Academy Science Products). The plate was incubated at 37 °C in a 5% CO2 
atmosphere for 48 hours. The coverslips were washed twice with sterile water and 
stained with 0.1% crystal violet in water for 10 min as above. Excess stain was 
removed by washing with sterile water and coverslips air-dried before mounting to 
glass microscopy slides (R & L Slaughter) with Depex mounting medium (VWR) for 
bright field microscopy (Axio Imager 2 microscope, Zeiss). 
 
2.13: Sequencing and Bioinformatics 
All clinical isolates from ST40 and ST31 were sequenced using Illumina platforms. 
Sequencing was performed by Gemma Kay (John Wain group; University of East 
Anglia, Faculty of Medicine and Health) and the Genomic Servicing Unit and 
Gastrointestinal Bacteria Reference Unit (GBRU) at PHE. The genome of prototype 
EAEC strain 042 has previously been published (Chaudhuri et al., 2010). 
Many of the bioinformatic analyses were performed using tools accessed via the 
MRC Cloud Infrastructure for Microbial Bioinformatics (MRC CLIMB) platform 
(Connor et al., 2016). Determination of Multi-Locus Sequence Type (MLST) was 
achieved using the Short Read Sequence Typing 2 tool (SRST2; (Inouye et al., 2014)) 
and the Galaxy computational biology platform. SRST2 was also used for E. coli 
serotype prediction and virulence factor genotyping. Escherichia virulence gene 
sequences were obtained from the Virulence Factors of Bacterial Pathogens 
database (VFDB; http://www.mgc.ac.cn/cgi-bin/VFs/genus.cgi?Genus=Escherichia). 
Local Basic Local Alignment Search Tool (BLAST) analysis and in-silico PCR were 
performed using BioEdit and FastPCR, respectively (Kalendar et al., 2017, Hall, 
1999). Core genome alignment and single-nucleotide polymorphism (SNP) 
detection was performed using Parsnp (Treangen et al., 2014), and phylogenetic 
trees presented using Phandango (Hadfield et al., 2018). 
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2.14: Statistics  
GraphPad Prism Version 6 software was used for statistical analysis throughout this 
project. For the comparison of two groups, parametric student’s t-test was used for 
cell line experiments and the non-parametric Mann-Whitney test was used for 
experiments with biopsies. Parametric analysis of variance (ANOVA) was performed 
for comparison of three or more groups, with Dunnett’s multiple comparison test 
used for gene expression experiments. All gene expression data were log10 
transformed prior to statistical analysis. A P value of < 0.05 was considered 
significant, and degrees of statistical significance are presented as follows: * = P < 
0.05 ; ** = P < 0.01 ; *** = P < 0.001 ; **** = P < 0.0001. 
  
99 
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virulence gene expression 
CHAPTER THREE 
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modulate EAEC virulence gene 
expression 
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3.1: Introduction 
Essential virulence factors have not been established for EAEC pathogenesis, unlike 
other E. coli pathotypes; for example, the type III secretion system (T3SS) required 
for typical EHEC virulence (Schüller and Phillips, 2010, Kaper et al., 2004). However, 
many putative EAEC virulence factors have been identified, linked to different 
aspects of human intestinal infection. EAEC is associated with high levels of 
aggregation, including self-agglutination and on biological surfaces. The aggregative 
adherence (AA) pattern of EAEC on cultured HEp-2 cells is a defining phenotype of 
this pathotype and has been associated with a family of adhesins termed 
aggregative adherence fimbriae (AAF). Many, but not all, typical EAEC possess a 
single AAF allele, with five variants (AAF/I to AAF/V) identified so far (Jonsson et al., 
2015, Berry et al., 2014, Kaur et al., 2010). Other adhesins have been implicated in 
EAEC adherence, including a non-specific E. coli fimbria named the E. coli common 
pilus (ECP) (Avelino et al., 2010, Rendón et al., 2007). AA has also been connected 
to dispersin (encoded by aap), a small surface protein which is suggested to mask 
charge interactions between fimbriae and affect spatial organisation with 
neighbouring bacterial cells (Blanton et al., 2018, Sheikh et al., 2002). 
The symptomatic diarrhoea caused by EAEC infection is likely a result of tissue 
damage and inflammation induced by the expression of bacterial toxins. Two such 
virulence factors produced by some EAEC isolates are the pore-forming toxin 
haemolysin E (HlyE), and a heat-stable enterotoxin EAST-1 (encoded by astA) linked 
to disruption of cGMP signalling and anion secretion from epithelial cells (Navarro-
Garcia and Elias, 2011, Savarino et al., 1993). A serine protease autotransporter of 
Enterobacteriaceae (SPATE) called plasmid encoded toxin (Pet) has also been 
associated with EAEC virulence, causing spectrin cleavage and cytoskeletal 
disruption (Betancourt-Sanchez and Navarro-Garcia, 2009, Eslava et al., 1998). A 
further SPATE found in many EAEC isolates is the mucinase Pic, which has been 
linked to both mucin digestion and induction of mucus hypersecretion by intestinal 
cells (Harrington et al., 2009, Navarro-Garcia et al., 2010). Many of these described 
putative virulence genes are located on the EAEC virulence plasmid pAA, including 
astA, aap, pet, and the AAF-encoding genes. The pAA plasmid also encodes a 
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transcriptional activator AggR, which regulates multiple virulence genes located on 
the pAA plasmid and the bacterial chromosome (Morin et al., 2013).  
One obstacle to further understanding the mechanisms underlying EAEC 
pathogenesis is a lack of suitable in vivo models. Previous animal models used to 
investigate EAEC infection include gnotobiotic piglets, and infant, antibiotic-treated, 
or immunocompromised (genetically or through nutritional restriction) mice. The 
piglet model is limited by scalability, cost and availability of large animal biosafety 
level 2 facilities, while the murine models do not replicate aspects of clinical human 
disease including overt diarrhoea (Philipson et al., 2013). As such, most EAEC 
studies rely on in vitro infection models. Human intestinal epithelial cell lines such 
as T84 and Caco-2 have been utilised for investigating bacterial interactions with 
the host epithelium. However, there remains some uncertainty regarding the ability 
of prototype EAEC strains to colonise these cell lines. Strain 042 has shown effective 
colonisation of T84 cells but poor adherence to Caco-2 (Nataro et al., 1996, 
Strauman et al., 2010), while 17-2 has been reported to colonise Caco-2 cells but 
has not been studied using the T84 cell line (Steiner et al., 1998, Couto et al., 2007). 
In addition, previous studies have used in vitro organ culture of human intestinal 
biopsies which demonstrated EAEC adherence to small intestinal and colonic 
epithelium. However, the extent of colonisation of specific strains and biopsy sites 
has differed between studies (Knutton et al., 1992, Nataro et al., 1996, Andrade et 
al., 2011). 
While the GIT is often considered AN, oxygen availability varies greatly between 
sites. There is a decreasing longitudinal oxygen gradient along the length of the 
human gut, but a radial oxygen gradient is also present due to oxygen diffusion 
across the epithelial barrier (Espey, 2013, Albenberg et al., 2014). Oxygen has 
previously been recognised as an environmental signal for the regulation of 
virulence in several enteric pathogens, including microaerobiosis enhancing host 
cell adherence and invasion by Salmonella Typhimurium and regulating the 
expression of virulence factors such as the Toxin co‐regulated pilus and cholera 
toxin in Vibrio cholerae (Marteyn et al., 2011, Lee and Falkow, 1990, Marrero et al., 
2009). In addition, low oxygen levels enhanced EHEC T3S and adherence to 
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polarised colonic epithelial cells (Schüller and Phillips, 2010). However, the effect of 
oxygen availability on EAEC virulence has not been previously characterised.  
In addition to oxygen, contact with the host epithelium can also stimulate 
expression of virulence factors by enteric pathogens (Stones and Krachler, 2016). 
For example, the expression of key virulence factors encoded on the locus of 
enterocyte effacement (LEE) pathogenicity island in EHEC is activated by 
mechanosensation via GrlA regulation, in response to host cell attachment and fluid 
shear force (Alsharif et al., 2015). While many studies have investigated putative 
EAEC virulence factors and whether they contribute to adherence, any resulting 
effect of host cell contact on regulation of virulence-associated genes has not been 
characterised. 
The objectives of this study were to: 
 Characterise the adherence and colonisation of the prototypical EAEC strains 
042 and 17-2 on human intestinal epithelial cell lines and intestinal biopsy 
samples 
 Establish a microaerobic VDC system as a model for EAEC infection of polarised 
intestinal epithelial cells 
 Determine the effect of oxygen levels and adherence to host cells on expression 
of EAEC virulence genes 
 Investigate the importance of the transcriptional regulator AggR for the 
response of EAEC to these environmental signals 
 
3.2: Results 
3.2.1: Prototype EAEC strains adhere to T84 and Caco-2 intestinal cell 
lines  
The human colon carcinoma cell lines T84 and Caco-2 were used for the 
characterisation of EAEC colonisation to intestinal epithelia in vitro. Both cell lines 
can form polarised monolayers in culture, with columnar cell shape, intact tight 
junctions, and high trans-epithelial electrical resistance (TEER) (Hidalgo et al., 1989, 
103 
 
Tran et al., 2014). T84 cells were used as a model for the colonic epithelium and 
have previously been employed for investigating EAEC infection (Nataro et al., 
1996). The Caco-2 cell line, whilst colonic in origin, was used as a model for small-
intestinal enterocytes. Features including expression of brush border enzymes and 
similar proteomic profiles to cells of the small intestine have led to the wider use of 
Caco-2 cells as an in vitro small bowel model for both pharmacological and 
microbial infection studies, including EAEC (Meunier et al., 1995, Lenaerts et al., 
2007, Steiner et al., 2000). 
To investigate the colonisation of EAEC on T84 and Caco-2, cells grown on coverslips 
were infected with EAEC prototype strains 042 and 17-2 for 5 hours, and bacterial 
colonisation was visualised by Giemsa or immunofluorescence staining (Figure 3.1). 
Giemsa staining showed that both 042 and 17-2 adhered to T84 and Caco-2 
monolayers by forming large bacterial aggregates on the cell surface, consistent 
with the AA phenotype. However, while adherent 042 were largely confined to 
these aggregates, some diffuse colonisation of 17-2 could also be observed 
separate from aggregative colonies. This morphological difference was consistent 
for both intestinal cell lines.  
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Figure 3.1 EAEC colonisation of intestinal cell lines. The EAEC strains 042 and 17-2 
colonised confluent monolayers of T84 and Caco-2 cells (Multiplicity of infection (MOI) = 10 
bacteria/cell, incubated for 5 hours). However, 042 demonstrated a denser colony 
morphology. Representative images of five experiments in duplicate, imaged by phase-
contrast microscopy.   
 
Colonisation patterns of EAEC 042 and 17-2 on T84 and Caco-2 cell monolayers 
were also confirmed by immunofluorescence staining (Figure 3.2). While the E. coli 
antibody detected both EAEC strains, some of the larger colonies observed after 5 
hours of infection were only partially stained. The limited penetration of the 
antibodies was evident when DAPI was used as a DNA counterstain.   
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Figure 3.2 Immunofluorescence staining of EAEC colonies on intestinal epithelial cell 
lines. EAEC were incubated with confluent T84 or Caco-2 cells for 5 hours and stained for 
DNA (DAPI) and bacteria (anti-E. coli). Larger colonies demonstrated only partial staining, as 
evident by the DAPI counterstain. Representative images are of 17-2 colonisation of T84 (A) 
and Caco-2 (B) cells. (MOI = 10 bacteria/cell). 
 
In addition to qualitative observations by microscopy, colonisation of the cell lines 
by 042 and 17-2 was quantified. Confluent T84 and Caco-2 monolayers were 
infected with EAEC for 2 or 5 hours. Cell layers were washed and lysed, and serial 
dilutions of the lysates plated on LB agar for colony counting. Colony counts were 
normalised by also plating out the inoculum for each experiment.  
Quantification of colony forming units confirmed the previous observation that 
both EAEC strains could effectively adhere to both cell lines (Figure 3.3). There was 
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no significant difference in colonisation between T84 and Caco-2 monolayers at 
either time-point. Adherence of 17-2 was consistently higher than that of 042, but 
this difference was only significant for the T84 cell line at 2 hours of infection (P < 
0.05). Overall, the quantitative and qualitative data suggests that EAEC prototype 
strains 042 and 17-2 can both adhere to monolayers of T84 or Caco-2 cells, but with 
minor differences in microcolony morphology and abundance. 
 
 
 
Figure 3.3 Colonisation of EAEC 042 and 17-2 to intestinal cells. Colonisation of confluent 
monolayers of (A) T84 and (B) Caco-2 was quantified by plate colony counting after 2 and 5 
hours of infection (MOI = 10 bacteria/cell) and was normalised against the initial inoculum. 
Data are shown as means ± SE of three independent experiments performed in duplicate. 
*P < 0.05 
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3.2.2: Intestinal cell lines do not tolerate simulated intestinal bacterial 
media  
This study aims to investigate the influence of the gut environment on EAEC, and 
one approach is to simulate physiological conditions in the experimental media. 
Simulated ileal environment medium (SIEM) and simulated colonic environment 
medium (SCEM) have previously been used to study virulence gene and proteome 
expression in EHEC (Polzin et al., 2013, Müsken et al., 2008). However, these 
studies were performed without the presence of intestinal epithelial cells. To 
investigate the tolerance of Caco-2 and T84 cells to incubation in simulated 
intestinal media, confluent monolayers were incubated in either full simulated 
media (Caco-2 in SIEM, T84 in SCEM) or with specific media components for 5 
hours. Cell viability was assessed by Trypan Blue staining and microscopy. In 
addition, immunofluorescence staining for actin and occludin was performed to 
visualise the integrity of the cytoskeleton and tight junction network, respectively.  
Incubation of Caco-2 and T84 cells in complete SIEM and SCEM, respectively, 
resulted in total cell detachment and loss of viability. Therefore, incubations were 
performed comparing normal non-supplemented cell culture medium (DMEM for 
Caco-2, DMEM/F-12 for T84) to the Bacto Tryptone used as the base media for 
SIEM and SCEM, and separate addition of bile salts or pancreatin at different 
concentrations, lysozyme, and the remaining soluble salts (NaCl, KH2PO4, NaHCO3, 
NaH2PO4, KHCO3). As expected, DMEM and DMEM/F-12 incubation maintained an 
intact monolayer of fully viable cells on the coverslips. In contrast, Bacto Tryptone 
alone caused partial loss of viability for both cell lines, with partial cell detachment 
for Caco-2 and disrupted cell morphology for T84. The addition of bile salts was also 
found to be toxic to the intestinal cells at >600 µM for Caco-2 and >200 µM for T84. 
These are far lower bile salt concentrations than the 6.6 mM in SIEM and 4.7 mM in 
SCEM as published for bacterial culture. 
Due to the poor tolerance of the cells to Bacto Tryptone alone, incubations were 
performed using DMEM or DMEM/F-12 as the base media. This did not improve the 
tolerance of either cell line to bile salts. For Caco-2 cells, 1% (w/v) pancreatin was 
used to introduce digestive enzymes to the medium. However, this caused major 
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detachment of the monolayer from the coverslip even at a reduced 0.1% 
concentration, although any residual cells were seen to be viable when stained with 
Trypan Blue. However, the lysozyme concentration specified for SIEM had no 
negative effect on Caco-2 cells, and the cell lines tolerated the other soluble salts in 
the SIEM and SCEM recipes.  
Immunofluorescence staining of cell monolayers on coverslips supported the 
results of the viability assays (Figure 3.4). When T84 and Caco-2 cells were 
incubated in DMEM/F-12 or DMEM respectively, a well organised actin network 
and intact tight junctions were observed. Bacto tryptone induced a partial loss of 
tight junction integrity as seen by occludin staining, as well as visible disorganisation 
of the actin cytoskeleton. The addition of SIEM/SCEM soluble salts caused no 
observable change to actin and occludin networks compared to DMEM and 
DMEM/F-12 controls, matching the tolerance seen with viability staining. Due to 
complete cell detachment in the presence of bile salts or pancreatin, 
immunofluorescence staining and microscopy could not be performed for these 
samples.   
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Figure 3.4 Immunofluorescence staining of T84 and Caco-2 cells to determine monolayer 
integrity. Confluent monolayers of T84 or Caco-2 cells were incubated for 5 hours with cell 
culture media (DMEM/F-12 and DMEM respectively) or Bacto-tryptone, and 
immunofluorescence staining performed for actin or occludin (green) and cell nuclei (blue). 
In cell culture media, cells formed an actin brush border (A; T84) and intact tight junctions 
containing occludin (B; Caco-2). Bacto-tryptone alone caused disruption of actin (C; Caco-2) 
and partial loss of tight junction integrity (D; T84). Representative images for experiments 
performed in triplicate. 
 
In summary, while SIEM and SCEM have been used for incubations of bacteria in 
previous studies, most of the components including bile salts and digestive enzymes 
were poorly tolerated by T84 and Caco-2 cells. As soluble salt concentrations in 
SIEM/SCEM were generally similar to those in DMEM and DMEM/F-12, subsequent 
infection assays in this project were performed in DMEM (Caco-2) or DMEM/F-12 
media (T84). 
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3.2.3: EAEC strains 17-2 and 042 adhere to human colonic but not 
small intestinal tissue 
The use of in vitro organ culture (IVOC) allows the study of interactions between 
bacteria and human intestinal epithelial tissue ex vivo. This has greater physiological 
relevance than standard cell culture, conserving the complex tissue structure and 
diversity of differentiated cells, and avoiding the carcinoma background of cell lines 
(Fang et al., 2013). Previous studies using IVOC have suggested that EAEC can 
colonise tissue from both the small and large intestine, but certain strains 
demonstrated significantly greater adherence to colonic tissue (Andrade et al., 
2011, Hicks et al., 1996).  To investigate the ability of 042 and 17-2 to colonise the 
human intestinal mucosa and detect any tissue tropism, IVOC experiments were 
performed using biopsies taken from adult patients at four sites of the GIT: 
duodenum (second/descending part), terminal ileum, transverse colon, and sigmoid 
colon. The biopsies were infected with EAEC 042 or 17-2 for 6-7 hours and 
examined by scanning electron microscopy (SEM) for bacterial colonisation. 
Both prototype strains colonised colonic biopsies, with extensive bacterial 
adherence observed to the epithelial surface, particularly around the edge of the 
crypts (Figure 3.5). Similar colonisation levels were observed on sigmoidal and 
transverse colon. As previously described for the adherence to T84 and Caco-2 cell 
lines, 042 formed distinct dense aggregates, while 17-2 established both large 
colonies and areas with a more diffuse pattern of adherence. Minimal colonisation 
by 042 and 17-2 was observed for IVOC of small intestinal tissue. Neither strain 
consistently adhered to biopsies from the terminal ileum, with only infrequent 
individual bacteria or small aggregates visible by SEM on some samples. No 
adherent EAEC were detected on duodenal biopsies (Table 3.1). These findings 
demonstrate that both 042 and 17-2 preferentially colonise human colonic mucosa. 
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Figure 3.5 EAEC colonisation of human intestinal tissue. Scanning electron microscopy of 
human biopsies from the terminal ileum, transverse and sigmoid colon infected with EAEC 
042 or 17-2 for 7 hours. Bars = 5 μm (top right panel), 20 μm (bottom panels) or 10 μm (all 
other panels). Shown are representative images of three experiments performed in 
duplicate. 
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Region EAEC strain 
042 17-2 
Duodenum 0/8 (0) 0/8 (0) 
Terminal ileum 4/7 (57)* 3/7 (43)* 
Transverse colon 6/7 (86) 4/7 (57) 
Sigmoid colon 6/7 (86) 2/6 (33) 
Table 3.1 EAEC adherence to human intestinal biopsies. Data are presented as number of 
biopsies with adherent aggregates/total number of biopsies (percentage). *Single bacteria 
or very small aggregates only. 
 
3.2.4: Establishment of a microaerobic VDC system 
The vertical diffusion chamber (VDC) system has been previously used by the 
Schüller research group to investigate the influence of oxygen concentration on 
pathogenesis of EHEC (Tran et al., 2014). Before use of this model for the study of 
EAEC infection, the tolerance of the human intestinal cells to incubation in this 
model was determined, as well as characterisation of the oxygen condition in the 
VDC. 
To investigate the stability of polarised epithelial monolayers in the VDC, T84 and 
Caco-2 cells were seeded onto collagen-coated Snapwells and differentiated for 10-
14 days. The culture medium was exchanged every 2 days, and the trans-epithelial 
electrical resistance (TEER) was recorded with a stable TEER above a threshold of 
1000 Ω × cm2 for T84 or 500 Ω × cm
2
 for Caco-2 cells indicating full polarisation. The 
Snapwell inserts containing the polarised cell monolayer were incubated in the VDC 
for 4 hours, with or without EAEC and in either an AE or MA conditions. Epithelial 
barrier integrity was investigated by comparing the TEER for each Snapwell before 
and after incubation (Figure 3.6). For T84 cells, incubation in the VDC in non-
supplemented DMEM/F-12 caused a decrease in TEER in AE and MA conditions and 
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with or without bacteria, but the TEER remained above the integrity threshold of 
1000 Ω × cm2. Additionally, neither apical MA conditions or presence of EAEC 
caused a significant decrease in barrier integrity. However, Caco-2 cells poorly 
tolerated the VDC incubation, with high levels of cell detachment from the Snapwell 
filter. As previous IVOC experiments demonstrated preferential adherence of EAEC 
042 and 17-2 to colonic tissue, all subsequent experiments were carried out using 
the T84 cell line. 
 
 
Figure 3.6 Epithelial barrier function during VDC incubation. Epithelial barrier function of 
polarised T84 cells was evaluated by TEER and is expressed as resistance after infection (4 
hours, MOI = 20 bacteria/cell) with 042 or 17-2 or a non-infected (NI) control, relative to 
resistance before infection. Incubations were performed under aerobic (AE) or 
microaerobic (MA) conditions. Caco-2 cells detached from Snapwell filters, therefore 
preventing TEER measurement post-infection. Data shown as mean ± SE from three 
independent experiments. 
 
To visualise bacterial colonisation and host cell morphology, polarised T84 cells 
infected with 042 or 17-2 for 4 hours under AE or MA conditions were stained for E. 
coli, actin, and cell nuclei and evaluated by immunofluorescence microscopy. To 
improve penetration of the anti-E. coli antibody, cells were fixed with ethanol 
rather than formaldehyde solution, and complete staining of EAEC colonies was 
114 
 
achieved using this method with no limitation. As shown in Figure 3.7, both EAEC 
strains demonstrated extensive colonisation of the epithelial cell surface. In 
addition, actin staining showed that the polarised T84 monolayers remained visibly 
confluent with an organised actin network and intact brush border. Some EAEC 
colonies were associated with areas of actin disruption, although it could not be 
determined if this was pre-existing and promoted binding or was a result of EAEC 
adherence. 
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Figure 3.7 Colonisation of polarised T84 monolayers in the VDC. Polarised T84 cells were 
incubated with 042 or 17-2 or non-infected control (NI) for 4 hours in the VDC (MOI = 20 
bacteria/cell). Aggregative adherence and epithelial integrity was visualised by 
immunofluorescence staining for EAEC (red) and actin (green). Data shown as 
representative images of four independent experiments. 
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To adapt the VDC system for EAEC experiments, oxygen concentrations during 
bacterial growth were characterised (Figure 3.8). This was achieved by measuring 
dissolved oxygen concentrations using an oxygen electrode probe over the course 
of a 4-hour incubation with EAEC, without T84 cells (with the probe calibrated 
relative to non-inoculated AE and MA chambers). In MA chambers, initial dissolved 
oxygen concentration was 3-4 %, but was fully depleted by 4 hours. For AE 
chambers, bacterial growth in the media caused oxygen levels to decrease from 
approximately 21% to 15% by 3 hours, and by 4 hours to 10 % and 5 % for 042 and 
17-2, respectively. 
 
 
Figure 3.8 Oxygen concentration during VDC incubation. Dissolved oxygen concentrations 
during bacterial incubation over 4 hours were determined as percentage of atmospheric 
pressure, using an oxygen electrode probe. Data is shown as mean ± SE for three 
independent experiments. 
 
To determine if these conditions induce changes in EAEC respiration pathways, 
bacteria were first isolated after 3 and 4 hours of incubation. After RNA extraction, 
the expression of the respiratory enzyme genes cyoA and cydB was determined by 
qPCR (Figure 3.9). While cyoA encodes a subunit of the lower oxygen affinity 
cytochrome O oxidase complex which is preferentially expressed in AE 
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environments, the product of cydB forms part of the high oxygen affinity 
cytochrome D oxidase, which is upregulated in conditions below approximately 5% 
oxygen (Cotter et al., 1990). For 042 and 17-2, AE conditions caused an induction of 
cyoA (P < 0.05 for 17-2; P < 0.0001 for 042) and downregulation of cydB (P < 0.01 
for 042) compared to MA conditions. This demonstrated a distinct difference in 
expression of genes involved in EAEC respiration in response to the relative oxygen 
availability between AE and MA chambers 
 
 
Figure 3.9 Relative expression of cytochrome oxidase genes. Bacterial respiration status 
after 3 hours of incubation was evaluated by qPCR gene expression analysis of low affinity 
cytochrome bo3 oxidase (cyoA) and high affinity cytochrome bd oxidase (cydB).  Gene 
expression is indicated as fold change under aerobic (AE) versus microaerobic (MA) 
conditions. Data was normalised against expression of housekeeper genes gyrA and mdoG. 
Data are shown as mean ± SE from three independent experiments in duplicate (*P < 0.05, 
**P < 0.01, ****P < 0.0001). 
 
3.2.5: Strain-specific modulation of growth and adherence by oxygen  
The oxygen levels in AE and MA chambers during VDC incubation were shown to 
induce the use of different terminal oxygen respiration enzymes in 042 and 17-2, 
validating that these are distinct experimental conditions which affect EAEC gene 
expression.  To determine the effect of oxygen availability on EAEC growth rate, 
strains 042 or 17-2 were incubated for up to 6 hours under AE or MA conditions in 
the absence of T84 cells and bacterial growth was evaluated by optical density at 
600 nm. As shown in Figure 3.10, faster bacterial replication was observed for 17-2 
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than 042 in both oxygen conditions. Both strains exhibited a significantly slower 
growth rate during MA incubation (P < 0.01 for 042; P < 0.0001 for 17-2), with an 
approximate two-fold reduction in optical density compared to AE condition by 6 
hours. 
 
Figure 3.10 Bacterial growth during VDC incubation. EAEC were incubated in the VDC 
system without host cells under aerobic (AE) or microaerobic (MA) conditions for 6 hours. 
Bacterial growth was quantified by optical density (600 nm). **P < 0.01, ****P < 0.0001 
versus MA conditions. 
 
The influence of oxygen concentrations on EAEC adherence to T84 cells was also 
investigated (Figure 3.11). VDC experiments were performed with polarised T84 
cells incubated with 042 or 17-2, followed by lysis of the T84 monolayer and plating 
of a serial dilution of lysate on LB agar for colony counting analysis. Initial assays 
evaluated adherence after 2 hours to determine initial colonisation. However, 
neither strain demonstrated a significant change in adherence rate when 
comparing AE to MA infection. 
To determine if oxygen influenced colonisation over a longer time period, an 
additional series of VDC experiments were performed whereby after 2 hours 
incubation of polarised T84 cells with EAEC, apical media were exchanged with 
sterile DMEM/F-12. After incubation for a further 2 hours, cell-associated bacteria 
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were quantified as above. At this longer time-point, the adherence of 17-2 was 
significantly higher under AE than MA conditions (P < 0.01), whereas no difference 
was observed for strain 042 (Figure 3.11). 
 
 
Figure 3.11 Influence of oxygen levels on EAEC colonisation of polarised T84 cells. EAEC 
were incubated with polarised T84 cells (MOI = 20 bacteria/cell) under aerobic (AE) or 
microaerobic (MA) apical conditions for 2 or 4 hours including a medium exchange after 2 
hours. Colonisation was quantified by plate colony counting and was normalised against 
the initial inoculum. Data are shown as means ± SE of four independent experiments 
performed in triplicate (**P < 0.01). 
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3.2.6: Oxygen induces virulence gene expression in EAEC 042 
To investigate the expression of putative EAEC virulence genes in response to 
oxygen availability, relative q CR analysis and the ΔΔCT method were applied (Livak 
and Schmittgen, 2001). Prior to this, the primers designed for this study were 
analysed for specificity and amplification efficiency. Primer specificity was 
determined for each primer pair by performing qPCR with cDNA generated from 
sample RNA of either 042 or 17-2 (depending on which strain contained the target 
gene), with the qPCR cycling parameters containing a dissociation curve analysis 
step. The resulting heat dissociation curves contained only single peaks for each 
primer pair, suggesting the generation of a single amplicon (Figure 3.12 A). The size 
of the amplification products was determined by agarose gel electrophoresis 
alongside a molecular-weight size marker (Figure 3.12 B). For each primer pair, a 
single band was observed to further confirm the presence of a specific amplification 
product, and the band positions were found to match the expected size of the 
amplicon. These results validated the designed primer pairs as specific for the 
target gene sequences. 
Relative q CR analysis using the ΔΔCT method requires validation of sufficiently high 
amplification efficiencies for all primer pairs. To determine this, qPCR was 
performed with a two-fold serial dilution of cDNA. The resulting CT values were 
plotted against dilution factor, allowing the amplification efficiency to be calculated 
from the gradient for each primer pair (Figure 3.13). The range of amplification 
efficiencies all exceeded 95%, above the 90% threshold recommended for use in 
experimental qPCR analysis (Table 3.2) (Svec et al., 2015). Values greater than the 
theoretical maximum of 100% may be due to inhibitors carried over from sample or 
reagents, as this is more pronounced in more concentrated cDNA samples and can 
skew the linear fit (Svec et al., 2015) 
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Figure 3.12 Validation of primer specificity. (A) Dissociation curves were generated for 
each primer pair during qPCR amplification. Single peaks indicate that primers amplified a 
single amplicon. Curves are representative of all qPCR experiments with these primers. (B) 
Agarose gel electrophoresis of qPCR products. Image is representative of two independent 
experiments in duplicate.    
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Figure 3.13 Validation of primer efficiency. qPCR was performed using a two-fold serial 
dilution of cDNA for each primer pair for (A) virulence genes and (B) reference genes. The 
resulting cycle threshold (CT) values were plotted against cDNA concentrations, to 
determine the gradient for calculation of primer efficiency. 
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Primer target Negative gradient Primer Efficiency % 
gyrA 3.09 110.7 
mdoG 3.37 98.0 
gapA 3.3 100.9 
rpoB 3.17 106.8 
aggR 3.29 101.3 
Pic 2.93 119.4 
cyoA 3.26 102.7 
cydB 3.15 107.7 
hlyE 3.24 103.5 
aafA 3.38 97.6 
aap 2.96 117.7 
aggA 3.2 105.4 
pet 2.99 116.0 
astA 3.28 101.8 
ecpA 2.85 124.3 
Table 3.2 Primer efficiencies. Cycle threshold (CT) values were plotted against cDNA 
concentrations for a two-fold serial dilution, with the gradient of the linear fit for each 
primer pair (Figure 3.13) used to calculate amplification efficiency. 
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The normalisation of relative qPCR data required the use of reference E. coli genes, 
and it was therefore important that the expression of these genes remained 
consistent between experimental conditions. Four potential reference genes were 
selected: gapA (glyceraldehyde phosphate dehydrogenase), rpoB (β subunit of 
bacterial RNA polymerase), gyrA (DNA gyrase), and mdoG (glucans biosynthesis 
protein G, glycan metabolism). qPCR was performed using cDNA from strains 042 
and 17-2 after a 4-hour VDC incubation under AE and MA conditions (Figure 3.14). 
The CT values indicated that gapA expression was possibly affected by oxygen level, 
whilst rpoB showed different expression levels in the two EAEC strains. In contrast, 
gyrA and mdoG showed consistent expression levels under all conditions and were 
therefore selected as reference genes for subsequent qPCR analysis. 
 
 
Figure 3.14 Effect of oxygen levels on expression of selected E. coli reference genes. qPCR 
was used to analyse expression of four E. coli genes in 042 and 17-2 after a 4-hour VDC 
incubation in aerobic (AE) or microaerobic (MA) conditions. Data are shown as mean ± SE 
for three experiments in duplicate.  
 
After optimisation of the qPCR protocol, the effect of oxygen availability on EAEC 
virulence gene expression was investigated by incubating strains 042 and 17-2 for 3 
hours in the VDC system under AE or MA conditions, without T84 cells. This time 
point was chosen to avoid oxygen depletion in the AE chambers, as previously 
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evaluated in Chapter 3.2.4. The bacteria were immediately treated with phenol-
ethanol to stabilise RNA, cDNA was synthesised, and gene expression was analysed 
by qPCR. Relative virulence gene expression under AE compared with MA 
conditions was evaluated using the ΔΔCT method (Figure 3.15 A). For 042, oxygen 
induced a significant two-fold upregulation in expression of aggR, aap, aafA, and 
ecpA (P < 0.05 to P < 0.01). Both aap and aafA are regulated by the transcription 
regulator AggR. There was no significant difference in gene expression for the 
remaining virulence factors in 042 when comparing AE and MA conditions. For 
strain 17-2, none of the examined genes were significantly upregulated by oxygen. 
However, aggR, aap, and the corresponding AAF gene in 17-2, aggA, demonstrated 
a fold change in expression of greater than 1, but this did not reach statistical 
significance. 
To determine if the presence of host cells influenced the response of EAEC to 
oxygen, this analysis of relative virulence gene expression was repeated for non-
adherent EAEC in apical VDC compartments containing polarised T84 cells (Figure 
3.15 B). The results were similar to those observed in the absence of T84 cells, with 
no significant changes in gene expression for 17-2, and upregulation of aggR, aap, 
aafA, and ecpA by oxygen for 042. The only observable difference was that 
expression of astA was significantly increased under AE versus MA incubation in the 
presence of T84 cells (P < 0.01). Overall, this shows that the VDC system can be 
used as a model system to investigate the effect of oxygen levels on EAEC virulence 
gene expression. The data demonstrates that oxygen causes a strain-specific 
upregulation of certain virulence genes for 042, independent of the presence of T84 
cells. 
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Figure 3.15 Oxygen enhances virulence gene expression in EAEC 042. (A) EAEC strains 17-2 
or 042 were incubated in the VDC for 3 hours under aerobic (AE) or microaerobic (MA) 
conditions. Relative expression of selected virulence genes was determined by qPCR and is 
indicated as fold change under AE versus MA conditions. Data are shown as mean ± SE for 
five independent experiments. (B) Polarised T84 cells were infected with strains 17-2 or 042 
for 3 hours (MOI = 20 bacteria/cell) under AE or MA conditions in the VDC. Expression of 
selected virulence genes by non-adherent bacteria was determined by qPCR. Data was 
normalised against expression of housekeeper genes gyrA and mdoG. Data are shown as 
mean ± SE for three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 
 
3.2.7: Adherence to host cells enhances EAEC virulence gene 
expression 
To examine the effect of adherence to human colonic epithelial cells on virulence 
gene expression, polarised T84 monolayers were incubated for 3 hours in the VDC 
system following apical inoculation with 042 or 17-2. At the end of infection, the 
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apical medium was immediately treated with phenol-ethanol to stabilise bacterial 
RNA, while the T84 Snapwells were removed and differential lysis performed to 
deplete eukaryotic cells and preserve bacterial RNA. Relative qPCR analysis with the 
ΔΔCT method was used to directly compare virulence gene expression between 
adherent and non-adherent bacteria from the same chamber. 
The qPCR analysis revealed that adherence to the polarised T84 monolayer 
increased the expression of most of the investigated virulence genes in both 042 
and 17-2 (P < 0.05 to P < 0.0001) (Figure 3.16). For both strains, the largest change 
in relative gene expression was recorded for EAST-1 toxin gene astA, which saw a 4-
fold upregulation for 17-2 and 8-fold increase for 042. Whilst the aggR-regulated 
genes aap and aafA/aggA were also increased in adherent bacteria, aggR itself was 
not upregulated in 042 and showed a relatively small increase in expression for 17-2 
in MA chambers. The relative expression of each gene in response to T84 contact 
was determined for both AE and MA apical conditions, with the results mostly 
unaffected by oxygen availability. The only exceptions were a significant 
upregulation of hlyE in 042 only under AE incubation, and aggR and ecpA in 17-2 for 
MA conditions only.    
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Figure 3.16 EAEC virulence gene expression is enhanced by host cell contact. Polarised 
T84 cells were infected with EAEC 042 or 17-2 (MOI = 20 bacteria/cell) and maintained 
under aerobic (AE) or microaerobic (MA) conditions for 3 hours. Relative expression of 
selected virulence genes in adherent and non-adherent EAEC was determined by qPCR and 
is indicated as fold change in adherent versus non-adherent bacteria. Data was normalised 
against expression of housekeeper genes gyrA and mdoG. Data are shown as mean ± SE for 
five independent experiments in duplicate. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 
0.0001. 
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3.2.8: Virulence gene induction by T84 cells is contact-dependant 
The induction of bacterial gene expression by host cells may be mediated by 
proximity to secreted host factors, or by physical contact mechanisms such as 
receptor binding (Stones and Krachler, 2016). To determine which of these options 
was responsible for the virulence gene upregulation observed for adherent EAEC, 
confluent T84 cells were grown in a 12-well culture plate and inoculated as follows: 
1) T84 monolayers were directly inoculated with EAEC and incubated for 3 hours, 
after which adherent and non-adherent bacteria were processed for qPCR analysis 
of relative virulence gene expression. 2) A sterile Transwell insert was added to 
wells with T84 cells, and bacteria incubated for 3 hours within the insert. Virulence 
gene expression was analysed by qPCR against a negative control of bacteria in a 
Transwell insert in a well without T84 cells. In this approach, EAEC were exposed to 
T84 proximity and any secreted factors, but the 0.4 µM Transwell filter prevented 
direct contact with the host cells (see Figure 2.3).  
Relative gene expression was determined for astA, aap, pet, and aafA (042) or aggA 
(17-2) (Figure 3.17). When comparing gene expression for adherent and non-
adherent bacteria from the direct inoculation method, this simpler model partially 
reproduced the previous VDC results. Adherence caused increased expression of 
aap and aafA/aggA for both strains, and astA for 17-2, although the fold-change 
was less than observed in the VDC model (P < 0.05 to P < 0.0001). The change in 
relative astA expression was not significant for 042, while neither strain 
demonstrated an upregulation of pet by T84 adherence. 
For the Transwell insert model, relative gene expression was compared between 
bacteria incubated with and without a T84 monolayer within the culture well. None 
of the virulence genes analysed were upregulated in the presence of T84 cells. 
These results indicate that proximity to T84 cells alone does not cause increased 
virulence gene expression, and that this effect is therefore dependent on physical 
host cell contact. 
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Figure 3.17 EAEC virulence gene induction by T84 cells is contact dependent. Confluent 
T84 cells were grown in 12 well plates, and 042 or 17-2 were added directly to the cells 
(MOI = 5 bacteria/cell) or prevented from direct cell contact by insertion of a porous 
Transwell insert. After 3 hours, expression of selected virulence genes was by quantified by 
qPCR and is expressed as fold change in EAEC in Transwell inserts with and without T84 
cells (no contact) or in adherent versus non-adherent EAEC in plates without Transwells 
(contact). Data was normalised against expression of housekeeper genes gyrA and mdoG. 
Data are shown as mean ± SE for three independent experiments in duplicate. *P < 0.05, 
**P < 0.01, ***P < 0.001, ****P < 0.0001. 
 
3.2.9: Adherence to host cells upregulates dispersin protein 
expression 
As adherence to T84 cells induced an increase in virulence gene expression in EAEC, 
experiments were designed to investigate if this upregulation was observable at the 
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protein level. Polarised T84 monolayers were incubated in the VDC with 042 or 17-2 
under AE conditions. An 042 aggR deletion mutant was also included as a negative 
control for 042. Non-adherent bacteria were collected by centrifugation of apical 
media, while the T84 monolayer was lysed to harvest adherent bacteria. Western 
blots were performed to compare protein levels between adherent and non-
adherent bacterial samples from the same chambers, using antibodies against 
dispersin (aap) and AAF/I (aggA). 
Visualisation of protein bands by chemiluminescence revealed that for 042, levels 
of dispersin appeared to be greater in adherent than non-adherent bacteria at all 
time points (Figure 3.18 A). This was quantified by densitometric analysis of band 
intensity, with normalisation against GroEL expression as a measure of total 
bacterial protein abundance (Figure 3.18 B). This was chosen as a control as the 
GroE chaperone system is stably expressed in E. coli unless induced by heat 
shock(Rudolph et al., 2010). Dispersin expression was higher in adherent 042, 
although the increase was only significant at 5 hours incubation (P < 0.01). The 
results were more variable with 17-2, and no significant change in dispersin was 
observed at any time point (Figure 3.19). While Western blot analysis was also 
performed for AAF/I in strain 17-2, the resulting antibody signal was too weak for 
reliable analysis. Overall, these experiments suggest that at least in the case of 042 
dispersin, the observed effect of T84 adherence on gene expression translates into 
a significant increase in protein expression. 
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Figure 3.18 Expression of dispersin by 042 is increased by T84 adherence. (A) Polarised 
T84 cells were infected with strain 042 (MOI = 20 bacteria/cell) for up to 7 hours under AE 
conditions. Expression of dispersin (Aap) in adherent (A) and non-adherent bacteria (NA) 
was determined by Western blot analysis. Bacterial lysates of an isogenic aggR mutant 
(ΔaggR) were included as negative control, and GroEL expression was used to normalise 
total protein amounts. Image is representative of four independent experiments. (B) Band 
intensities were quantified with ImageJ and protein expression is indicated as fold change 
in adherent versus non-adherent bacteria. Data are shown as mean ± SE for four 
independent experiments. ** P < 0.01. 
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Figure 3.19 Expression of dispersin is not induced by T84 adherence for 17-2. Polarised 
T84 cells were infected with strain 17-2 (MOI = 20 bacteria/cell) for up to 7 hours under AE 
conditions. Expression of dispersin was determined by Western blot analysis and band 
intensities were quantified with ImageJ. Protein expression is indicated as fold change in 
adherent versus non-adherent bacteria. Data are shown as mean ± SE for four independent 
experiments. 
 
3.2.10: Dependence of virulence gene induction on AggR regulation 
The transcriptional regulator AggR modulates the expression of multiple EAEC 
virulence genes and is often described as promoting pathogenesis (Morin et al., 
2013, Huttener et al., 2018, Harrington et al., 2006). The results of the VDC 
experiments in this study demonstrated an upregulation of aggR by oxygen in strain 
042, but no change induced by T84 adherence. To investigate the importance of 
AggR for the virulence gene expression in response to oxygen and host cell contact, 
experiments were performed using an isogenic 042 aggR deletion mutant and the 
corresponding complemented strain (kindly provided by Douglas Browning, 
University of Birmingham; first published in (Sheikh et al., 2001, Sheikh et al., 
2002)).  
The mutant strains were initially validated by the observation of aggregation and 
colonisation phenotypes (Figure 3.20). Wild-type, aggR deletion, and 
complemented 042 strains were incubated in DMEM/F-12 medium for 4 hours, 
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with or without confluent T84 cells. Wild-type 042 formed large, dense aggregates 
in liquid culture, while the deletion mutant displayed no auto-agglutination with 
only individual bacteria observed. Following arabinose-induced expression of aggR, 
the complemented strain displayed some aggregation, although this was not fully 
restored to wild-type levels. On T84 cells, the wild-type strain demonstrated AA. 
When aggR was deleted, no aggregation occurred and only low levels of individual 
adherent bacteria were observed. Complementation of aggR partially reversed this 
effect, with AA observed but at a lower density than wild-type 042 colonies. 
 
Figure 3.20 Aggregative adherence phenotype requires AggR.  Confluent T84 cells in 24 
well plates were infected (MOI = 10 bacteria/cell) with EAEC 042 wild-type (A), ΔaggR 
mutant (B) and complemented strain (C) for 4 hours and treated with Giemsa stain. Shown 
are representative images of two experiments performed in duplicate. 
 
To evaluate the effect of AggR on total virulence gene expression irrespective of 
signals such as oxygen and adherence, the relative expression of aggR, astA, aap, 
and aafA was determined for bacteria when comparing the deletion mutant and 
complemented strain against wild-type 042 (Figure 3.21). Gene expression was 
analysed by qPCR following a 3-hour VDC incubation in AE conditions, without host 
cells. Plasmid complementation of aggR caused a small increase in expression of all 
four genes, significant for aap and aafA (P < 0.05 and P < 0.01, respectively). 
Deletion of aggR caused a strong significant decrease in aap and aafA expression (P 
< 0.001 and P < 0.0001, respectively), which are known to be AggR regulated (Morin 
et al., 2013). The deletion mutant did not have decreased expression of astA 
compared to wild-type 042. 
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Figure 3.21 Relative gene expression in mutant strains compared to wild-type 042. 
Virulence gene expression following a 3-hour incubation in the VDC of non-adherent 
bacteria was quantified by qPCR and is expressed as fold change in ΔaggR mutant (white) 
and complemented strain (grey) versus wild-type. Data was normalised against expression 
of housekeeper genes gyrA and mdoG. Data are shown as mean ± SE for four independent 
experiments in triplicate, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. 
 
The effect of oxygen on expression of aggR, astA, aap, and aafA was determined by 
incubating 042 wild-type, ΔaggR and the complemented strain under AE or MA 
conditions in the VDC for 3 hours, without host cells. Arabinose was added to 
induce plasmid-derived aggR expression for the complemented strain. Relative 
qPCR analysis showed increased expression by oxygen of all 4 genes, although this 
only reached statistical significance for aggR in this set of experiments (P < 0.05) 
(Figure 3.22). When aggR was deleted, oxygen did not induce upregulation of the 
aggR-regulated genes aap and aafA, as well as astA. The increased gene expression 
in AE versus MA conditions was restored for astA and aap in the complement. 
However, data variability caused the difference between wild-type and mutant 
strains to not reach statistical significance for these genes. 
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Figure 3.22 Influence of oxygen on virulence gene expression in 042 aggR mutants. Wild-
type 042 (WT), ΔaggR mutant and complemented strain (Comp) were incubated in the VDC 
for 3 hours under AE or MA conditions. Relative expression of selected virulence genes was 
determined by qPCR and is indicated as fold change under AE versus MA conditions. Data 
was normalised against expression of housekeeper genes gyrA and mdoG. Data are shown 
as mean ± SE for four independent experiments. *P < 0.05, **P < 0.01 
 
To determine if AggR regulation is involved in the response of 042 virulence gene 
expression to host cell adherence, confluent T84 monolayers grown in 24-well 
plates were incubated with 042 wild-type, aggR deletion, or aggR complement 
strains for 3 hours and qPCR analysis was performed for aggR, astA, aap, and aafA 
(Figure 3.23). The loss of aggR did not abolish the effect of T84 adherence, as no 
significant difference was determined for relative gene expression of astA, aap, or 
aafA between 042 wild-type and ΔaggR. However, the results for the aggR 
complemented strain were unreliable and not consistent with either the wild-type 
or aggR deletion strain. 
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Figure 3.23 Host cell-induced virulence gene expression is not dependent on AggR. 
Confluent T84 cells in 24 well plates were infected (MOI = 10 bacteria/cell) with EAEC 042 
wild-type (WT), ΔaggR mutant and complemented strain (Comp) for 4 hours. Transcription 
of selected virulence genes in adherent and non-adherent EAEC was determined by qPCR 
and is indicated as fold change in adherent versus non-adherent bacteria. Data was 
normalised against expression of housekeeper genes gyrA and mdoG. Data are shown as 
mean ± SE for four independent experiments in triplicate. *P < 0.05, **P < 0.01, ***P < 
0.001, ****P < 0.0001. 
 
Overall, the results using these mutant strains suggest that the upregulation of 042 
virulence gene expression by adherence to T84 cells is not dependent on AggR 
regulation. While a trend was observed for the requirement of aggR for the 
increase in relative virulence gene expression caused by oxygen, this was not 
statistically significant and remains undetermined.  
 
3.3: Discussion 
As EAEC is a heterogenous pathotype, most fundamental research of virulence has 
been performed using prototype strains. Two of the most commonly used strains 
are 042 and 17-2, both isolated from South American paediatric diarrhoeal cases in 
the 1980s. 042 was isolated during a case study in Lima, Peru in 1983, while 17-2 
was obtained from an infant with diarrhoea in Santiago, Chile (Nataro et al., 1985, 
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Vial et al., 1988). In an adult human volunteer study, 042 induced diarrhoeal illness 
while other EAEC strains including 17-2 had no effect (Nataro et al., 1995). Animal 
models of infection have also been used, with 042 colonising the murine intestine 
but only inducing diarrhoea in combination with interventions such as zinc 
deficiency (Bolick et al., 2014, Roche et al., 2010). Rabbits orally infected with 17-2 
were colonised in the terminal ileum and colon, but did not develop diarrhoeal 
symptoms (Kang et al., 2001). The genomes of these two prototype strains have 
also been investigated. Both 042 and 17-2 are typical EAEC possessing a pAA 
plasmid and the transcriptional regulator AggR, as well as putative EAEC virulence 
genes such as dispersin, the mucinase Pic, and the toxins EAST-1 and HlyE (Morin et 
al., 2013, Chaudhuri et al., 2010, Weintraub, 2007, Cerna et al., 2003). However, 
there are also notable differences such as the Pet toxin encoded only by 042, and 
different AAF variants (AAF/I in 17-2 and AAF/II in 042) (Nataro et al., 1992, 
Chaudhuri et al., 2010, Suzart et al., 2001). 
As there is a lack of suitable in vivo models for EAEC infection, this study applied 
complimentary in vitro and ex vivo models to investigate 042 and 17-2 intestinal 
infection. (Philipson et al., 2013). In particular, the ability of these strains to 
colonise different sites in the GIT was evaluated. Additionally, the adaptation of 
EAEC for enteric pathogenesis was investigated using molecular biology techniques 
to determine the effect of intestinal environmental signals on virulence gene 
expression. 
 
3.3.1: EAEC colonisation of intestinal epithelial cells and tissue 
A key step in EAEC pathogenesis is adherence to the intestinal epithelium and the 
formation of bacterial aggregates. The ex vivo colonisation of human intestinal 
biopsies by 042 and 17-2 was investigated using the IVOC model. This has strong 
biological relevance compared to traditional cell culture, avoiding the abnormalities 
in metabolism and structure exhibited by cancer-derived cell lines (Rajan et al., 
2018). Tissue samples were taken from the second part of the duodenum, terminal 
ileum, transverse colon, and sigmoid colon to compare EAEC adherence. SEM 
revealed that both strains colonised colonic biopsies, with some regions displaying 
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extensive colony coverage across multiple crypts. Strain 042 colonised a higher 
proportion of biopsies from the transverse and sigmoid colon (both 86%) than 17-2 
(57% and 33%, respectively). This suggests 042 has a greater ability to infect adult 
colonic mucosa, which would correlate with 042 but not 17-2 causing diarrhoea in 
adult volunteers, albeit in a very limited small cohort study (Nataro et al., 1995). It 
was also observed that 042 often demonstrated denser and more distinct colonies 
than 17-2. The contrast between strong colonisation and complete absence of 
adherent bacteria observed for biopsies from different donors supports how host 
susceptibility may contribute to the heterogeneity of EAEC virulence. This could 
include factors such as genetic backgrounds, immune response, microbiota 
composition, and nutritional status (Kaur et al., 2010).  
Neither 042 or 17-2 formed adherent aggregates on small intestinal biopsies. While 
some terminal ileal biopsies were associated with individual bacteria or very small 
aggregates, no larger established colonies were observed on any occasion. No 
adherent EAEC were found on duodenal biopsy samples. This apparent tissue 
tropism is supported by previous IVOC studies for EAEC, where consistent 
colonisation of colonic tissue fragments was reported, compared to either no 
bacteria or much lower adherence on small bowel regions infected with 17-2 
(Knutton et al., 1992, Hicks et al., 1996) or 042 (Andrade et al., 2011, Nataro et al., 
1996). While the experiments herein used tissue samples from adults, some of the 
previous IVOC studies demonstrated similar results with biopsies from children. 
This suggests that despite the greater clinical association of EAEC with paediatric 
diarrhoeal illness, the tissue tropism for colonic colonisation is consistent during 
aging. In agreement with human ex vivo data, an in vivo rabbit infection model also 
reported 17-2 was recoverable throughout the colon but not in the duodenum, 
although 17-2 was present in the terminal ileum in this case (Kang et al., 2001).  
There are conflicting conclusions on cytotoxicity, with some studies observing no 
mucosal abnormalities (Knutton et al., 1992), while others reported enlarged crypt 
openings and cell extrusion (Hicks et al., 1996) or possible microvilli effacement 
(Andrade et al., 2011). In this study, any similar observations were rare for infected 
colonic biopsies, and not deemed sufficiently distinct from uninfected control tissue 
to support a cytotoxic bacterial effect. As these reported cytotoxic indications are 
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based on microscopical observations, it is probable that differences in individual 
interpretation contribute to the lack of consensus.     
In parallel with IVOC experiments, two well-established human intestinal epithelial 
cell lines were used; T84 and Caco-2. Although both are colon carcinoma-derived 
cell lines, the differences in their fine structure and function have led to their use as 
models for different GI tissue types. T84 cells exhibit structural similarity to 
colonocytes and form highly polarised columnar epithelia upon confluency (Madara 
et al., 1987). Conversely, confluent Caco-2 cells spontaneously differentiate into a 
structure reminiscent of small intestinal enterocytes. This includes the development 
of a small intestinal brush border and the expression of specific surface enzyme 
markers such as sucrase, maltase, lactase, alkaline phosphatase, gamma-
glutamyltransferase, aminopeptidase N, and dipeptidyl-dipeptidase IV (Jumarie and 
Malo, 1991). T84 cells do not undergo such differentiation, maintain shorter 
microvilli and express colonic markers such as monocarboxylate transporter 1, 
responsible for improved barrier function in response to butyrate exposure 
(Devriese et al., 2017). Due to these distinctions, T84 and Caco-2 cells were used in 
this study as culture models for the colonic and small intestinal epithelium, 
respectively. 
It was demonstrated that 042 and 17-2 colonised both T84 and Caco-2 cell 
monolayers, with similar efficiency at most time points. When quantified by CFU 
counting of cell lysates plated on LB agar, the level of adherence was only 
significantly different at 2 hours incubation on T84 cells. While not statistically 
significant, adherence was consistently higher for 17-2 than 042 with both cell lines, 
although this may be due to the faster growth rate of 17-2 in cell culture media 
rather than superior cell adhesion. These prototype strains have been previously 
studied in interaction with T84 and Caco-2 cells, with some discrepancies. T84 cells 
have been proposed as a suitable colonic model for 042 infection due to similar 
adherence and possible cytotoxicity compared to observations in IVOC, yet the 
same study reported poor adherence of 042 to Caco-2 cells (Nataro et al., 1996). 
This disagreement with the findings presented here may be due to a difference in 
analysis techniques. While this study determined colonisation qualitatively by 
immunofluorescence, phase-contrast, and bright-field microscopy, and 
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quantitatively by plating, Nataro et al. used SEM which involves more rigorous 
processing protocols. In addition, several subclones of the Caco-2 cell line are 
available which differ in properties. In contrast to 042, strain 17-2 has been shown 
to effectively colonise Caco-2 cells in multiple publications (Steiner et al., 1998, 
Couto et al., 2007). However, to my knowledge the adherence of 17-2 to T84 cells 
has not previously been characterised.  
While 042 and 17-2 demonstrated similar levels of colonisation, a morphological 
difference was observed on both cell lines, as was also previously described with 
IVOC. While both strains formed adherent aggregates on the surface of the cell 
monolayers, a denser aggregation was frequently observed for 042 compared to 
17-2. In addition, 042 bacteria were mostly confined to aggregates only, whereas 
17-2 demonstrated a more diffuse adherence pattern alongside the aggregative 
colonies for some samples. While this did not affect the quantity of adherent 
bacteria in these experiments, these observations do suggest possible differences in 
adherence mechanisms.  
One relevant difference between 17-2 and 042 is the expression of different AAF 
variants, AAF/I and AAF/II, respectively. The AAF operons have well-conserved 
usher and chaperone genes, but the structural pilin subunit has high sequence 
diversity between variants (Boisen et al., 2008). While the relative adherence 
characteristics between each type have not been clearly defined, they are known to 
affect phenotypes. Different AAFs show variation in agglutination of erythrocytes 
from different species, suggesting differences in receptor recognition (Berry et al., 
2014). On a structural level, AAF/V has been shown to possess an inserted helix 
which is predicted to prevent the fibronectin binding common to the other four 
subunits (Jonsson et al., 2017a). The phenotypic difference between variants is 
further evidenced by a study which demonstrated that AAF/V caused significantly 
greater HEp-2 cell adherence and biofilm formation than AAF/III when cloned into 
the same laboratory E. coli strain (Jonsson et al., 2015). There is also evidence that 
the AA phenotype of EAEC is likely to be a multi-factorial process. As well as AAFs, 
the dispersin protein, type I fimbriae, heat-resistant agglutinin 1, and the E. coli 
common pilus are amongst the virulence factors associated with EAEC AA (Blanton 
et al., 2018, Moreira et al., 2003, Avelino et al., 2010). While the factors responsible 
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for the morphological differences observed between 042 and 17-2 in this study 
remain undetermined, this further demonstrates the heterogeneity of EAEC strains. 
The results of the IVOC infection experiments with 042 and 17-2 suggest that EAEC 
primarily colonise the colon. This emphasises the value of using ex vivo tissue 
models in addition to in vitro cell line experiments, as the EAEC strains did not 
demonstrate greater adherence to the colonocyte-like T84 cells than the small 
intestinal enterocyte model, Caco-2. As the key binding targets for EAEC adherence 
are poorly understood, it may be that despite the enterocyte-like differentiation of 
confluent Caco-2 cells, they retain elements of their colonic background which 
allows EAEC colonisation (Izquierdo et al., 2014a, Devriese et al., 2017). This would 
explain why the cell culture results do not reflect the tissue tropism observed in the 
IVOC infection model. 
 
3.3.2: Intolerance of intestinal epithelial cell lines to simulated 
intestinal media components 
Various simulated intestinal fluids have previously been designed to mimic the 
conditions of the human intestinal environment for studies such as the effect on 
drug structure and uptake (Ingels et al., 2004, Doak et al., 2010). Versions have also 
been used for microbiology, including the influence of a simulated gut environment 
on pathogenic E. coli. Two previously described compositions were selected; 
simulated colonic environment medium (SCEM) and simulated ileal environment 
medium (SIEM). Each contains biologically relevant concentrations of salts, bile 
acids (cholic and deoxycholic acid) and glucose, as well as additional digestive 
enzymes in SIEM. One study used these media to investigate the intracellular 
proteome of an EHEC O157:H7 strain under different simulated conditions, 
revealing that the environment affected expression of nucleotide biosynthesis 
pathway proteins, virulence factors and stress response genes (Polzin et al., 2013). 
SIEM and SCEM have also been used to study the Sfp fimbriae of EHEC O157:NM, 
which are not expressed under standard laboratory growth conditions (Müsken et 
al., 2008). This study planned to evaluate the effect of these simulated conditions 
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on EAEC colonisation of the intestinal epithelium. However, SIEM and SCEM had 
previously been used for bacterial culture alone, so experiments were first 
performed to determine if these media could support co-culture with intestinal 
epithelial cells. Simulated intestinal fluids have been used with Caco-2 cells 
previously, but these did not contain bioactive components such as bile salts or 
digestive enzymes (Ingels et al., 2004). Therefore the tolerance was tested of 
enterocyte-like Caco-2 cells and colonocyte-like T84 cells to SIEM and SCEM, 
respectively.  
As complete simulated media caused total cell detachment and loss of viability, 
individual media components were tested for cytotoxicity. Using increasing 
concentrations of bile salts (cholic acid and deoxycholic acid), toxic effects were 
observed with concentrations above 400-600 µM for Caco-2 cells and 200 µM for 
T84 cells. This agrees with previous studies where a selection of bile acids, including 
cholic and deoxycholic acids, caused cytotoxicity in Caco-2 cells at concentrations 
higher than 400 µM. In addition, changes in tight junction structure and barrier 
function, and disorganisation of occludin were reported similar to the observations 
presented here (Raimondi et al., 2008). Moreover, deoxycholic acid exhibited 
cytotoxic effects on T84 cells above a concentration of 200 µM, which agrees with 
the data in this study (Niamh et al., 2009).  
The bile acid concentrations specified for SIEM and SCEM were 6.63 mM and 4.73 
mM, respectively. This is within some estimates of the physiological range for bile 
acids in the human small intestine (Hamilton et al., 2007). However, bile acids 
undergo active reabsorption in the distal small intestine, with as little as 2-5% 
entering the colon (Niamh et al., 2009, Li and Chiang, 2014). The relatively high 
concentration of bile acids in SCEM may therefore be inaccurate when compared to 
physiological colonic conditions. While Caco-2 cells undergo differentiation and 
present features of small intestinal enterocytes, both T84 and Caco-2 are colon 
carcinoma-derived cell lines. As such, the bile acid cytotoxicity demonstrated in 
these experiments may be explained by the inability of colonic epithelial cells to 
tolerate prolonged exposure to the higher bile acid concentrations of the small 
intestinal environment. In addition, these cell lines do not secrete a mucus layer, 
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which likely protects intestinal cells from bile acid toxicity in vivo (Niv et al., 1992, 
Navabi et al., 2013, Shekels et al., 1996)  
The published composition of SIEM includes the addition of the digestive enzymes 
α-amylase, trypsin, chymotrypsin, and lipase (Polzin et al., 2013). However, in this 
study these components were replaced due to concerns of loss of enzymatic 
activity during media storage between experiments. The alternative of adding the 
enzymes to aliquots of unsupplemented SIEM before each assay was not practical 
due to the small volumes required. Instead, 1% (w/v) pancreatin, which is extracted 
from porcine pancreas and contains a biologically relevant mixture of mammalian 
digestive enzymes, was added to SIEM aliquots immediately before use (Markell et 
al., 2017). However, the inclusion of pancreatin in SIEM caused major detachment 
of Caco-2 cells from coverslips even at ten-fold reduced concentrations. 
Interestingly, any residual cells were viable by Trypan Blue staining, suggesting 
disruption of focal cell adhesions by enzymatic action of pancreatin, without loss of 
cell viability. Pancreatin is typically used for in vitro food digestion models rather 
than cell culture (Hur et al., 2011). It has been successfully utilised in infections of 
stem cell-derived human intestinal organoids by Rotaviruses, but this is a non-
adherent model so cell detachment would not be observed (Finkbeiner et al., 
2012). One study previously used pancreatin to simulate gastric digestion of 
potentially harmful proteins, which were subsequently tested on Caco-2 
monolayers. However, the pancreatin enzymes were deliberately heat-inactivated 
before samples were incubated with the Caco-2 cells to avoid potential alterations 
of monolayer integrity and viability (Markell et al., 2017). Therefore, the inclusion 
of digestive enzymes in SIEM is suitable for investigating effects on bacteria alone, 
but causes problems in combination with adherent cell culture due to the 
enzymatic disruption of cell attachments. 
Not all SIEM and SCEM components were poorly tolerated, with lysozyme and the 
various specified salt concentrations causing no observed cytotoxicity or cell 
detachment. However, the exclusion of multiple important components would have 
reduced the relevance of the simulated conditions, as well as complicating any 
comparison of results with previous publications. Additionally, even using a 
simulated medium modified for intestinal epithelial tolerance could induce 
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underlying changes in the cells, potentially influencing interactions with EAEC and 
making comparisons to data produced using standard cell culture more challenging. 
It was also noted that the standard culture media for T84 and Caco-2 cells 
(DMEM/F-12 and DMEM, respectively) contain comparable salt concentrations to 
the simulated media specifications (Appendix 3). Overall, it was determined that 
the simulated intestinal media were not suitable for further use in this study. 
 
3.3.3: Oxygen as a regulatory signal for EAEC virulence 
One of the major benefits of the VDC as an in vitro culture model is the ability to 
control oxygen levels in the media through perfusion of aerobic (AE) or anaerobic 
(AN) gas mixtures. As the VDC system has not previously been used for the study of 
EAEC, oxygen levels during bacterial incubation were determined with an oxygen 
sensitive electrode probe before establishment of the infection protocol. As 
expected, bacterial growth caused depletion of oxygen over time, especially for the 
faster-replicating strain 17-2. The initial dissolved oxygen concentration in 
microaerobic (MA) chambers was in the range of 1.5-2.5%, which is comparable to 
the estimates of 1-2% in previous studies using the VDC model (Schüller and 
Phillips, 2010). It also corresponds to estimates for the human gut epithelial surface 
of 2-4% oxygen, with a steep gradient approaching AN conditions for the central 
lumen (Zeitouni et al., 2016).  
In addition to oxygen measurements, E. coli respiration was analysed by qPCR 
analysis of terminal cytochrome oxidase expression. The cyoA gene is part of the 
cytochrome o oxidase complex used by E. coli under AE growth, while cydB is a 
subunit of the high-affinity cytochrome d oxidase complex which is expressed under 
MA conditions and shown to be important for E. coli colonisation in the mammalian 
intestine (Tseng et al., 1996, Jones et al., 2007). Oxygen limitation causes the 
transition from cytochrome o oxidase to cytochrome d oxidase as the major 
terminal oxidase for E. coli respiration, controlled by the ArcA global regulator 
(Alexeeva et al., 2003). When the relative expression of these genes was compared 
between bacteria incubated in AE or MA VDC compartments for 3 hours, cyoA was 
downregulated by microaerobiosis as expected. The expression of cydB was 
146 
 
increased for EAEC in MA chambers, but not as strongly as the decrease in cyoA. 
This may be partially explained by the dissolved oxygen measurements, which 
showed that the chambers initially maintained under MA conditions began to 
approach full AN status by 3 hours of bacterial growth. As the cytochrome d oxidase 
complex is expressed strictly in MA conditions, a transition to AN respiration may 
have occurred. This switch, regulated by the FNR system, would account for the 
relatively small upregulation of cydB observed (Sawers, 1999, Tseng et al., 1996). 
Combined with the measurements of dissolved oxygen concentrations, this data 
confirms that the AE and MA conditions as set up in the VDC system maintain a 
distinct difference in oxygen availability throughout the incubation, and that this 
induces related gene expression changes. As oxygen was also further depleted 
during AE incubation of 17-2 by 4 hours, a 3-hour incubation period was selected 
for investigating changes in EAEC gene expression in response to oxygen 
availability.     
After establishment of oxygen levels during EAEC incubation under AE and MA 
conditions, growth and relative virulence gene expression for EAEC were evaluated. 
As expected for a facultative anaerobe, EAEC replication was greater in AE versus 
MA conditions as AE respiration allows more energy efficient metabolism and 
growth in E. coli (Jones et al., 2007). Analysis by qPCR revealed that for strain 042, 
aggR, aap, aafA, and ecpA were upregulated under AE conditions. The results were 
consistent for non-adherent EAEC incubated in chambers with polarised T84 cells, 
although for 042 the EAST-1 toxin gene astA was also significantly upregulated in AE 
chambers.  
Dispersin and AAF/II are both part of the AggR regulon, and these three genes were 
induced to a similar degree, suggesting an AggR-mediated response to oxygen. 
When an 042 aggR deletion mutant and complemented strain were investigated, 
absence of aggR caused a non-significant decrease in the induction of aap and aafA 
by oxygen compared to the wild-type strain, which was restored by 
complementation for aap. However, astA expression, which is not reported as 
AggR-regulated, was also affected in the knockout strain. These experiments 
suggest that AggR signalling may be involved in the transcriptional response of 042 
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to oxygen availability, but uncertainties in the data support an influence from other 
unidentified factors.  
How oxygen-sensing may influence AggR expression remains unknown. AggR itself 
has been linked to positive regulation by a DNA-binding protein Fis, and is 
negatively regulated by the E. coli global regulator HN-S, both of which are nucleoid 
proteins associated with gene transcription in rapidly growing cells (Morin et al., 
2010, McLeod and Johnson, 2001). While there is some evidence of cross-talk 
between Fis and the ArcA/FNR redox-sensing transcription factors, the link between 
oxygen availability and AggR remains to be investigated (Cameron et al., 2013).  
The E. coli common pilus (ECP) is not reported to be under AggR regulation but was 
also induced by oxygen. Some precedence for oxygen regulation of ecpA has been 
reported in EHEC, where protein expression was higher in low oxygen levels than 
full aeration, but lowest during AN incubation (Rendón et al., 2007). This 
corresponds with reduced ecpA gene expression by 042 in the MA chambers in this 
study, which were close to AN after 3 hours. This suggests ECP expression is 
enhanced in oxygen conditions similar to the mucosal interface, but the regulatory 
mechanism is unknown. The astA gene is also not under AggR regulation and has 
not been previously linked to oxygen sensing. However, astA expression was only 
significantly upregulated by oxygen in the presence of T84 cells. This may be linked, 
as astA was the most strongly induced virulence factor by T84 adherence, and 
shedding of bacteria from adherent 042 aggregates might confound results for non-
adherent bacteria.   
Unlike 042, the prototype strain 17-2 did not demonstrate significant changes in 
expression of any of the investigated virulence genes in response to oxygen. The 
AggR associated genes (aggR, aap, aggA) showed an increase in expression under 
AE conditions, but this did not reach statistical significance. This could be a lack of 
response for 17-2 or could indicate different kinetics for this strain. It is unclear why 
the response to oxygen availability differs between 042 and 17-2, but this is further 
evidence of the heterogeneity intrinsic to EAEC as a whole.  
While the effects of oxygen on EAEC virulence have not been previously 
characterised, oxygen has been reported as an important signal for other enteric 
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pathogens (Marteyn et al., 2011). In many cases, MA conditions similar to the low 
oxygen availability of the GIT have been reported to enhance aspects of virulence. 
For example, Salmonella Typhimurium demonstrated increased adherence and 
invasion of canine kidney epithelial cells at low oxygen tension (Lee and Falkow, 
1990). In addition, enterocyte binding, mucus penetration, and intracellular 
macrophage survival in mice were enhanced for S. Typhimurium after oxygen-
restricted growth (Singh et al., 2000). For Salmonella, the oxygen-sensing FNR 
regulator is implicated in modulating virulence gene expression including the T3SS 
on Salmonella pathogenicity island 1, and FNR mutants are severely attenuated in 
murine infection (Fink et al., 2007). Low oxygen levels also enhanced maturation of 
the T3SS and secretion in EHEC, along with T3SS-associated adherence to epithelial 
cells (Schüller and Phillips, 2010, Ando et al., 2007, Carlson-Banning and Sperandio, 
2016). The expression of Sfp adhesion fimbriae by sorbitol-fermenting EHEC 
O157:NM strains is also dependent on low oxygen tension (Müsken et al., 2008). 
There is also evidence of pathogens using the oxygen diffusion gradient across the 
intestinal epithelium as a specific signal for activation of virulence systems. A 
previous study on Shigella flexneri showed that oxygen-starvation enhanced 
expression of a T3SS essential for cell invasion and virulence, yet also caused an 
FNR-regulated suppression of effector protein secretion. This resulted in 
accumulation of virulence proteins inside the bacterial cell which was relieved by 
the oxygen gradient in proximity to the mucosal surface, thereby restricting full 
T3SS activity to the precise site of action (Marteyn et al., 2010). It has been 
speculated that oxygen gradient sensing may also contribute to chemotaxis and 
motility in Salmonella within the mucus layer (Bärbel et al., 2008). In E. coli, the 
enhancing effect of oxygen gradients on bacterial motility has been described 
(Douarche et al., 2009). It is possible that mucosal oxygen diffusion could modulate 
EAEC migration towards the epithelial surface in addition to influencing virulence 
gene expression. 
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3.3.4: Host cell contact as a regulatory signal for EAEC virulence 
Previous IVOC studies presented here and by others suggested preferential EAEC 
binding and colonisation of the colon (Andrade et al., 2011, Nataro et al., 1996, 
Hicks et al., 1996). Therefore, polarised T84 monolayers were chosen as a model for 
the colonic epithelium in this part of the study. Epithelial barrier function of 
polarised T84 monolayers was monitored during incubation by measuring the 
transepithelial electrical resistance (TEER). While an initial drop in TEER was 
observed after mounting of the Snapwell inserts (possibly due to the switch to non-
supplemented cell culture media and physical stresses within the chamber), 
infection with 042 or 17-2 did not cause a significant loss of barrier function 
compared to non-infected monolayers over a 3h time period, which agrees with 
previous work using polarised T84 cells infected with 042 (Strauman et al., 2010). 
Therefore, while 042 adherence may disrupt the T84 monolayer integrity over time, 
barrier function was sufficiently stable during the 3 hours of the infection assay. 
The relative expression of nine EAEC virulence genes was determined for adherent 
versus non-adherent bacteria from the same inoculated VDC compartments. 
Phenol-ethanol treatment was used to stabilise mRNA at the experimental end-
point, which has been demonstrated to efficiently preserve gene expression 
profiles in E. coli (Bhagwat et al., 2003). In contrast to the regulatory effect of 
oxygen in 042, adherence enhanced expression of not only colonization-associated 
virulence genes but also those encoding toxins and SPATEs (astA, hlyE, pet, and pic) 
for both strains. The effect of adherence on gene expression was largely consistent 
in both AE and MA conditions, suggesting that this is linked to separate signalling 
pathways than the response to oxygen. This also rules out the effect of hypoxia-
induced changes to epithelial cells, such as membrane alterations, cytoskeletal 
rearrangements, or endoplasmatic reticulum stress (Zeitouni et al., 2016). Such 
changes have been previously associated with modulating virulence of 
enteropathogenic bacteria, with hypoxic stress decreasing internalisation of 
Shigella flexneri but enhancing invasion of HT-29 enterocyte cells by Listeria 
monocytogenes and some E. coli (Lima et al., 2013a, Wells et al., 1996).  
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While AggR-regulated factors such as dispersin and the AAFs were induced by 
adherence, no change in expression of aggR itself was observed for adherent 042. 
This result suggests that unlike the response of 042 to oxygen, enhanced EAEC 
virulence gene expression following epithelial adherence may be independent of 
AggR regulation. An aggR-deletion mutant in 042 demonstrated loss of the AA 
phenotype on T84 cells and showed a more than 100-fold decreased expression of 
the AggR-regulated genes aap and aafA, but not astA (not part of the AggR 
regulon), compared to wild-type 042. A plasmid complement restored expression of 
aggR, aap, and aafA to above wild-type levels. However, deletion of aggR did not 
abolish the relative upregulation of astA, aap, and aafA by T84 adherence, 
supporting the hypothesis that this effect is independent of AggR signalling. 
Unexpectedly, T84 adherence did not upregulate aafA or aap expression in the 
complemented strain. The pBAD30 plasmid used has sensitive promoter induction 
and a reported medium-high copy number (10-12 copies per cell), resulting in 
increased expression of plasmid-encoded genes (Sheikh et al., 2006, Guzman et al., 
1995). AggR is a transcriptional regulator with many genetic interactions, so 
increased expression may disrupt other important pathways (Morin et al., 2013). 
The potential disadvantages of overexpression for loss of physiological relevance 
and detrimental effects on the bacteria were briefly discussed when the pBAD 
plasmids were originally constructed (Guzman et al., 1995). In addition, glucose acts 
as a repressor for the araBAD promoter on this plasmid, with the relatively 
abundant glucose concentration in DMEM/F12 medium therefore potentially 
complicating the stability of expression levels and outcomes for the complemented 
strain (Guzman et al., 1995, Siegele and Hu, 1997) 
Many enteric pathogens use chemical cues from the intestinal environment to 
regulate virulence gene expression. EHEC is a well characterised example, shown to 
modulate virulence in response to various environmental factors such as acid 
stress, microbiota metabolites, and even host hormones (Foster, 2013). Often these 
signals are secreted by the host epithelium. For example, EHEC O157:H7 recognises 
epinephrine and norepinephrine using two adrenergic kinases, QseC and QseE, 
leading to enhanced LEE gene expression, bacterial motility, Shiga toxin production, 
and A/E lesion formation on epithelial cells (Njoroge and Sperandio, 2012). 
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Similarly, A/E lesions and expression of virulence regulators (including Ler, QseC, 
and QseE) and Shiga toxin are all increased in EHEC in response to ethanolamine, 
which is generated by turnover of both host epithelial cells and the microbial flora 
(Kendall et al., 2012). However, EHEC virulence is also mediated by physical 
interactions with the host epithelium. Mechanosensation is necessary for full LEE 
expression via GrlA regulation, dependent on both strong surface attachment and 
fluid shear forces (Alsharif et al., 2015, Islam and Krachler, 2016). 
This study demonstrated that direct bacterial contact with the host epithelium was 
required for enhanced EAEC virulence gene expression as separation of bacteria 
from the host cells by a Transwell membrane did not cause any changes in 
transcription. Notably, induction of astA, aap, and aafA/aggA expression in 
adherent EAEC was less pronounced in experiments conducted in 12-well plates 
compared with the VDC system. This may be caused by differences in interactions 
with the less polarised T84 cells in wells compared to the highly-polarised 
monolayers on Snapwells in the VDC model, such as the expression and apical 
localisation of potential binding receptors (Navabi et al., 2013). Additionally, the 
well plate model is a static incubation with gravity promoting bacterial settling on 
the epithelial surface, while the gas flow through VDC compartments causes more 
dynamic conditions. Fluid shear forces are important in the mechanosensation 
described for adherent EHEC, so this may also contribute to the greater gene 
expression change for adherent EAEC in the VDC model (Alsharif et al., 2015). 
This data suggests that the observed effect of T84 adherence on EAEC virulence 
gene expression is dependent on mechanical contact rather than sensing of 
chemical components. Previous studies have shown that adherence of Vibrio 
cholerae to intestinal epithelial INT 407 cells induces two major virulence factors, 
cholera toxin and the toxin-coregulated pilus, as well as the virulence regulatory 
gene toxT. Interestingly, toxT induction was independent of the conventional toxT 
activators ToxR and TcpP, which is similar to the apparently AggR-independent gene 
expression in this work (Dey et al., 2013).  
While many EAEC adherence factors have been described, the binding receptors 
have yet to be fully characterised. However, some possible interactions have been 
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identified. The AAF genes are similar in organisation to the Afa/Dr family of E. coli 
adhesins which bind to extracellular matrix (ECM) components. Previous studies 
have shown that 042 adheres to surfaces coated with ECM proteins, that AAF/II 
demonstrates binding to fibronectin specifically, and that fibronectin interactions 
also involve integrin α5β1  (Farfan et al., 2008, Izquierdo et al., 2014a). However, 
the ECM is localised at the basement membrane and is not typically accessible to 
enteric bacteria, although there is evidence that some ECM proteins including 
fibronectin may be exposed to the apical environment during inflammation (Walia 
et al., 2004). Interestingly, AAFs induce inflammation in intestinal epithelial cells 
during EAEC infection (Harrington et al., 2005, Boll et al., 2012). Cytokeratin-8 (CK8) 
has also been identified as a potential EAEC receptor and binding site for AAF/II 
(Izquierdo et al., 2014b). The accessibility of bacteria to CK8 in vivo is unclear, as it 
is usually associated with intermediate filaments underlying the apical brush border 
of polarised intestinal epithelial cells (Coch and Leube, 2016). In contrast, many 
cancer-derived cell lines used in bacterial adherence studies express CK8 on the 
plasma membrane surface, which may limit the physiological relevance (Gires et al., 
2005). A target for EAEC binding that is expressed on the intestinal epithelial 
surface is the mucin glycoprotein MUC1 (McGuckin et al., 2011). Interactions 
between AAFs and MUC1 enhance EAEC adhesion and cause a pro-inflammatory 
response (Boll et al., 2017). Increased MUC1 levels are associated with Citrobacter 
rodentium infection in the murine colon (a model for EHEC and EPEC pathogenesis), 
and previous studies have shown that the EAEC Pic mucinase increases mucus 
secretion and promotes intestinal colonization and growth in the presence of mucin 
(Lindén et al., 2008, Harrington et al., 2009, Navarro-Garcia et al., 2010). To my 
knowledge, none of these binding interactions have been associated with 
modulating EAEC virulence gene expression.  
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3.4: Summary  
The results of this study can be interpreted as evidence of two separate 
environmental signals that allow EAEC to adapt for intestinal colonisation (Figure 
3.24). The first is a response to oxygen, which occurs as the bacteria approach the 
mucosal surface. From the more AN lumen, enteropathogenic bacteria encounter 
an oxygen gradient established by diffusion of oxygen across the epithelial barrier 
from the bloodstream (Marteyn et al., 2011). This relative increase in oxygen 
concentration acts as a signal to prime the bacteria for adherence. Correspondingly, 
the data for EAEC 042 demonstrates an oxygen-induced and AggR-regulated 
upregulation of key virulence factors for initial epithelial adhesion: the adhesins 
AAF/II and the E. coli common pilus, and dispersin.  
Once physical contact is established with colonic epithelial cells, the expression of 
further EAEC virulence factors is induced. As well as adherence-related genes, this 
includes upregulation of genes linked to colony spatial organisation (aap), 
modulation of the mucus layer (pic), and secreted toxins (astA, hlyE, pet) (Navarro-
Garcia et al., 2010, Velarde et al., 2007). The data suggests the induction of 
virulence gene transcription at this stage is independent of AggR regulation. 
Subsequently, colony expansion and interactions between host cells and EAEC 
factors such as flagella and toxins can induce inflammation and symptomatic 
diarrhoeal illness (Steiner et al., 2000).  
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Figure 3.24 Proposed model for EAEC response to oxygen and host epithelial contact 
during infection. Yellow region represents biofilm development and green particles 
represent toxin secretion. Adapted from (Hebbelstrup Jensen et al., 2014). 
 
  
155 
 
Chapter 4 Phenotypic and genotypic analysis of EAEC 
sequence types associated with disease or carriage 
CHAPTER FOUR 
Phenotypic and genotypic analysis 
of EAEC sequence types associated 
with disease or carriage 
 
 
 
 
 
 
 
 
 
Collaborative work:  
Biopsies provided by Anne Smith, Vivienne Cook, Anups De Silva, Richard Tighe, and 
Bernard Brett 
SEM support provided by Bertrand Lézé 
Whole-genome sequencing performed by Gemma Kay and John Wain, and Genomic 
Servicing Unit and Gastrointestinal Bacteria Reference Unit at Public Health England 
Bioinformatic support provided by Rob Kingsley, Matt Bawn, and Oliver Charity  
  
156 
 
4.1: Introduction 
A major limitation for monitoring EAEC pathogens is a lack of virulence markers. 
While a number of virulence genes have been associated with EAEC pathogenesis, 
many are only present in a minority of clinical strains. In addition, the importance of 
specific virulence factors for an EAEC strain to cause enteric disease rather than 
asymptomatic carriage remains unclear (Okhuysen and DuPont, 2010, Bafandeh et 
al., 2015). Correlations of putative virulence genes such as astA, aap, pic, and aggA 
with diarrhoea have been reported, but these associations are often inconsistent 
between studies (Pereira et al., 2007, Zamboni et al., 2004, Bafandeh et al., 2015, 
Hebbelstrup Jensen et al., 2017). For example, one case-control study with 128 
EAEC strains found no statistical difference in the prevalence of any of 11 major 
EAEC virulence factor genes between cases and controls (Elias et al., 2002). Also, 
while a virulence gene may be identified in an isolate’s genome, it may not be 
expressed under physiological conditions or contribute to in vivo pathogenesis.  
To investigate these relationships, this study aimed to compare EAEC strains from 
case-control studies and outbreaks for differences in virulence-associated 
phenotypes in vitro, as well as analysing genotypic differences in putative virulence 
genes. The phenotypes evaluated included biofilm formation and the HEp-2 
adherence assays as models of bacterial aggregation, with the latter established as 
the gold-standard diagnostic tool for EAEC. The in vitro adherence of the clinical 
isolates to a human colonic epithelial cell line, and ex vivo colonisation of human 
colonic biopsies, was also investigated. These are experimental models for the 
colonisation of the epithelium of the human colon, a key part of typical EAEC 
pathogenesis (Hebbelstrup Jensen et al., 2014).  
Traditionally, serotyping has been widely applied for investigating pathogenic E. 
coli, remaining in use due to the applicability across pathotypes and the ability to 
use serotypes for functions such as outbreak tracking. While EHEC O157:H7 is an 
example of a serotype strongly associated with virulence, serotyping has not proven 
effective for distinguishing pathogenic strains for EAEC. Additionally, performing 
phenotypic serotyping is labour-intensive and typically limited to specialised 
reference laboratories (Jenkins, 2015, Fratamico et al., 2016). A more recent 
157 
 
alternative typing scheme is Multi-Locus Sequence Typing (MLST), first developed 
for Neisseria meningitidis, but now applied to many pathogens including E. coli 
(Maiden et al., 1998, Larsen et al., 2012). This technique uses the allelic profile of 
seven core gene fragments, traditionally amplified by PCR, to type matching strains 
into corresponding sequence types (STs). Although lacking the discriminatory power 
to differentiate individual strains, MLST can be a powerful tool for investigating 
population genetics. One such study investigated the STs present in a collection of 
564 clinical EAEC isolates, sourced from multiple case-control cohort studies as well 
as sporadic and outbreak strains (Chattaway et al., 2014b). A key finding was that 
certain STs had statistically significant higher or lower association with disease than 
the overall collection (Figure 4.1). In particular, ST40 had an increased ratio of 
disease case strains versus control strains, while ST31 had a higher proportion of 
asymptomatic carriage. These groups were selected for further characterisation in 
this study. 
 
Figure 4.1 Minimal spanning tree of 564 clinical EAEC isolates. (Chattaway et al., 2014b) 
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Following the previous MLST study using these EAEC strains, the collection has since 
been genome sequenced in collaborations with Public Health England (PHE) and 
Norwich Medical School. This allows the use of bioinformatic tools to compare the 
virulence gene profile of ST40 and ST31 strains. In addition, sequencing data can be 
exploited for in silico typing approaches, including serotyping, MLST, and 
phylogenetic analysis, which can reveal additional detail compared with traditional 
phenotype-based techniques alone (Fratamico et al., 2016).  
The objectives of this study were to: 
 Investigate if strains from ST40 and ST31, which differ in their epidemiological 
association with disease, demonstrate differences in virulence-associated 
phenotypes in vitro 
 Use whole genome sequencing data to evaluate serotype, ST, and phylogenetic 
variation of these strains 
 Identify genotypic differences in virulence genes between ST40 and ST31 strains  
 
4.2: Results 
4.2.1: Virulence-associated in vitro phenotypes 
The first part of this project aimed to use in vitro and ex vivo models to investigate 
any phenotypic difference between EAEC strains from ST40, epidemiologically 
associated with disease, and ST31, associated with carriage. Eight ST31 strains (4 
isolated from cases of diarrhoea and 4 controls) and eight ST40 strains (6 cases and 
2 controls) were investigated in this study (see Table 2.1 for full sources).  
 
4.2.1.1: Adherence to HEp-2 cells 
Many of the ST40 and ST31 strains were isolated from case-control studies and 
classified as EAEC by PCR probes only. Therefore, all strains were first confirmed as 
EAEC using the gold-standard diagnostic tool, the HEp-2 adherence assay. 
Prototype EAEC strains 042 and 17-2 were also included as positive controls. HEp-2 
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cells were incubated with bacteria for 3 hours, and the adherence phenotype for 
each strain was evaluated by microscopy. 
All EAEC isolates from this study adhered to HEp-2 cells and the underlying 
coverslip, but differences in morphology were observed between STs (Figure 4.2 
and 4.3). The prototype EAEC strains 042 and 17-2 demonstrated typical 
aggregative adherence (AA), with dense bacterial aggregates and a “stacked-brick” 
colonisation pattern. ST40 strains demonstrated AA comparable to 042 and 17-2, 
including large aggregative colonies. However, ST31 isolates exhibited more 
variation in the adherence pattern. Although some areas of AA were seen for all 
strains, aggregates were typically smaller and less dense than observed for ST40 
and there were also regions of more diffuse colonisation. In addition, ST40 strains 
had an observably higher level of total adherence than ST31. Overall, all strains 
displayed the AA phenotype on HEp-2 cells to confirm the EAEC classification, 
although differences in adherence were observed between the STs.     
160 
 
 
Figure 4.2 Aggregative adherence phenotype of ST31 strains. HEp-2 cells were incubated 
with ST31 EAEC for 3 hours (MOI = 20 bacteria/cell), and the colonisation phenotype 
evaluated by microscopy. Prototype EAEC strain 042 was included as a positive control. 
Images are representative of experiments performed in duplicate. 
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Figure 4.3 Aggregative adherence phenotype of ST40 strains HEp-2 cells were incubated 
with ST40 EAEC for 3 hours (MOI = 20 bacteria/cell), and the colonisation phenotype 
evaluated by microscopy. Prototype EAEC strain 17-2 was included as a positive control. 
Images are representative of experiments performed in duplicate. 
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4.2.1.2: Biofilm formation  
Biofilm formation by the EAEC isolates was assessed using a crystal violet assay, 
which is a widely used method for determining bacterial aggregation (O'Toole, 
2011). EAEC were incubated for 48 hours in a 96-well microtiter culture plate and 
crystal violet stain used to quantify bacterial density by absorbance. The incubation 
conditions used (37 °C in DMEM) had previously been reported to induce maximal 
biofilm formation for the EAEC prototype strain 042 (Sheikh et al., 2001). Strain 042 
was used as a positive control and produced denser biofilms than all the clinical 
isolates. Overall, ST40 strains demonstrated significantly higher biofilm formation 
than those from ST31 (P < 0.05) (Figure 4.4). Only one ST40 isolate (221654) 
produced an average absorbance below 0.2, while only one strain from ST31 
(E104931) exceeded this value. In addition, biofilm formation by case and control 
isolates did not differ significantly for either ST. EAEC were also incubated with glass 
coverslips for 48 hours as above and stained with crystal violet for microscopy 
(Figure 4.5). The observed biofilm density was consistent with the quantitative 
data, with ST40 strains exhibiting greater bacterial aggregation than ST31 isolates. 
 
Figure 4.4 Biofilm formation by EAEC isolates. Bacteria were incubated in 96-well plates at 
37 °C for 48 hours and treated with crystal violet stain. Biofilm density was quantified by 
absorbance at 595 nm (OD595). Data are shown as mean ± SE for 3 experiments, each with 5 
technical replicates. * P < 0.05. 
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Figure 4.5 EAEC biofilm on abiotic surface. EAEC were incubated with a glass coverslip for 
48 hours and stained with crystal violet for bright-field light microscopy (representative 
images of ST40 and ST31 strains, and 042 prototype strain as positive control). 
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4.2.1.3: Adherence to T84 intestinal epithelial cells 
To ascertain whether EAEC strains from ST40 and ST31 differ in their ability to 
colonise intestinal epithelial cells, a cell culture model of infection was used. 
Confluent cells of the T84 colon carcinoma-derived cell line were incubated for 2 
hours with EAEC. Bacterial adherence was quantified by plating of lysates on LB 
agar and CFU counting, normalised against inoculum concentration. 
All isolates adhered to T84 cells. However, ST40 isolates demonstrated significantly 
higher adherence than those from ST31 (P < 0.001) (Figure 4.6). EAEC strain 042 
was also evaluated as a positive control. All ST40 strains adhered to the T84 
monolayer to a comparable or greater extent than 042 in these assays. Conversely, 
all ST31 isolates exhibited lower adherence than either the positive control or any 
individual ST40 example. When isolates from a case or control source were 
compared within STs, no significant differences were detected. 
 
Figure 4.6 Adherence of EAEC to T84 cells. Confluent T84 cells were incubated with EAEC 
(MOI = 10 bacteria/cell) for 2 hours. Adherent bacteria were quantified by plating of cell 
lysates on LB agar and counting colony forming units (CFU). Adherence was normalised 
against the concentration of the inoculum. Data are shown as mean ± SE for three 
independent experiments, in duplicate. *** P < 0.001 
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4.2.1.4: Colonisation of human colonic biopsies 
Having demonstrated a significant difference in the ability of ST31 and ST40 EAEC 
strains to adhere to T84 cells, the colonisation of human intestinal epithelial tissue 
was next investigated. This aimed to determine if the difference between the STs 
was maintained for adherence to ex vivo mucosa with greater physiological 
relevance than cell culture. Therefore, IVOC experiments were performed using 
sigmoid colonic biopsies obtained from consenting patients undergoing endoscopy 
at the Norfolk and Norwich University Hospital. The sigmoid colon was selected as 
prototype EAEC strains 042 and 17-2 demonstrated greater adherence to colonic 
than small bowel biopsies (see Chapter 3.2.3), and sigmoid colonic samples were 
more consistently available from both sigmoidoscopy and colonoscopy procedures. 
The mucosal surface of the biopsy samples was inoculated with EAEC and incubated 
for 7 hours on a rocking platform. Each strain was assessed using biopsies from at 
least 3 different donors. 
Initially, evaluation of the abundance of adherent bacteria was performed using 
immunofluorescence staining with an anti-E. coli antibody and co-staining of 
epithelial cells for actin and cell nuclei (Figure 4.7). However, while the anti-E. coli 
antibody did successfully stain some adherent EAEC colonies, it was difficult to 
resolve the bacteria for accurate quantification. In addition, non-specific staining 
was observed in many samples, which could not be satisfactorily distinguished from 
stained bacteria.  
Therefore, scanning electron microscopy (SEM) was employed for evaluation of 
IVOC samples. After incubation with EAEC, biopsies were washed in PBS to remove 
mucus and processed for SEM (Figure 4.8). Absolute quantification of adherent 
bacteria was not deemed feasible as each biopsy sample varied in size, and 
extensive EAEC colonisation was often observed beyond the limits for reliable 
counting. Therefore, a semi-quantitative analysis was performed whereby each 
sample was scored against a defined numerical scale for both colony size (see 
Figure A1.1 for representative images) and frequency of colonisation. The 
combined score of the two features was used as a colonisation score for each 
biopsy.  
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Figure 4.7 Immunofluorescence staining of colonic biopsies infected with EAEC. Biopsies 
were incubated with EAEC for 7 hours. Biopsy samples were stained for cell nuclei (blue), 
actin (green) and E. coli (red), and imaged by immunofluorescence microscopy. 
Representative images of three independent experiments, in duplicate.  
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Figure 4.8 Scanning electron micrographs of EAEC colonisation of colonic biopsies. The 
biopsies were incubated with EAEC for 7 hours and then washed for removal of the mucus 
layer. Samples were fixed and dehydrated for evaluation by SEM. The images are 
representative of three independent experiments in duplicate. 
 
168 
 
As observed for T84 cells, ST40 isolates colonised colonic tissue to a comparable or 
greater extent than the positive control, 042. While ST40 adherence was relatively 
consistent for all strains, greater variation was observed in the ability of ST31 
strains to colonise biopsy samples (Figure 4.9). Some ST31 isolates demonstrated a 
median colonisation score comparable to the 042 control, whereas others showed 
low levels of mucosal binding. Also apparent was that many individual biopsies had 
no observable bacteria for ST31, while all biopsies infected with ST40 isolates had a 
score of at least 2. No adherent bacteria were ever observed for ST31 strain 
E104967. 
When comparing the STs overall, ST40 strains exhibited significantly higher 
colonisation levels of human colonic biopsies than ST31 strains (P < 0.01). Within 
the ST groups, no significant difference was evident between case and control 
isolates for ST40, while control isolates displayed higher adherence than case 
isolates for ST31 (P < 0.01).    
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Figure 4.9 Colonisation of colonic biopsies by EAEC. Biopsies from the sigmoid colon were 
incubated with EAEC for 7 hours, and bacterial colonisation was evaluated by SEM. Biopsies 
were additively scored for size and frequency of observed colonies on a 0-4 scale. Red and 
green represent case and control isolates, respectively. Triangles are individual biopsies for 
the 042 positive control, circles are ST31, and squares are ST40. Horizontal bar represents 
median score. Data are shown for three independent experiments, in duplicate. *** P < 
0.01. 
 
4.2.2: Genotypic characterisation of ST40 and ST31 strains 
Whole-genome sequencing (WGS) has recently been performed for the EAEC 
strains investigated in the project. This was undertaken as part of a larger 
collaborative work to sequence all of the EAEC collection at PHE, with the 
sequencing performed by Gemma Kay (John Wain group; University of East Anglia, 
Faculty of Medicine and Health) and the Genomic Servicing Unit and GBRU at PHE, 
using the Illumina Mi-Seq and Hi-Seq platforms respectively. The available genetic 
data was utilised in this study to compare the EAEC putative virulence gene 
distribution between ST40 and ST31 strains, as well as use bioinformatic 
approaches to analyse strain typing and phylogeny. 
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4.2.2.1: Confirmation of multi-locus sequence type 
The STs of the EAEC isolates used in this project were previously determined by 
multi-locus sequence typing (MLST) by PCR for seven E. coli gene targets (adk, 
fumC, gyrB, icd, mdh, purA and recA) (Chattaway et al., 2014b). To confirm the 
original ST assignments, in silico MLST was performed using the WGS data for all 16 
strains. 
Two different bioinformatic tools were used. In the first method, the sequence data 
was analysed with the MLST tool incorporated in the Galaxy computational biology 
platform. In addition, the Short Read Sequence Typing for Bacterial Pathogens 
(SRST2) tool was utilised, and the sequencing reads for each strain were analysed 
against a custom fasta sequence database containing the allele sequences for each 
of the MLST target genes. The combination of aligned alleles for each strain was 
then converted to ST according to previously defined MLST profiles. Both tools gave 
corroborating results confirming that all strains belonged to ST40 or ST31 as initially 
assigned (Table 4.1). The Galaxy MLST tool identified strain E103617 as ST31 but 
indicated a higher level of uncertainty than for the rest of the group. However, the 
SRST2 output confirmed the ST for this strain.  
Previously assigned ST Strain 
SRST2 
MLST 
Galaxy 
MLST 
ST31 E103617 31 31? 
 
E107526 31 31 
 
E104946 31 31 
 
E104967 31 31 
 
E99975 31 31 
 
E104969 31 31 
 
E104931 31 31 
 
E104940 31 31 
ST40 1337 40 40 
 
1091 40 40 
 
153145 40 40 
 
221654 40 40 
 
146052 40 40 
 
232736 40 40 
 
E107759 40 40 
 
E109907 40 40 
 
Table 4.1 In silico sequence typing of EAEC isolates 
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4.2.2.2: In silico serotyping and core genome phylogeny 
These EAEC strains were originally isolated from different epidemiological studies 
and disease cases and not all had been previously fully characterised by classical 
antigen serotyping. Therefore, in addition to confirming the MLST results for all of 
the ST40 and ST31 strains, the sequencing data was also used to analyse the 
serotypes present in these two groups. WGS of the strains allowed in silico serotype 
prediction by alignment of defined O and H antigen genes (Table 4.2). This was 
performed using the SRST2 tool against a fasta sequence database containing the 
sequences for each characterised antigen allele. 
For the ST40 group, all strains were identified as positive for the H21 flagellin. This 
matched previous antigen typing for most strains other than 1091 and 1337, which 
had been serotyped as H11. The LPS antigen was identified as O111 for all ST40 
strains other than E107759 (O127) and 146052 (unidentified). The ST31 strains 
were identified as belonging to two serotype groups. Four strains (E104931, 
E104969, E103617, E104940) were serotyped as O130 and H26 or H27. Strain 
E107526 was also positive for H27 but could not be matched to any O antigen 
allele. The remaining three ST31 isolates (E104946, E104967, E99975) were 
identified as O15:H18.  
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ST Strain Previous antigenic 
serotyping 
In silico 
serotyping  
31 E107526 O?:H? O?:H27 
31 E104931 O?:H? O130:H26 
31 E104969 O130:H25 O130:H26 
31 E103617 O130:H27 O130:H26 
31 E104940 O130:H27 O130:H27 
31 E104946 O?:H? O15:H18 
31 E99975 O15:H18 O15:H18 
31 E104967 O?:H? O15:H18 
40 146052 0154:H21 O?:H21 
40 232736 O111:H21 O111:H21 
40 1091 O111ac:H11 O111:H21 
40 221654 O111:H21 O111:H21 
40 153145 O111:H21 O111:H21 
40 1337 O111ac:H11 O111:H21 
40 E109907 O111ab:H- O111:H21 
40 E107759 O?:H? O127:H21 
Table 4.2 In silico serotyping of EAEC strains. The in silico serotype was analysed using the 
SRST2 tool with whole-genome sequences for each strain. The previous serotype data 
generated by antigen testing was provided by the GBRU at PHE (ab and ac represent 
polysaccharide minor subtypes of O111).   
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To further explore the diversity of these 16 EAEC strains, a phylogenetic analysis 
was performed (Figure 4.10). A core genome alignment was undertaken using the 
Parsnp tool, with the clinical isolate sequences analysed against 042 as a reference 
genome. This software generates a multi-alignment of all genomes and identifies 
single-nucleotide polymorphisms (SNPs) within the core genome of all strains. This 
data set is then used for reconstruction of the whole-genome phylogeny. The 
resulting phylogenetic tree was processed and visualised using the Phandango 
software. Overall, this data demonstrates the ST31 and ST40 strains are from highly 
distinct lineages, and that the ST31 strains contain multiple serotype groups. 
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Figure 4.10 Core genome phylogenetic tree of EAEC strains. Bootstrap confidence values 
are shown in blue for each branch. Tree scale is sequence substitutions per site. 
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4.2.2.3: Genotype profiles for putative EAEC virulence factors  
As the previous experiments had demonstrated a difference in virulence-associated 
phenotypes between ST31 and ST40 strains, the genotypes of these groups were 
next investigated for putative virulence factors. In particular, the distinct presence 
or absence of virulence genes was determined between the two STs. Initially, a 
specific subset of virulence genes was selected for investigation which 
corresponded to the EAEC-associated virulence factors studied in Chapter 3 of this 
project, with the addition of all AAF structural subunit alleles: aggR, pic, aap, astA, 
hlyE, pet, ecpA, aggA, aafA, agg3A, hdaA, and aaf5A. 
To minimise the risk of experimental bias, multiple tools were used in parallel to 
analyse the presence of virulence genes in the sequence data for each strain: (1) 
Basic Local Alignment Search Tool (BLAST) was applied to search for virulence gene 
query sequences in genome assemblies, using both a custom local BLAST search 
(BioEdit software) and the BLAST function provided by the Galaxy bioinformatics 
platform. (2) In silico PCR was performed with genome assemblies using the 
FastPCR software tool to predict any amplification for previously used PCR primer 
sequences for each gene. (3) Finally, the SRST2 tool was applied to perform 
alignments of the virulence gene sequences, using sequencing read files instead of 
assemblies.  
While there was some variation in specificity, the results for most virulence genes 
were largely consistent across all tools utilised. As SRST2 has been reported to 
outperform assembly-based methods for accurate gene detection, the results of 
method 3 was used for further analysis (Inouye et al., 2014) (Table 4.3). The data 
from methods 1 and 2 are presented in Figure A1.2 in Appendix 1.  
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Table 4.3 Virulence gene profile for ST40 and ST31 EAEC strains. Alignments performed 
from sequence reads using SRST2 software. * = alignment below 90% identity threshold. 
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The genes pic, aap, and hlyE were conserved in all 16 strains. The astA gene (EAST-1 
toxin) was present only in ST40 strains. In addition, all ST40 genomes contained 
ecpA, while only 2 of the 8 ST31 strains were positive for this gene. The other major 
difference observed was in the AAF types. While ST40 strains were associated with 
aaf5A (AAF/V), the ST31 genomes aligned with agg3A (AAF/III) or aggA, (AAF/I). For 
the SRST2 tool, the coverage threshold had to be reduced from the 90% default 
value for the aggA alignment to be reported in these strains. The ST31 AAF variants 
corresponded with the previously identified serotypes, AAF/III with O15:H18 and 
AAF/I with O130:H26/27. 
This subset contained some of the major putative virulence genes for EAEC, but 
many other genes have been associated with the pathotype. In addition, other E. 
coli virulence factors not specific to EAEC may be of importance in pathogenesis. 
Therefore, the investigation of genotypical differences between ST40 and ST31 
strains was expanded from the initial specific set of virulence factors to a much 
larger genetic database. The Virulence Factors of Bacterial Pathogens database is an 
online resource containing sequence data for potential virulence genes. This 
resource was used to generate an Escherichia database of 2686 genes from 134 
different strains, which were aligned against the sequencing data for each of the 16 
EAEC strains using the SRST2 tool. This identified 302 genes present in at least one 
strain. This data set was then manually curated for target genes identified only in 
one ST and not the other (Table 4.4). The results contain many additional genes of 
interest, as well as the previously identified EAST-1 and AAF genes. 
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Table 4.4 Distinct putative EAEC virulence genes for ST40 and ST31 strains. This table lists 
the putative virulence genes identified as specific to ST31 or ST40 genomes only, and/or in 
specific ST31 serotypes. 
 
Overall, the use of bioinformatic tools with the sequenced EAEC genomes identified 
differences in virulence gene profiles which may be associated with the difference 
in virulence-associated phenotypes between ST40 and ST31 strains.   
 
4.3: Discussion 
This research was designed to investigate the difference between EAEC STs with 
different epidemiological associations with disease or carriage, as established in a 
previous MLST study (Chattaway et al., 2014b). As previous studies have not 
established specific EAEC virulence genes as reliable markers of virulence, this work 
analysed phenotypes as indicators of functions involved in pathogenesis. Therefore, 
Sequence type (serotype) Gene / operon Predicted function 
ST31 
 
EC042_4532  utative type VI secretion protein 
air/eaeX Adhesion 
aslA Periplasmic sulfatase 
chuA, S-Y Heme utilisation 
ehaB Adhesion 
kpsD Capsule 
pkgA Putative type III secretion effector 
sitABCD Iron/Manganese uptake 
ST31 (O130) aggBCD Accessory genes for AAF/I  
ST31 (O130) & ST40 gspC-M Cryptic type II secretion pathway  
ST31 (O15:H18) 
 
agg3A AAF/III structural subunit 
hlyABCD Alpha-haemolysin 
papA-K, X   pilin, adhesion 
ST31 (O15:H18) & ST40 agg3BCD Accessory genes for AAF/III 
ST40 astA EAST-1 toxin 
cfaABCD CS1 fimbriae, adhesion 
ehaA Adhesion  
hcp Missing designation in VFDB 
stgCD Stg fimbriae, adhesion 
ycbF, R-V Predicted chaperone-usher 
fimbriae, adhesion 
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eight strains were screened for each of the ST40 and ST31 complexes for an in vitro 
study of virulence-associated phenotypes alongside bioinformatic analysis of WGS 
data. The prototype strain 042, which is the best characterised and most frequently 
used EAEC strain in laboratory studies of infection, was utilised as a positive control 
throughout. 042 has also been previously identified as an ST31 strain (Okeke et al., 
2010, Chattaway et al., 2014b). While both ST10 and ST40 were significantly 
associated with disease in the previous MLST publication, ST40 was chosen for this 
study due to the high strain diversity of the ancestral lineage ST10 which includes 
many different E. coli pathotypes (Yu et al., 2018, Chattaway et al., 2014b).  
Of the 16 clinical strains investigated (Table 2.1), most were originally isolated from 
two large cohort studies of diarrhoeal illness in the UK (Chattaway et al., 2014b). All 
eight ST31 strains and two ST40 isolates were collected during the English case-
control Infectious Intestinal Disease Study (IID1). Between 1993 and 1995, bacteria 
were isolated from a total of 4,664 stool specimens collected from cases of clinically 
significant intestinal infectious disease, or from age and sex matched healthy 
controls within the study cohort (2,443 cases and 2,221 controls) (Amar et al., 2007, 
Sethi et al., 1999). A further two ST40 strains were isolated during the Second Study 
of Infectious Intestinal Disease in the Community (IID2). This was a case-only study 
undertaken between 2008 and 2009, which produced a dataset from 3,966 stools 
from individuals with diarrhoea (O'Brien et al., 2010). Both IID1 and IID2 used a PCR 
probe (CVD432) specific for the anti-aggregation transporter gene aatD for 
identification of EAEC (Chattaway et al., 2013, Baudry et al., 1990). The remaining 
ST40 strains were derived from sporadic diarrhoea cases catalogued by the 
Gastrointestinal Bacteria Reference Unit of Public Health England. While some 
subsets of strains from this EAEC collection have been studied for the presence of 
virulence and antimicrobial resistance genes, none have previously been analysed 
for in vitro phenotypes (Chattaway et al., 2017).  
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4.3.1: ST40 strains demonstrate greater aggregation and adherence 
than ST31 strains 
4.3.1.1: Biofilm formation 
A phenotype often associated with EAEC pathogenesis is the strong formation of 
biofilms (Mohamed et al., 2007b). The association of biofilm formation with 
bacterial pathogenesis has been well described. In particular, biofilm communities 
have enhanced resistance to clearance by immune system responses, 
environmental stresses, and antimicrobial therapeutics (Costerton et al., 1999, Xu 
et al., 2000). Biofilms are important during human infection with Salmonella and 
many E. coli pathotypes, enhancing resistance and persistence on biological 
surfaces such as epithelial cells, and abiotic surfaces such as implanted medical 
devices (Steenackers et al., 2012, Sharma et al., 2016). EAEC has been associated 
with exceptional biofilm formation, with studies of clinical EAEC isolates 
demonstrating significantly greater quantified biofilm density compared to other E. 
coli isolates (Mendez-Arancibia et al., 2008, Mohamed et al., 2007b, Wakimoto et 
al., 2004). This has led to the theory that mucosal biofilm development contributes 
to EAEC persistence and symptomatic disease, especially in chronic infections in 
infants and immunocompromised patients (Nataro and Kaper, 1998, Kaur et al., 
2010). The role of biofilm expression as a virulence-associated factor for EAEC has a 
longstanding consensus in the field (Sheikh et al., 2001, Weintraub, 2007, Huang et 
al., 2004). This would support the results showing increased biofilm formation in 
ST40 strains as indicative of increased virulence potential compared to ST31.  
In addition to a likely role in pathogenesis, biofilm formation can be important for 
EAEC persistence in the food chain. For example, biofilm formation and associated 
virulence factors such as AAF/I promote the colonisation of fresh produce, including 
the type of fenugreek sprouts contaminated as the source of the O104:H4 outbreak 
in 2011 (Borgersen et al., 2018, Nagy et al., 2016). The enhanced resistance 
characteristics of biofilms are also associated with the difficulty of safely 
disinfecting fresh produce for many pathogens, including pathogenic E. coli (Yaron 
and Römling, 2014). Therefore, the greater biofilm potential displayed by ST40 
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strains could correlate with increased exposure to consumers and contribute to 
higher rates of disease, independent of pathogenesis. 
However, biofilm formation is a multi-factorial process, and several virulence 
factors including the transcriptional activator AggR and adhesins AAFs, ECP, and Air 
are reported to be involved in EAEC biofilm formation (Garnett et al., 2012, Sheikh 
et al., 2001, Sheikh et al., 2006, Mohamed et al., 2007b). There is potential for 
functional redundancy, so presence or absence of single factors may not be reliable 
for prediction of biofilm phenotype. It is also possible that the factors which 
contribute to biofilm development in vitro do not function the same way in vivo on 
biological surfaces (Hebbelstrup Jensen et al., 2014). Furthermore, some 
epidemiological studies have found similar levels of biofilm production in EAEC 
isolates from cases and controls (Mohamed et al., 2007b). Notably, a virulent ST131 
EAEC clonal group in Japan caused disease despite displaying low biofilm potential 
in vitro (Imuta et al., 2016).  
Biofilm formation was analysed using the well-established microtiter plate assay, 
with crystal violet staining used to quantify bacterial density. Although this is a 
static model which does not allow the development of mature biofilm properties as 
effectively as flow cell systems, the microtiter plate assay is suitable for the study of 
early stages of biofilm formation (O'Toole, 2011, Merritt et al., 2005). Additionally, 
as EAEC develop denser biofilms in this model than other E. coli pathotypes, it has 
been proposed as a simple initial screening tool for EAEC (Wakimoto et al., 2004). 
Prototype 042, included as a positive control, exhibited higher biofilm formation 
than all 16 clinical isolates. This is unsurprising, as 042 is known to produce dense 
biofilms and has been used as a model for studies investigating the effect of 
temperature on EAEC biofilm growth (Hinthong et al., 2015). Strain 042 was also 
recently used to demonstrate that deletion of aggR or aafA inhibits the 
establishment of biofilm (Huttener et al., 2018). Importantly, the growth conditions 
used in this assay (37 °C in DMEM) match those identified as optimal for 042 biofilm 
development in a previous study (Sheikh et al., 2001). 
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4.3.1.2: Colonisation of intestinal epithelial cells 
While the relevance of biofilm formation for EAEC virulence is uncertain, adherence 
to mucosal surfaces is likely involved in development of diarrhoea. Previous studies 
have used IVOC and enteroid models to determine that the colon is the major 
colonisation site for enteric infection, as EAEC strains demonstrate lower levels of 
adherence to small bowel tissue (Knutton et al., 1992, Rajan et al., 2018, Braga et 
al., 2017). Additionally, in this project greater colonisation of colonic biopsies than 
small intestinal biopsies was observed for the prototype EAEC strains 042 and 17-2 
(Chapter 3.2.3). The colonocyte-like cell line T84 has previously been established as 
a suitable in vitro model of EAEC infection (Nataro et al., 1996). Therefore, both 
human colonic biopsies and T84 cells were used to investigate the adherence of 
ST40 and ST41 isolates to human intestinal mucosa. 
The colonisation of colonic biopsies by the clinical EAEC isolates was analysed semi-
quantitatively using SEM. ST40 isolates demonstrated significantly greater IVOC 
colonisation than those of ST31. All ST40 strains displayed similar or greater median 
colonisation scores than the positive control (O42), while the ST31 group displayed 
less consistent adherence including one strain, E104967, which demonstrated no 
observable adherent bacteria. A corresponding difference in adherence was 
observed for T84 monolayers, using CFU counting from plated lysates for absolute 
quantification. There was less variation between strains within STs for this model, 
and the increased adherence of the ST40 group was more clearly pronounced 
compared to the IVOC data. This may be attributed to the relative simplicity of a 
single cell-type culture model opposed to whole ex-vivo tissue, especially 
considering the likely variability of interactions with biopsies from different donors. 
Biopsy colonisation may involve more complex interactions, such as additional 
receptors for adhesin binding and the presence of a mucus layer, with differences in 
related virulence factors contributing to the greater variety between strains (Fang 
et al., 2013). The semi-quantitative nature of the IVOC analysis compared to the 
absolute quantification of T84 adherence may also be a factor in this difference. 
However, a greater ability for colonic epithelial adherence was determined in ST40 
versus ST31 strains for both models. This confirms a phenotypic difference between 
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the STs that is therefore not attributable to an individual model artefact, such as 
the carcinoma background of T84 cells. 
Intestinal epithelial adherence is proposed as a key step in EAEC pathogenesis 
(Izquierdo et al., 2014b, Harrington et al., 2006). In addition to a role in subsequent 
biofilm formation, auto-agglutination of EAEC bacteria has also been suggested as 
occurring in the lumen and enhancing the initial adhesion to the mucosal surface 
(Hebbelstrup Jensen et al., 2014). Therefore, the aggregation phenotype may also 
be directly relevant to epithelial colonisation during infection, connecting the 
biofilm and adherence assay results here presented. There are many potential 
genetic factors behind these phenotypical differences, which are discussed in 
further detail in chapter 4.3.2 and 4.3.3. In brief, the AAF adhesins are strongly 
associated with both adherence and biofilm formation in EAEC pathogenesis 
(Farfan et al., 2008, Jonsson et al., 2017a, Shamir et al., 2010, Hinthong et al., 
2015). The virulence factor dispersin is also important, due to its function in 
masking electrostatic interactions to allow proper dispersal of adhesins such as 
AAFs during AA (Blanton et al., 2018, Velarde et al., 2007). The AAFs and dispersin 
are regulated by the transcriptional activator AggR, which is essential for 
aggregative adherence in typical EAEC strains (Harrington et al., 2006, Hebbelstrup 
Jensen et al., 2014). Other factors associated with the adherence of EAEC include 
the SPATE Pic, which has mucinolytic and mucus secretion regulatory functions that 
are suggested to aid mucosal colonisation and subsequent biofilm formation 
(Harrington et al., 2009, Navarro-Garcia et al., 2010). Other adhesins, such as the E. 
coli common pilus, are linked to EAEC adherence, especially for the subpopulations 
which lack a known AAF (Avelino et al., 2010). All of the above virulence factors 
were included in the analysis of ST40 and ST31 genomes for specific EAEC virulence-
associated genes, as discussed in Chapter 4.3.2. The broader genotype comparison 
performed using the VFDB resource (see 4.3.3) also included further genes of 
interest for biofilm and adherence phenotypes. 
A further phenotype associated with the pathogenesis of EAEC is the induction of 
an immune response. An undergraduate placement student in this research group, 
Leah Bundy, recently studied the same ST40 and ST31 strains for the effect of 
incubation with T84 cells on secretion of IL-8. An enzyme-linked immunosorbent 
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assay approach was used to demonstrate that the ST40 strains induced a 
significantly greater IL-8 response than ST31 isolates (P < 0.001) (Appendix 1, Figure 
A1.3) (Bundy, 2018). Inflammatory cytokines including IL-8 and IL-1 have previously 
been reported for clinical cases of EAEC infection (Greenberg et al., 2002, Steiner et 
al., 1998). As an inflammatory response is proposed as a key factor in EAEC-related 
diarrhoeal illness, this phenotypic difference between the STs supports the 
epidemiological association of ST40 with disease and ST31 with carriage 
(Hebbelstrup Jensen et al., 2014). Two bacterial factors linked to immunogenicity of 
EAEC are AAFs and flagella, both of which differed between ST31 (AAF/I and AAF/III; 
H18/26/27) and ST40 (AAF/V; H21) strains (Harrington et al., 2005, Savar et al., 
2013, Yanez et al., 2016).  
Overall, the results of these in vitro virulence-associated phenotype assays support 
an intrinsic phenotypic difference between the ST40 and ST31 groups. ST40 
demonstrated a significantly greater adherence to intestinal epithelial cells, 
increased biofilm-like aggregation, and induction of IL-8 secretion from host cells. 
Therefore, this phenotype data supports the previous epidemiological findings of 
greater pathogenicity for ST40 versus ST31 strains, and suggests some of the 
underlying mechanistic differences (Chattaway et al., 2014b). It is often proposed 
that the current definition of EAEC as a pathotype includes both pathogenic and 
non-pathogenic subpopulations, contributing to the heterogeneity of virulence 
(Chattaway et al., 2013, Okeke and Nataro, 2001). This comparison of ST40 and 
ST31 supports the possibility of distinct variation in virulence for different EAEC 
lineages, although this may be further complicated by the effect of host 
susceptibility.    
 
4.3.2: Differences in specific putative virulence genes 
All sixteen of the ST40 and ST31 strains evaluated in this study have been genome 
sequenced using Illumina platforms. This sequencing data was available for the 
investigation of genotypic differences, including the virulence gene profiles of each 
strain. Initially, this was focused on a specific set of virulence genes associated with 
aspects of EAEC pathogenesis (aggR, pic, aap, astA, hlyE, pet, ecpA, aggA, aafA). 
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These target genes were described in detail in Chapter 3, where their 
transcriptional response to intestinal environmental signals was characterised for 
prototype strains 042 and 17-2. The query sequences for each gene (Appendix 1.1) 
were obtained from the published genome of prototype EAEC strain 042, other 
than the AAF/I gene aggA from strain 17-2 (Chaudhuri et al., 2010). In addition to 
aafA (AAF/II) and aggA (AAF/I), the major subunit genes for the remaining AAF 
variants III-V (agg3A, hdaA, and aaf5A) were included (Bernier et al., 2002, Jonsson 
et al., 2015, Boisen et al., 2008).  
Multiple bioinformatics tools were used to determine the virulence gene profiles of 
each strain from WGS data, which gave largely consistent outputs (Appendix 1, 
Figure A1.2). However, the results obtained using the SRST2 tool were chosen for 
further analysis. This software is specifically designed to perform alignments from 
short-read Illumina sequencing data against databases of target genes, such as 
virulence or antimicrobial resistance genes (Inouye et al., 2014). It uses raw 
sequencing reads, which gives an advantage over the other methods which require 
genome assemblies. This is due to the quality of an assembly limiting the sensitivity 
and efficiency of alignments, and therefore SRST2 has previously been 
demonstrated to outperform assembly-based approaches (Inouye et al., 2014, 
Clausen et al., 2016). In addition, the in silico PCR method is reliant on the quality of 
primer design as well as assembly quality.  
When the presence and absence of these specific virulence genes was determined 
for the ST31 and ST40 strains in this study, the most obvious difference was that all 
ST40 isolates possessed the astA gene, while this was completely absent from the 
ST31 group. This gene encodes the EAST-1 toxin, a heat-stable enterotoxin first 
identified in prototype EAEC strain 17-2 (Savarino et al., 1993). Due to homology of 
the 38-amino acid EAST-1 peptide with the enterotoxic domain of heat-stable 
enterotoxin a (STa) of ETEC, it has been proposed to share a similar activity 
(Menard et al., 2004). Stimulation of guanylate cyclase is predicted to disrupt 
regulation of cGMP and cAMP signalling in host epithelial cells, leading to abnormal 
fluid secretion in the intestines (Ménard and Dubreuil, 2002). While EAST-1 positive 
strains have been associated with paediatric disease, intestinal fluid accumulation 
was not induced by EAST-1 in in vivo mouse and gnotobiotic piglet models (Menard 
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et al., 2004, Vila et al., 1998, Ruan et al., 2012). While astA may theoretically 
contribute to increased symptomatic infections caused by ST40 strains compared to 
ST31, it has not been associated with adherence and would not account for the 
observed phenotypic differences between the STs. The value of astA as a marker for 
EAEC has been previously proposed, due to a prevalence in atypical EAEC lacking 
other markers such as aggR or aap (Jenkins et al., 2006). However, it should also be 
considered that astA is not restricted to EAEC, having been identified in multiple 
diarrhoeagenic E. coli pathotypes and some Salmonella strains, so would need to be 
used alongside specific EAEC targets (Paiva de Sousa and Dubreuil, 2001, 
Yatsuyanagi et al., 2003). 
Another distinction between ST40 and ST31 genotypes was the AAF profile of the 
strains. ST40 isolates exclusively possessed the most recently identified AAF/V 
variant. Three of the ST31 strains encoded AAF/III, while it was predicted that the 
remaining ST31 isolates contained AAF/I. However, the alignment with the query 
aggA sequence was below the default 90% coverage threshold for the SRST2 tool 
(although greater than 80%), but the remaining aggB-D genes of the AAF/I operon 
were later identified in these ST31 strains, which supports the identification. While 
the accessory genes are highly conserved, there is precedence for sequence 
variation in the major subunit for other AAFs, such as an 83-100% identity range in 
AAF/V from different strains (Jonsson et al., 2015). This supports that this alignment 
in ST31 does represent AAF/I, and not a novel AAF variant. Similar results were 
obtained in a previous study of clinical EAEC isolates in Japan, where the majority of 
ST40 strains expressed AAF/V (Imuta et al., 2016). Only one ST31 strain was 
included which was positive for AAF/I, thereby matching the major ST31 subgroup 
in these results. The AAF variants are widely distributed in EAEC, with no one 
variant dominating overall in previous studies, although many strains also lack all 
currently identified AAF genes (Suzart et al., 2001, Boisen et al., 2008). It remains to 
be determined if particular AAF variants confer a greater potential to cause disease, 
and therefore could be used as markers of EAEC virulence. Interestingly, one study 
has reported that AAF/V causes significantly higher HEp-2 adherence and biofilm 
formation than AAF/III when expressed by the same laboratory E. coli strain, which 
agrees with the results presented here (Jonsson et al., 2015). This could be linked to 
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mechanistic differences, as AAF/V possesses a specific and conserved mutation that 
abolishes binding to fibronectin. As AAF/V is still prevalent in clinical isolates, it was 
suggested that this mutation either enhances binding to alternative receptors or 
aids evasion of the host immune response (Jonsson et al., 2017a). Further study is 
required to investigate if the AAF type is relevant for the intrinsic virulence 
potential of EAEC strains. Interestingly, when the sequencing data was used for 
serotype prediction, the AAF variants aligned with the serotype profiles. In ST31, 
O130 and O15 were associated with AAF/I and AAF/III, respectively, while AAF/V-
positive ST40 strains belonged mostly to serotype O111:H21.  
The comparison of virulence gene profiles also revealed that ecpA was present in all 
ST40, but only in 25% of ST31 isolates. ECP is a common adherence factor present 
in commensal and pathogenic E. coli types (Rendón et al., 2007). It is widespread in 
EAEC, although experiments using ecpA deletion mutants suggest it is most 
important for adherence in AAF-negative strains (Avelino et al., 2010). The presence 
of ECP alone did not result in greater adherence within the ST31 group, as the ECP-
positive isolate E104931 exhibited relatively poor mucosal colonisation and biofilm 
formation. While ECP may be a contributory factor in the stronger general 
adherence displayed by ST40 versus ST31 strains, this data does not suggest the 
presence of ECP alone increases virulence-associated phenotypes for individual 
strains. In addition, the high prevalence of ECP across many pathogenic and non-
pathogenic E. coli strains suggests that it is of limited relevance for identifying 
specific virulent EAEC risks (Stacy et al., 2014, Saldaña et al., 2009, López-Banda et 
al., 2014). 
 
4.3.3: Diversity of E. coli virulence factors and core genome 
To identify additional virulence-associated genes differing between ST31 and ST40 
genomes, the Virulence Factors of Bacterial Pathogens database (VFDB) was 
utilised. This online resource has been collecting functional and genetic data on 
virulence factors associated with many families of bacterial pathogens since 2004 
(Chen et al., 2005). In recent years, it has been specifically enhanced for data 
quality and usability as a tool for bioinformatic mining (Chen et al., 2016). At the 
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time of use, the Escherichia database contained 2686 putative virulence genes, of 
which 302 genes aligned with the sequences of at least one of the 16 EAEC isolates 
in this study. This data set was manually analysed to identify genes which differed 
between the STs. 
This analysis confirmed the presence of astA in ST40 strains only, as well as the 
three AAF/III-positive ST31 isolates. The accessory genes of the AAF/III operon 
(agg3B-D) were also present in all ST40 isolates, which initially appears 
contradictory to their predicted AAF/V association. However, when AAF/V was 
discovered it was determined that while the agg5A-encoded subunit had a novel 
sequence, aside from a conserved signal peptide, the operon uses the same 
accessory factors as AAF/III (Jonsson et al., 2015).  
Multiple virulence-associated Escherichia genes were found in either ST40 or ST31 
exclusively and were subsequently researched for any previously described 
functions which may contribute to the phenotypic differences between these STs. 
 
4.3.3.1: ST40 specific virulence genes 
Amongst the VFDB genes exclusively found in the ST40 strains were several 
additional adherence systems. These included genes of the cfa operon, which 
encodes the CFA/I fimbriae. This is the prototypical rigid rod-shaped fimbria widely 
expressed by ETEC, and present in approximately a third of strains in one large 
dataset (Wolf, 1997). CFA fimbriae are important for ETEC adherence to human 
intestinal mucosa and erythrocytes (Nataro and Kaper, 1998, Levine, 1981, 
Sakellaris et al., 1999). However, this family is usually strongly associated with the 
ETEC pathotype only, and to my knowledge have not been previously reported in 
EAEC (Wurpel et al., 2013). The full stg operon was also present in the ST40 strains, 
while ST31 isolates lacked the important usher and chaperone genes stgC/D (Forest 
et al., 2007). Stg fimbria are typically associated with the Salmonella enterica 
serovar Typhi, where they are involved in epithelial attachment and survival in 
macrophages (Forest et al., 2007, Berrocal et al., 2015). However, an orthologous 
Stg operon has also been reported in an avian pathogenic E. coli (APEC) strain and 
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UPEC isolates, which when cloned into an E. coli K12 strain caused enhanced 
adherence to human epithelial cells (Lymberopoulos et al., 2006). Genes of the ycb 
operon were also present in ST40 strains. This operon is poorly understood as it is 
not expressed under normal laboratory conditions, but is predicted to encode 
chaperone-usher fimbriae with adherence properties to abiotic surfaces (Korea et 
al., 2010). A version of the operon has been described in EHEC O157:H7, where it 
contributed to intestinal epithelial cell adherence. However, that study identified 
the ycbQ gene as the key structural fimbrial subunit, which is absent in the ST40 
strains, therefore the operon may not be functional in ST40 EAEC strains (Samadder 
et al., 2009). 
A further virulence gene which may contribute to ST40 adherence is ehaA. This 
encodes a type V secretion system autotransporter associated with outer 
membrane expression in Gram-negative bacteria (Henderson et al., 2004). EhaA 
was identified as prevalent in EHEC O157:H7 and other serotypes using conserved 
autotransporter motifs. Overexpression of EhaA in E. coli K12 resulted in increased 
bacterial aggregation, enhanced biofilm formation, and adhesion to bovine rectal 
epithelial cells (Wells et al., 2008, Tseng et al., 2014). However, deletion of ehaA 
from wild-type EHEC did not decrease biofilm formation, so the biological 
importance of this putative adhesin remains to be determined (Wells et al., 2008). 
Additional ST40 genes included a gsp operon. The gsp genes are part of a type II 
secretion pathway first identified as a cryptic operon in E. coli K12 (Francetic and 
Pugsley, 1996). These genes were also found in ST31 strains of the O130 serotype. 
Type II secretion has been linked to many functions in Gram-negative bacteria, 
including virulence protein export, but the activity of the gsp genes is unclear in this 
context (Cianciotto, 2005). A hcp gene was also identified in ST40 genomes, 
however the designation of this gene was missing in the VFDB database. This could 
refer to the gene encoding the hybrid cluster protein, a hydroxylamine reductase 
involved in oxidative and nitrosative stress responses, or the hemolysin coregulated 
protein, a putative type VI secretion system effector first associated with Vibrio 
cholerae which has a homologue identified in EAEC 042 (Wolfe et al., 2002, 
Williams et al., 1996, Dudley et al., 2006b). Alignments of the ST40 WGS data 
against query gene sequences for these targets were inconclusive. 
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The VFDB resource allowed the identification of many genes found only in the ST40 
strains used in this study. Many of these have functions relevant to the investigated 
virulence-associated phenotypes, including adherence fimbriae which could 
contribute to the greater colonisation potential of the ST40 isolates. However, it is 
important to note that while these genes were found in the genome sequences, 
their expression may be restricted to specific environments, and some of the 
targets may be part of incomplete operons and thus be inactive systems in these 
isolates. 
 
4.3.3.2: ST31 specific virulence genes 
The virulence-associated gene profiles from the VFDB alignment were also analysed 
for genes found only in ST31 strains. One difference was the presence of ehaB in all 
the ST31 isolates, whilst the ST40 genomes contained ehaA as previously discussed. 
Both EhaA and EhaB are autotransporter proteins associated with adhesion and 
biofilm formation, with similarly high prevalence in EHEC (Wells et al., 2008, Farfan 
and Torres, 2012). Conserved paralogues of ehaB have been identified across many 
E. coli pathotypes, including EAEC. However, unlike ehaA, the introduction of ehaB 
to a laboratory E. coli strain did not promote adherence to Caco-2 and bovine lung 
and rectal epithelial cells (Wells et al., 2009). The same study showed that EhaB 
binds the ECM proteins collagen I and laminin. While both EhaA and EhaB are 
common in pathogenic E. coli, differences in their activity or specificity could 
potentially contribute to phenotypic differences between ST31 and ST40 alongside 
other adherence factors such as AAF variant.   
An EAEC-specific factor associated with ST31 strains was Air. The air gene, encoding 
the enteroaggregative immunoglobulin-repeat protein, was previously termed eaeX 
as an unknown outer membrane protein gene (Ren et al., 2004). Air is a large 
surface adhesin with repeated bacterial immunoglobulin domains and secreted via 
a T3SS. It shares homology with invasin from Yersinia and intimin from EPEC. When 
air was deleted from 042, the mutant strain demonstrated reduced biofilm 
formation and impaired HEp-2 cell adherence (Sheikh et al., 2006). As such, the 
presence of Air in ST31 but not ST40 strains is surprising, as the ST31 was associated 
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with lower biofilm formation and cell adhesion in this study. However, the role of 
Air in vivo remains to be established as, unlike other established EAEC genes aap 
and pic, deletion of air did not affect EAEC colonisation of mice (Harrington et al., 
2009).  
As well as adherence systems, genes connected to nutrient acquisition were 
identified in the ST31 genome sequences. The sitABCD operon is an 
iron/manganese transport system and a member of the periplasmic binding 
protein-dependent ATP-binding-cassette (ABC) family of metal transporters (Sabri 
et al., 2008). First identified in Salmonella enterica Typhimurium, Sit homologues 
are found in many enterobacteria including pathogenic E. coli (Zhou et al., 1999). As 
well as metal ion transport, the sit operon has also been associated with resistance 
to oxidative stress in APEC (Sabri et al., 2006). The loss of the sit operon has been 
linked to attenuated virulence in in vivo infection models of Salmonella 
Typhimurium and APEC but has not been studied in EAEC (Sabri et al., 2008, 
Janakiraman and Slauch, 2000). The ST31 strains also encoded the E. coli chu heme 
utilisation operon. This includes a heme outer membrane receptor (chuA), a 
periplasmic chaperone and an ABC-transporter system (chuTUV) and a heme 
oxygenase (chuS) releasing free iron for bacterial use (Suits et al., 2005). This 
operon has been reported in EHEC O157:H7 and UPEC strains (Porcheron et al., 
2013). The Chu system is a homologue of the Shu heme uptake transporter system 
described in Shigella dysenteriae (Wyckoff et al., 2005). However, as EAEC is 
typically a non-invasive pathogen it is unclear if heme exploitation significantly 
contributes to virulence. The Sit and Chu systems may contribute to ST31 growth in 
the intestinal environment, but their importance for virulence in EAEC is less clear 
compared to other enteric pathogens (Porcheron et al., 2013). 
Other ST31 specific genes have poorly characterised functions in relation to 
potential EAEC virulence determination. The aslA gene encodes a periplasmic 
sulfatase which has been associated with invasion of brain microvascular 
endothelial cells. This has been studied in relation to the penetration of the blood-
brain barrier by neonatal meningitis E. coli (Hoffman et al., 2000). Previously 
described in DEC including EHEC O157 and EAEC 042, pkgA encodes a 
phosphorylase‐kinase‐like glucoamylase which is associated with the E. coli T3SS-2, 
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and proposed as a potential effector protein (Zhou et al., 2014). Due to homology 
with eukaryotic phosphorylase kinases, PkgA has been suggested to act by 
disrupting glycogen metabolism in host cells (Pallen, 2003). Transposon insertion 
mutagenesis identified a PkgA homologue in EHEC O26:H- which promoted 
intestinal colonisation in calves (van Diemen et al., 2005). Further study of PkgA 
function is needed to understand if it may act as an EAEC virulence factor. There is 
also uncertainty to the relevance of kps operon genes in ST31. This operon is 
responsible for the production of the polysialic acid capsule common in NMEC and 
some UPEC strains (King et al., 2007, Johnson et al., 2008). All ST31 isolates 
possessed kpsD, encoding a periplasmic protein involved in polysialic acid 
membrane transport (Wunder et al., 1994). However, only three of the eight strains 
contained kpsM, and none possessed kpsT, with the rest of the operon not 
currently included in the VFDB. This suggests that the Kps system is incomplete and 
likely inactive in ST31, especially as this capsule type is typically only associated with 
extraintestinal pathogenic E. coli and not EAEC (Park et al., 2009, Johnson and 
Russo, 2002). Finally, the EC042_4532 gene is part of a large uncharacterised locus 
identified in 042 with predicted homology to type VI secretion systems, but the 
function is otherwise unknown (Chaudhuri et al., 2010). 
A more specific difference was the presence of the complete hlyABCD operon in 
O15:H18 ST31 strains only. This operon encodes the alpha-haemolysin toxin and 
associated activation and export machinery (Herlax et al., 2010). Although typically 
associated with extraintestinal infections, alpha-haemolysin is expressed by some 
EAEC strains including 17-2 and induces macrophage cell death in vitro (Fernandez-
Prada et al., 1998). These genes are seemingly unrelated to the virulence 
phenotypes tested in this study, with the O15:H18 group correspondingly 
demonstrating no phenotypical differences to the other ST31 strains, but it remains 
possible that alpha-haemolysin could contribute to EAEC virulence in vivo. The 
O15:H18 serotype also contained the pap operon encoding the P fimbriae mostly 
associated with UPEC. All the genes required for fimbrial expression, papA-K, were 
present (Kuehn et al., 1992). P fimbriae have been associated with urinary tract 
infection in a human volunteer study, but also enhance intestinal colonisation and 
persistence for commensal E. coli (Wullt et al., 2000, Herías et al., 1995, Adlerberth 
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et al., 1998). The O15:H18 ST31 strains also contain papX, which is associated with 
repressing flagellar motility during expression of fimbriae (Simms and Mobley, 
2008). If the pap operon is expressed it could contribute to intestinal epithelial 
adherence, however the O15:H18 ST31 strains did not significantly differ from the 
other ST31 isolates during in vitro adherence and colonisation experiments in this 
project. 
 
4.3.3.3: Core-genome phylogeny  
A core-genome phylogenetic analysis was also performed, using alignment against 
042 as a reference genome (Chaudhuri et al., 2010). This revealed that the ST40 and 
ST31 strains are distinct lineages with a high degree of separation in core-genome 
single nucleotide polymorphisms. The ST40 strains clustered together on one 
branch of the phylogenetic tree, supporting the serotype data which suggested that 
the 8 strains of this ST represented a single related group. The ST31 strains were 
more closely aligned to the 042 reference genome, which has been previously 
identified as ST31 (Okeke et al., 2010, Chattaway et al., 2014b). The ST31 strains 
were separated into branches matching the two identified serotype groups (O130 
and O15), with E107526 (O?:H27) demonstrating further separation corresponding 
with the unknown O-antigen. 
The use of core-gene SNPs has been reported as an effective approach for inferring 
phylogeny due to the highly clonal nature of E. coli. It has been shown to separate 
lineages from a mixed E. coli population, accurately fitting with MLST assignment 
(Kaas et al., 2012). It also corresponds well with the results of traditional 
phylotyping as performed by multiplex PCR (Gordon et al., 2008). Interestingly, 
analysis of variation in core E. coli genes has suggested that many of the genes used 
in MLST schemes have relatively low diversity, which may limit the resolution for 
distinguishing strains (Kaas et al., 2012). However, it is unlikely that MLST schemes 
will be modified, due to the development of WGS-based typing techniques with 
greater resolution power and cost-effectiveness (Larsen et al., 2012)  
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4.3.4: Whole-genome sequencing and in silico typing 
The clinical EAEC isolates in this study had previously been sequence typed using 
PCR-based MLST (Chattaway et al., 2014b). With the genome sequences available, 
it was possible to reconfirm the assignment of STs for each strain by using in silico 
analysis, by searching the sequence data for the MLST alleles as opposed to PCR 
amplification. This was performed twice using SRST2 and Galaxy platform tools, 
with both giving matching results to the pre-existing ST assignments. This 
demonstrates the effectiveness of in silico MLST in combination with WGS of clinical 
isolates, which with the ever-decreasing expense of sequencing is reported as more 
efficient and cost-effective than traditional PCR MLST (Larsen et al., 2012). This has 
evolved further in the last few years, as core genome MLST has been developed. 
This exploits the scale of available data from WGS by comparing genome-wide 
gene-by-gene alleles from typically 1500 to 4000 genes conserved within a species, 
thereby allowing far greater resolution than the 5 to 7 alleles used for conventional 
MLST. However, the standard MLST schemes are predicted to remain useful for the 
foreseeable future, due to their established widespread application in modern 
molecular epidemiology systems (Kimura, 2018). 
Serotyping is a further surveillance technique which can benefit from WGS. By using 
in silico tools to identify specific O-antigen and flagellin genes from sequence data, 
serotypes can be determined without performing labour-intensive conventional 
antisera testing. Serotyping from genetic data circumvents traditional limitations 
such as bacterial autoagglutination or lack of antigen expression in vitro (Robins-
Browne et al., 2016). Traditional serotyping can also be fallible due to sera quality 
variation and the risk of cross-reactivity during testing (Ballmer et al., 2007). Here, 
SRST2 was used to perform serotype prediction from sequence reads for the 16 
clinical EAEC isolates, an approach which has been previously successful for 
studying serotype distribution between pathotypes including EPEC, ETEC, and UPEC 
(Ingle et al., 2016). As previously discussed, the results identified two separate 
serotype groups for ST31 and one related group for ST40. Interestingly, the ST31 
serotypes correlated with differences in AAF type, although they did not exhibit 
differences in in vitro adherence phenotypes. Overall, the in silico serotyping 
provided greater detail than previous traditional serotyping performed for these 
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isolates, and identified H-antigens for all strains and O-antigens for all but two. 
Unexpectedly, the predicted H-antigens did not always match the previous results 
obtained using antisera, although it remains to be determined if this discrepancy is 
due to limitations of the in silico analysis or the previous serotyping. This data is a 
small-scale example of the usefulness of in silico serotyping in combination with 
WGS as a pathogen surveillance tool, which is predicted to increasingly replace 
traditional serotyping (Robins-Browne et al., 2016).   
Serotyping can be useful for predicting pathotypes due to some specific 
associations, such as the predominance of O157:H7 for disease cases of EHEC, as 
well as established applications for public health surveillance and outbreak 
detection (Fratamico et al., 2016). However, EAEC strains are highly heterogenous 
in serotype. For example, the IID1 study found at least 40 O-serogroups for 
identified EAEC isolates (Okeke and Nataro, 2001). The serotypes of the clinical 
isolates in this study have been previously reported in infection. For example, O111 
(identified for ST40 strains in this study) are a serogroup associated with paediatric 
diarrhoea, including EHEC, EPEC, and EAEC. Within this group, H21 is one of the 
most common accompanying flagellin antigens in disease cases (Alikhani et al., 
2011). The serotypes here identified for ST40 strains have also been previously 
associated with AAF/V, with the aaf5A gene sequence used for bioinformatics 
alignment in this study acquired from an O127:H21 strain (GenBank: AB571097.1), 
and a reported O111:H21 aaf5A gene (GenBank: AB513347.1) has a high sequence 
identity. The virulence risk of this serotype is further highlighted by a UK household 
outbreak of O111:H21 EAEC in 2012. This strain was identified as ST40 and positive 
for AAF/V, but had also acquired a gene for Shiga toxin (Stx2c) (Dallman et al., 
2012). This raised obvious parallels to the 2011 O104:H4 E. coli outbreak, and the 
danger of emerging EAEC/STEC hybrid strains (Navarro-Garcia, 2014). The serotypes 
predicted for the ST31 strains in this project were also reported in previous EAEC 
infection studies. For example, O15:H18 was the most prevalent EAEC serotype in 
children of less than 5 years of age, which were hospitalized for acute 
gastroenteritis in Israel (Tobias et al., 2015). In addition, EAEC O15:H18 strains have 
been previously identified containing alpha-haemolysin genes, a combination also 
identified in this study (Beutin et al., 2005). 
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Altogether, this work used in silico typing tools with WGS data to confirm MLST and 
serotyping for these clinical EAEC isolates. This demonstrated both the efficiency 
and advantages of this approach versus traditional laboratory typing. On-going 
advances in typing and surveillance are likely to significantly contribute to 
improving the detection of virulent EAEC subgroups within this heterogenous 
pathotype (Robins-Browne et al., 2016).  
 
4.3.5: Host Susceptibility 
In addition to comparing virulence-associated phenotypes and genotypes between 
STs, the data was also analysed to determine if strains isolated from disease cases 
had a more virulent phenotype than those from asymptomatic carriage controls, 
within the same ST. It was found that case isolates did not demonstrate stronger 
aggregation or colonisation than control isolates for any of the investigated 
phenotypes. In fact, the control strains exhibited higher biopsy colonisation than 
case isolates for ST31 (P < 0.01). However, the limitations of a small sample size 
should also be considered, especially as only two control strains were available for 
ST40.  
These results suggest the importance of host susceptibility for symptomatic EAEC 
infection. The heterogeneity of EAEC for causing disease, as well as variability of 
symptoms, has been well described (Okeke, 2009, Estrada-Garcia and Navarro-
Garcia, 2012). While this may be associated with the genetic diversity of the 
pathotype, the high occurrence of asymptomatic carriage is also likely to be related 
to individual susceptibility to pathogenesis (Estrada-Garcia et al., 2014). This further 
complicates the study of EAEC overall, and any attempts to distinguish between the 
proposed pathogenic and non-pathogenic subtypes (Chattaway et al., 2013). 
Some possible mechanisms for host susceptibility to enteric pathogens including 
EAEC have been identified (Flores and Okhuysen, 2009). Often these consist of SNPs 
in host immune system components (Estrada-Garcia and Navarro-Garcia, 2012). For 
example, CD14 is a component of the Toll-like receptor 4 complex with recognition 
for bacterial LPS and involved in the innate immune response in the intestinal 
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mucosa. Specific polymorphisms in the CD14 gene were found to significantly 
influence the susceptibility of adults to traveller’s diarrhoea, with EAEC and ETEC 
identified in patient stool (Mohamed et al., 2011). A similar effect has been 
reported for lactoferrin, an iron-binding protein which can inhibit growth of enteric 
pathogens and disrupt surface-bound virulence factors including AAFs to reduce 
EAEC adherence and biofilm formation in vitro (Ochoa et al., 2006, Ochoa and 
Cleary, 2009). A novel SNP in the lactoferrin gene was associated with significantly 
increased risk of traveller’s diarrhoea (Mohamed et al., 2007a). An additional study 
of traveller’s diarrhoea identified a SN  in osteoprotegerin, an immunoregulatory 
protein within the tumour necrosis factor receptor superfamily. Osteoprotegerin 
was produced by T84 cells in response to diarrhoeagenic E. coli infection, and the 
SNP increased the risk of diarrhoea in an adult traveller cohort (Mohamed et al., 
2009). EAEC infection induces production of the cytokine interleukin-8 (IL-8) in in 
vitro models and faecal samples (Steiner et al., 1998, Greenberg et al., 2002). A 
polymorphism in the IL-8 promoter has been shown to increase both the chance of 
EAEC-associated diarrhoea and subsequent faecal IL-8 concentration (Jiang et al., 
2003). However, these studies have focused on otherwise healthy adult travellers, 
and there remains uncertainty whether single gene SNPs contribute significantly to 
disease susceptibility overall (Estrada-Garcia and Navarro-Garcia, 2012). 
Beyond host genetics, other factors may influence the development of 
symptomatic disease in individual EAEC infections. The role of specific populations 
of the intestinal microbiota in the prevention of infectious disease is the topic of 
extensive research (McKenney and Pamer, 2015). Specific interactions have been 
reported in other E. coli pathotypes, including Lactobacillus reuteri inhibition of 
EPEC adherence, and mixed microbial communities associated with preventing 
EHEC attaching/effacing lesions (Walsham et al., 2016, Liu et al., 2015). However, 
while similar protective interactions are likely during EAEC infection, they have yet 
to be studied in detail.  
A more established factor in the development of EAEC-associated disease is a 
compromised immune system. This has been well-studied in the context of HIV-
positive populations, which alongside malnourished children was one of the initial 
patient groups to be significantly associated with EAEC as an enteric pathogen 
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(Huang et al., 2006b). Many studies have found HIV-positive individuals to be at 
increased risk of EAEC-associated diarrhoea, with symptomatic severity also linked 
to progression of HIV disease (Mossoro et al., 2002, Samie et al., 2007, Wanke et 
al., 1998). Diarrhoeagenic E. coli are also a risk for immunosuppressed patients such 
as those undergoing cancer therapies, with EAEC previously associated with acute 
and chronic infections in this population (Chao et al., 2017) 
Another predisposing factor may be co-infection with other enteropathogens. The 
large UK IID1 and IID2 studies found an association of EAEC infection with the 
presence of other enteric bacterial pathogens such as Campylobacter and norovirus 
(Chattaway et al., 2013). A paediatric gastroenteritis study in Israel also reported 
especially severe diarrhoea for co-infections of EAEC and norovirus (Tobias et al., 
2015). Data from a multisite birth cohort study (Malnutrition and Enteric Diseases 
(MAL-ED) study) across sites in Asia, Africa, and Latin America found no negative 
effect of subclinical EAEC infection alone, but co-infection with other 
enteropathogens caused significant infant growth deficiencies (Lima et al., 2017b). 
It has been proposed that while true pathogenic EAEC variants can cause illness in 
isolation, other less virulent EAEC subtypes may affect disease severity only in 
combination with other pathogens (Chattaway et al., 2013). This would be a 
confounding factor contributing to the heterogeneity of data on EAEC virulence.  
As case isolates did not outperform carriage isolates for virulence-associated 
phenotypes in this study, the data supports the theory that host susceptibility is a 
major factor for the development of symptomatic disease following EAEC 
colonisation. However, this does not diminish the significance of the difference in 
phenotypes observed between ST40 and ST31. Conversely, the heterogeneity of 
individual susceptibility to EAEC infection enhances the value of characterising 
subtypes with an intrinsic increased disease risk overall, as well as the study of 
genotypes for potential molecular markers for improving identification of virulent 
EAEC. 
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4.3.6: Implications for identifying EAEC virulence risk 
While the primary aims of this study focused on the comparison of two specific STs 
of EAEC clinical isolates, the techniques applied in this investigation provide some 
insight into both the challenges and opportunities for ongoing EAEC research in 
general. The heterogeneity of the pathotype is well established, which is a 
challenge for the identification of pathogenic strains against a background of 
frequent asymptomatic EAEC carriage (Hebbelstrup Jensen et al., 2014).  
The original classification of EAEC is based on its aggregative adherence phenotype 
on HEp-2 cells, which still represents the gold-standard diagnostic tool (Kaur et al., 
2010). This diagnostic technique requires time-consuming cell culture and 
specialised facilities and expertise, practically restricting the use of the assay to a 
limited number of sufficiently equipped reference laboratories (Weintraub, 2007). 
The basis on phenotypical observations is also subjective and may introduce 
inconsistency between different practitioners. Despite suggestions for improving 
the ease of the HEp-2 assay, such as the use of storable pre-prepared formalin-fixed 
HEp-2 monolayers, many studies instead rely on the use of molecular techniques 
(Miqdady et al., 2002). One of the most common is the CVD432 probe, which 
targets the dispersin transporter operon aat (Baudry et al., 1990). Alternatively, 
multiplex PCR approaches are used to identify the plasmid-borne genes aggR and 
aap, or the chromosomal aaiC gene (Croxen et al., 2013, Cerna et al., 2003).  
The majority of ST40 and ST31 strains used in this study were identified as EAEC 
using the CVD432 probe as part of the IID1 and IID2 studies (Chattaway et al., 
2013). Therefore, the HEp-2 adherence assay results are novel for these isolates. 
The HEp-2 adherence assay is considered insufficient for distinguishing between 
pathogenic and non-pathogenic EAEC (Estrada-Garcia and Navarro-Garcia, 2012). 
However, differences were observed in the adherence phenotypes of the ST40 and 
ST31 groups. HEp-2 cells are not an intestinal epithelial cell type, so colonocyte-like 
T84 cells and sigmoid colonic biopsies were used as physiologically relevant models 
(Nataro et al., 1996). The data presented here demonstrated that adherence to T84 
cells consistently distinguished between ST40 and ST31 strains. This suggests that 
intestinal epithelial cell culture assays may have value for identifying EAEC 
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subgroups with greater adherence as a risk indicator of potential virulence. 
However, this has the same practical limitations as the HEp-2 assay, requiring 
sufficient cell culture facilities and expertise.  
AA has since been shown to be a multi-factorial phenotype, contributing to the 
genetic variety of the pathotype (Moreira et al., 2003). As such, the use of probes 
against single genes which are frequent in typical EAEC overall, will inevitably 
identify strains with heterogenous virulence phenotypes. Attempts to determine 
genes which are a marker for EAEC virulence by direct comparison of genomes for 
case and control isolates have so far proven unsuccessful. Therefore, this project 
has used the alternative approach of investigating phenotypic differences between 
groups of strains with epidemiological associations with disease or carriage, in 
combination with analysing virulence genotypes. 
 
4.4: Summary 
In this part of the study, it is demonstrated that ST40 strains, previously associated 
with a higher epidemiological rate of disease, display stronger virulence-associated 
phenotypes than ST31 strains, associated with asymptomatic carriage. These 
phenotypes encompassed elements of intestinal epithelial adherence and biofilm 
formation, which are considered key steps in  EAEC pathogenesis (Kong et al., 
2015). While the evidence supports an intrinsic difference in virulence between the 
two STs, clinical isolates from disease cases did not outperform carriage control 
isolates. This potentially indicates the importance of host susceptibility for disease 
outcome, although a larger sample size is needed to confirm this conclusion.  
Bioinformatic analysis allowed confirmation and further clarification of the 
sequence typing, serotyping, and core-genome phylogeny of these 16 EAEC isolates. 
This demonstrates the power of in silico tools in combination with WGS as an 
alternative to traditional lab-based typing approaches (Jenkins, 2015). Genotype 
comparisons were also performed which have identified a number of virulence 
genes which differ between ST40 and ST31. These include adhesins (such as AAFs 
and ECP) which may contribute to the different colonisation phenotypes observed. 
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Collaborators (Lisa Crossman and John Wain, UEA) are currently expanding this 
genotypic comparison to all 51 ST40 and ST31 isolates available through PHE to 
determine if the differences in genes identified here are maintained in a larger 
collection of strains. Future study is also needed to characterise the importance of 
these targets, such as applying molecular biology to investigate the effect of 
introducing or deleting the genes into strains on in vitro virulence phenotypes.  
It is increasingly recognised that EAEC pathogenicity cannot be predicted by any 
single factor, and that virulence is dependent on a range of contributory genes 
(Estrada-Garcia et al., 2014). There also remains the risk of pathotype crossover 
events, such as the gain of EHEC factors including Shiga toxin in the deadly O104:H4 
outbreak, despite the EAEC background strain demonstrating relatively average 
virulence phenotypes (Haarmann et al., 2018). The advances in the use of WGS for 
epidemiology are hoped to allow improved definition of pathogenic subpopulations 
within the heterogenous EAEC pathotype (Robins-Browne et al., 2016).  
The AA exhibited by EAEC is multi-factorial and associated with many putative 
virulence genes. These findings have demonstrated that a phenotypical analysis 
identifies functional differences between EAEC isolates. This allows for future 
targeted screening of candidate genes which may be responsible for the phenotypic 
results. The factors identified in this study may therefore be relevant for identifying 
EAEC virulence markers in the future.   
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Chapter 5 Conclusions 
 
CHAPTER FIVE 
CONCLUSIONS 
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The aim of this PhD project was to investigate the enteric pathogenesis of EAEC. 
The first part of the study involved the characterisation of interactions between 
prototype EAEC strains and intestinal epithelial models, and determination of the 
effect of host cell adherence and oxygen concentration on virulence gene 
expression. The second part of this project focused on determining functional 
phenotypes and corresponding genotypes in EAEC sequence types associated with 
disease or carriage in order to identify markers of EAEC pathogenicity. This chapter 
summarises the major findings of this study and their impact, as well as proposes 
future research opportunities arising from this work. 
 
5.1: Prototype EAEC colonisation and virulence gene 
regulation 
The relevant site of intestinal EAEC infection is an important consideration for 
studies of host-pathogen interactions. In the first part of this project, in vitro and ex 
vivo intestinal epithelial models were evaluated for suitability to investigate EAEC 
virulence. This has demonstrated that two prototype EAEC strains, 042 and 17-2, 
adhere with similar efficiency to the human intestinal epithelial cell lines T84 and 
Caco-2, used as models for colonocytes and small intestinal enterocytes, 
respectively. This contrasts with a previous study which concluded only T84 cells 
were suitable for colonisation by strain 042 (Nataro et al., 1996), and is also the first 
reported example of strain 17-2 adhering to T84 cells to my knowledge.  
The use of the IVOC model with biopsies from different parts of the human 
intestine revealed a tissue tropism for EAEC colonisation of colonic tissue agreeing 
with previous IVOC studies. Reports of EAEC colonisation of small intestinal biopsies 
are less consistent in the literature, and data herein supports the suggestion that 
EAEC can colonise the colonic epithelium more effectively (Andrade et al., 2011, 
Nataro et al., 1996, Knutton et al., 1992, Hicks et al., 1996). The predominant 
association of EAEC colonisation with colonic tissue in the physiologically relevant 
IVOC model allowed an informed selection of colonocyte-like T84 cells for 
experiments in the VDC system.  
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This study represents the first use of the VDC model for EAEC research, and has 
presented evidence of separate regulatory effects of epithelial cell contact and 
oxygen concentration on the expression of virulence genes. It is proposed that the 
increasing oxygen diffusion gradient in proximity to the mucosal surface induces 
the expression of virulence factors enhancing EAEC adherence to epithelial cells, 
such as the adhesins AAF/II and the E. coli common pilus, and dispersin. Physical 
contact with the colonic epithelium then stimulates increased expression of 
additional virulence genes. As well as adherence-related genes, this includes genes 
involved in colony spatial organisation (aap), manipulation of the mucus layer (pic), 
and secreted toxins (astA, hlyE, pet). Importantly, the data suggests that the latter 
response is independent of the transcriptional activator AggR, often considered a 
key virulence regulator in EAEC. 
While transcriptional changes were significant for many virulence genes, increased 
protein expression was only demonstrated for dispersin by 042 in response to T84 
cell contact. Therefore, future work could determine the effect of these signals on 
translation of other virulence factors and investigate if further regulation affects 
any changes at the protein level. Oxygen concentration only influenced gene 
expression in strain 042 and not 17-2, suggesting strain specificity or differences in 
transcription kinetics. It would be interesting to determine the effect of oxygen 
availability on additional EAEC strains, such as representative isolates from the ST40 
and ST31 groups studied in the other part of this project. 
Follow-up studies could aim to identify the mechanisms involved in the 
transcriptional changes reported in this work. As it was shown that the increased 
gene expression in adherent bacteria is dependent on physical contact, the T84 cell 
receptors responsible for adherence need to be determined. Epithelial surface 
factors associated with EAEC binding include cytokeratin-8 and MUC1 (Izquierdo et 
al., 2014b, Boll et al., 2017). Candidate epithelial cell receptors for EAEC should be 
investigated in future work for a role in regulation of virulence factor expression, 
for example by gene silencing by RNA interference or blocking of receptors with 
specific antibodies. Furthermore, physical signals such as fluid shear forces have 
been associated with mechanosensation by EHEC and require future study in EAEC 
(Alsharif et al., 2015). In addition, further research is needed to characterise the 
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molecular mechanisms involved in the response of EAEC to oxygen and epithelial 
adherence. According to results presented in this study, the AggR transcriptional 
activator is implicated in oxygen-dependent virulence gene expression, and has 
been previously associated with the ArcA/FNR redox-sensing transcription factors 
(Cameron et al., 2013). Future work could experimentally investigate the potential 
role of these factors by determining the effect of molecular biology interventions 
on the induction of EAEC virulence genes in response to oxygen or T84 adherence.  
The VDC system allowed for the investigation of EAEC responses to oxygen 
concentrations, which would not be possible with traditional cell culture models. 
However, this model does not address other physiologically relevant conditions in 
the human gut such as the presence of bile salts and digestive enzymes, which were 
not tolerated by the intestinal epithelial cell lines used. One limitation may be the 
lack of a protective mucus layer, which could be addressed by developing a mixed 
culture of T84 cells with a higher mucin-secreting type such as the goblet cell-like 
LS174T cell line. Future studies of EAEC virulence genes associated with 
pathogenesis would also benefit from greater use of in vivo experiments, 
particularly for elucidating functions related to long-term effects such as 
malnutrition or sustained inflammatory responses. However, this is currently 
limited by a lack of suitable animal models which exhibit symptomatic enteric 
disease in response to EAEC infection. 
 
5.2: Association of EAEC phenotype and genotype with 
epidemiological disease or carriage 
EAEC is a genetically heterogenous pathotype, likely related to the ability of 
multiple factors to confer the defining aggregative adherence phenotype. It is also 
recognised that EAEC contains diverse strains including pathogenic and non-
pathogenic groups (Chattaway et al., 2013). Previous studies demonstrated only 
limited success in identifying specific virulence genes significantly associated with 
EAEC pathogenicity, and their findings were often inconsistent. It is likely that EAEC 
pathogenesis relies on combinations of biological functions, which can each be 
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affected by different factors, thereby limiting the use of single genes as absolute 
virulence markers (Estrada-Garcia et al., 2014). Therefore, the rationale for the 
second part of the study was to evaluate EAEC strains for in vitro phenotypes 
relevant to pathogenesis followed by analysis of WGS data for related genotypic 
differences. 
This work built on a previous MLST study of clinical EAEC isolates, which identified 
an epidemiological association of ST40 strains with higher rates of disease and ST31 
strains with asymptomatic carriage (Chattaway et al., 2014b). In this project, it has 
been shown that ST40 strains exhibit significantly greater adherence to T84 
intestinal epithelial cells, colonisation of colonic biopsies, and formation of biofilm, 
in comparison to ST31 strains. Additionally, a final year undergraduate student in 
this group demonstrated that ST40 isolates induced higher levels of IL-8 secretion 
from T84 cells. Therefore, the epidemiological association of the ST40 group with 
disease correlates with the experimental results for phenotypes related to EAEC 
pathogenesis, with T84 adherence exhibiting the most distinctive difference 
between STs. 
While screening for virulence-associated phenotypes could be effective for 
predicting the pathogenic risk of EAEC strains, such assays are impractical for rapid 
and cost-effective public health applications. However, the characterisation of 
virulence gene profiles associated with the phenotypic differences may identify 
markers that can be used for screening by PCR or genome sequencing approaches. 
Analysis of WGS data for the ST40 and ST31 strains used in this study determined 
genotypic differences with relevance for EAEC biological functions. These include 
adhesins associated with colonisation phenotypes, and bacterial surface factors 
implicated in induction of host inflammatory responses.  
A limitation of this study was the relatively small sample size (8 strains from each 
ST). However, a current collaboration with Dr Lisa Crossman, UEA, is expanding the 
genotypic comparison to include all available EAEC ST40 and ST31 genomes 
sequenced at UEA and PHE (currently 51 total isolates) 
While putative virulence genes differing between ST40 and ST31 were identified, 
there remains uncertainty regarding their expression and importance for in vitro 
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phenotypes. Therefore, future work should also focus on determining the 
functional influence of these virulence factors. Molecular biology studies could be 
performed to introduce, overexpress, or delete target genes in EAEC strains and 
determine if virulence-associated phenotypes are altered. It would also be 
interesting to investigate if specific interventions can abolish the significant 
differences between ST40 and ST31 isolates, such as changing the AAF variants. 
Finally, this work applied bioinformatics tools for the in silico typing of EAEC strains 
using WGS data. The results of in silico MLST analysis were consistent with the 
previous ST assignments performed using PCR. The use of genome sequences to 
predict serotypes revealed greater detail than was available from laboratory 
antigen testing. However, there were some inconsistencies in assigned antigens, so 
further research is needed into the relative accuracy of in silico serotyping. It is 
likely that further advances in sequencing and bioinformatic technologies will 
continue to improve the options available for characterising populations of 
pathogenic bacteria. This is predicted to also affect the future definition of E. coli 
pathotypes, which is of particular relevance for a group as heterogenous as EAEC 
(Robins-Browne et al., 2016). 
 
5.3: Summary  
In summary, work from this PhD project has discovered novel regulation of EAEC 
virulence factors implicated in pathogenesis by signals associated with the human 
gastrointestinal environment. Oxygen concentration and physical contact with host 
epithelial cells both modulate the expression of virulence genes and might serve to 
restrict transcription to intestinal niches advantageous for colonisation. This study 
has also demonstrated the potential of screening clinical EAEC isolates for 
virulence-associated phenotypes. ST40 strains, epidemiologically associated with a 
higher rate of disease, were compared to ST31 strains, associated with 
asymptomatic carriage. The ST40 isolates exhibited greater adherence to in vitro 
and ex vivo colonic epithelium models, increased formation of biofilm, and higher 
induction of pro-inflammatory IL-8 secretion from host cells. Also presented are 
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genotypic differences between the STs related to pathogenic functions, including 
adhesins, toxins, and flagella. The findings of this project contribute to the 
understanding of EAEC pathogenesis in the human host and provide new targets for 
the future development of virulence markers for high-risk EAEC strains. 
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Appendix 1.1: Virulence gene query sequences 
 
>aggR  Sequence ID: FN554767.1 
TTATTGGCTTTTAAAATAAGTCAAGAATTGTTTTGGTGTTATGCCAAAATGTTTTACAAAAAGCCTAATG 
AAATATGATGTACTGGAAAATCCTATCATATTAGATATTTGTGATATCTGATATGAGTTATCAAGCAACA 
GCAATGCTGCTTTGCTCATTCTTGATTGCATAAGGATCTGGTTAAAAGTAATATACTCTGACTCAAGCCT 
TTTCCTTATTGTTATCTCTGATACATTAAATTCATCTGCAATAATAGCTAGAGTCCATCTCTTTGATAAG 
TCTTTCTCGATTATGTTTCTGACTTTATCAGAAAAGAAGCTTACAGCCGATATATAAATTGACTCTATAA 
TTTTTTTGTTGTTTTCGATCTTTGATATAAGATATATCAAATCTGAAGTAATTCTTGAATCATCATTATT 
ATCGATACTCTTGAATGTATCTAATACAGAATCGTCAGCATCAGCTACAATTATTCCTTTTGACCAATTC 
GGACAACTACAAGCATCTACTTTTGATATTCCGTATATTATCATCAGGGCATCCTTTAGGCGTCTTAATG 
TATCGCTGCTTAATCTGATTGCGATAAATGGATTTGCTGTTGATTTCTTCTTTTGCAATCTTACTGATAT 
ATTTATTCCTCTCTCAAGAAATATGAGTTCATTTCTAAGATATGTATTGCTTCCTTCTTTTGTGTATACA 
TCGATTGTACAATTAGATGTATATAGTACAGTGTACTGATGTATTCTGATATTGTTGATTTTTATAATCT 
CTTTTTCGATGTTTTGTTTTAATTTCAT 
>pic FN554766.1 
TCAGAACATATACCGGAAATTCGCGTTTACCGCATTATCCACGTTATATTTACCAAAGGCTGACTTCTCA 
AACTCCAGACCAAAGCGCATATTGTCCTTTATCTGCGCATTCATACCAACATTAAACAGCATCCGGCTGT 
CCTTCTCTCCTTTTATCCGTTTCTCCCCGGACGCATCACGCAGTACGGTCTCTCCATTATTCAGCAGGTC 
AAACTGCCAGCTGGTTCCGGCACGGGCCGTCACACTCCAGTCCTTACCACTGAAGGTCTTGCCCAGTTCA 
ACCCCTGTTCTTCCAACCAGCGGACTGAAGTCCCTGTTCTTCATGCTCAGGTCCATATCACCGTCTTTCC 
AGCGGAATGTTTTCCCGGACACGGCGCCGTAAACCAGTTCAGCCTGCGGCTCAATGAACGTGTCCTCTGT 
CAGGTGATAGCGGTAACCCGTTTCAGCACCGGCATACCAGGAATGGGTGTTGTAGTGTTTCGTTCCCAGG 
CTAGCAAAGTTACCTGTGTAATCATTGTCATGGTGAATATATTTACCAATCAAATCGATATAGGCACCGG 
ACTCAAACAATGCTGAAGCATACAGACCGCCCCCCACCGATTTCGTCTTTCCGCTGAATGCATGGCTGTC 
TGCACTGCTGTCGGTATAGGTCATCGTGACACCGGTAAACAGGTCCACACCGTCCAGTTCATGTTTTTTG 
TCAAAGCCGACCTGAACATGGGTGTAATTATCACTGTAACCACCGTCTGCAGAACCGGCACCACTCATGA 
TGCGCGCCCAGGCACCGGCATCACCGTTTGTGTCACGCAGGTCACCCATACGTTTGTTCAGATTGTTAAC 
TTCCGTCATGAAGTTTTTATACCCGGCATTCATGAAACTGTCAGCCTTCGCGGCAGCGGCTTTATCAGCC 
TCCGCTTTAAAACCATCCAGTATCCACTTCGTATTGCCACCACTGGTATCAACATGCAGGGTTGGGGTCA 
CCCGACTGAAACCTGTCACCCGGGTGCCGGCCTTAAACATCTCTGCTGAAGTTCCCGCCGGTGCCGTGAC 
CAGAGGAATATTCAGGGCCTGTCCCTGAGCAGGATTATTCATAAAGCTGACGTTCAGGCTGTTATCTGAA 
CCAGTGGCTTTTTCAGTCACATTAATTTTATCGGCATTTTTCAGGTCCGTACGCAAAACAAAATCACTGC 
CTGTTGCATCCAGTTTATTCACCGTCAGGGTACGGAATGTACGGTCTCCTTCAGAACTAATACGGCTGTT 
TCTGACGGTAAGACTGTGGATGGCAGAGTCCCCACCCAGAGTCCACAGTGCATTATGCATACTGACATCA 
GCCCTGCCACCGGTTATGGCACCATTGAATGCTGCGTTATAGCCCTCAAGAAGACTGCCGGCAAACGCCG 
ATGCAGCCGTTTCCGCAGAAGCCAGTTCTGCCGGCGTGTCAGACCCGATGGTAACTGTTGATGCCGCAGA 
GGCATGAATATCACCGGAAGCATGTGCTCCACGGGTAATTTCCAGTGCTGCGTTATCGCCGGTCAGGTCA 
TATCCGTCCGTCAGATATACAGCAGGGGCATACTGATTAGCCGTATCTTTAACCGGTGTACCGCTCAGGG 
TGATTTTGCCGTTCTTACCGGCCTGAATATGCCCGTCGCTGAAAAGACCGTTCAGTGCTGTAAGATGACC 
GCCATCATGCACTGTCAGTGAACTGCCGGCAAAAGCACCCGGGGCTGTCAACAGGACGTCCGGAGAGGTG 
ATGCTGACGGCACTGTCATAAGCGTCAATCCCCCCGGTGAACCTGCTGCCGATATCCAGGGCTGAGTTAT 
GGTTCAGCGTAATATTCCCTTCATACTGGCTCCTGTCATTCACGGTGTCCGGGACAGAGGTACCTTCCTC 
CGGAATGACATAATTTCCTGTTCCGTCATTTTTATCCACAAATGCCCTGTCACTTCCCAGTGTGATATGG 
CTGTTATCCGACTTAATGTCACTGTTCAGCGAGGCGTTACGTGAAAGATGGAAGTCAGCGTCTTTCAGCG 
ACAGTGTTTTCATTGTAAACTGACGGTTTTCCCAGTCTTTCTGGTTCAGGCTGACCGGTGCACTGCCACT 
GATGGAGGCATGGATAACCGGATGTCCCTGGAATATCAGGGTGCCACTGTCCTGACTCAGGGTACCTTCC 
GGCAGGTTCACGCTACCATCAAAGATGACCTTTCTTCCCCCCGGCACCTGTGGAATGGCGACATCCATAT 
TCCCGGTCAGCTGACCATGAAAGATAACGGGTTGTTTTGCCCGCCCGGCCAGGATCCTATCTTTTACTGT 
CTGAACTGCTTTGTTTTTGTCCATGCCAACAAACTCCCACTGAGCCGGATCATTCAGGCTGTTCCCCCAC 
AGAGTGTTACCATAGCTGGCAGATTTCAGAATATAGAAGCGGGTCTGGCTGTTGAGTATCATGCTGTACA 
GGTTTCCTGGAGTGCCGGTACCACCAAAGGGGGATATATTTCCAATCGTCGGTTCACTGACATTTGTATC 
CTGAGCCTTAAGATCCAGTAAAAGCTGGGATTTTTGCTGTGCATTATTTGTAATCACCGCCCCGTAATCA 
GCAGCCTGCAGTCGGGTGAAGGTAACGGCATTACCATTAAGGTCAAGCTTACCTCCCCGGTATCCCCATG 
AAATGTTATCCGGATTGACCTGACGGGCATCCCCGAGCACCACGGTCGGACGTCCGCTGGCGAGGTTCAC 
TGAACTGAAGGCCTGGATATTACCTGCAGTGTCTGCCTGCTGGTTAAGTACAACGATACCGTCTCCCGTT 
TTCAGTCCTCCCGGGTTTACACCTGTTCCGTTTATGGTCAGGGTTCCTTCCCCCAGCTTATGCAAGTTGT 
CACCGGCAACGCCGTTGACCTTCCAGGTTACATTCGTCCCCTTGTCAGTAATAATGCCGGCACCCGTCCA 
TGTTTTTCCGGATTCAGCAGATACGGTGTAACTGTCTTTAAATTCGAGATAACCGGCACCCTGAGTCACA 
CTGTCTTTCAGGATAATTGCACCATTCTGCCCGCTGAATACCAGATTTTTACCGGCATTGAGGTCATTGT 
CTTTCTGCCCGTGCATGGTCCAGTTTTTACTGCCCTGGCTCAGGGTACCTGTGCCTGATGTTTTGTCGTA 
TGTCCAGTTCAGGGGGCCCAGTCCGGAAACAAAGTCTACGGGGGCATCGAAATCGTCCTGCATAACCTGG 
TTCAGATAATCTGTTGGTATGACATTCCACCAGTTCGTAGCACCATTAATACCTGCATATGCTCTTAATA 
CAGCAACAATAACCCATTTTTTTTGTTGTTTATCATAAGCAAACAAAGGAGAACCACTATCCCCAGGGGC 
TCCATAGTCAGGTAAAGGGCCGTTTACAGGATTATAAGTTTGCCCGGGATTAGAGACTATTGTTGCATCA 
GATATCAGAGGAACTCCTGTGGTTCCTCCTGTTTTAAAAGCATATCCACCGGCAACCTTAACTAAATTTC 
CGTCCTTGTCCTTAGTGTACTGCGTACCACTACCCACCCGATAAAAAGCGGTGTAACGTTCAGTGTATTT 
ATAAGCATTGGCTTTGGTTCCTTCTGATGTTACCGCTGAGGGAATAACTTCTGTAACCAGTTTATTCAGA 
CGTGGAGCATGGAAGTCAATAGAAGGGTGGTTATTACGGTCAACAAGGGAATATGTATTTTTCCCATTAC 
CAAAGCTCACACTCCGATATCCTCCGTTATGCTTTACGCTGACGATATACTGAGGTGATACAAGCGTAGC 
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AACGCCATTTGAGCTCACACTGCTGAAATCGGCCATTGGGGCTTTACCCAGTCTTCCCACAAGTTTTCCG 
TCCTTATCATATACCGGAATATCATTGGCACCAGGTACAAAAAGCCCTTTGTTTTCGGCGAAATCACGAT 
AAATCTGATAGGCAATATCGGAACGGACAATACCCGCCTGGGATATCTGAGAGTAACACAGACAGATTGC 
TGGAATGCCAGCCAGAAGAATATGCGTTAATCTTCGGCATGTCTTTTTTATTACCCTGCGGGCAAGTTCA 
GAGACAGCAATAAGCCCCCCGGTGACGGGGCAATATTTAAGAGAATAAACTTTATTCAC 
>aap FN554767.1 
TTATTTAACCCATTCGGTTAGAGCACGATATTTTTGGACTCCAACCTTATTTGTCTTGTTAATGTCTTGG 
TTCGTATTTACAGGTGTGGAGGGGGTAACAACCCCTTTGAAGTTGCTTGTTGTGCCATCATTATAATAAA 
ATACCCCAGAGACAGACACCCCCCTTACTTTCCCTTCATTAAGGCCTTGCATACATACTGAGACACCGCT 
GTTATAAGTATACTGTACTCCAGACTGTTTTATACATTGGGACGGGTCCACATTATCTGCGTTCCAACCG 
CTACCACCCGCAAAAGCATTCAGGCTGATACCCAAGATGCCAGAAAAGATAACAAACTTAATTTTTTTCA 
T 
>astA FN554767.1 
TCAGGTCGCGAGTGACGGCTTTGTAGTCCTTCCATGACACGAAGCGCAGGCTGTTGCGCACCATATGCAC 
GATGCATAACTGGATGCGGGCCTTCGGATATACTGTGTTGATGGCAT 
>hlyE FN554766.1 
TCAGACTTCAGGTACCTCAAAGAGTGTCTTCTTACCGTGTCTTTTCTGATACTCATTACAGGTGTTAATC 
ATTTTTTTTGCCGCTTCTTTTAGCAAAGAAAGCATTAAATCATCATAATCAACGTAGAATCTGGTTGTTT 
CAGTTTCCGTTTTTATCTCCCCGATGGCGGCTATTTCGGTGGTTAATTTCAATTTGGCGGCATCGATATC 
TTTATTCGCTTGTTTAACCGTGTTAGACAGGGTGGTAAAGAAACTCTGCACAGACTTTAACTTGTTCTTC 
AATTCTGGAATCAGTTTCCCTTCAACTACGCCCGCAGCAATAGAATAGGAAATGATTAATCCAAATGGAC 
CGGCGACGACACCGGCTGCGGCACCGGCATACGCTTCCTTCCTGATTTTATCTACCTGTGACTGGAAATA 
GCTGCTTTTTTCTGAAAAATCATTGGTTAACTGGCTATCTAACGCCAGCAGTTTTCCGGAAGCGTTGTTG 
AAACTTTGTGAGCTTACCAGCAGAGATTTTTGCGCTTCATTCAGCTTCGTGATGCCGTCATCCAGTACCT 
TAATGAGAATGTCTTTCTGGGCGGATGCTTTCTTCTCATTGTACTCATCAAATAGCAAAATATATGCTGC 
GAGCAATTGTGTCGCAACACCACACCATTCATACACCGTTTGGGTTGCTTCAAAATACTTATCCTGGCTA 
TCCATAAGTAAGGTTTTAATATCGCCAACTAAAACGGAGGCTGCCTGTGAATACTCCTGTTTAAAGCGAC 
TTAACTCTTTTATGGTTTCATCGAAGGTCTGCCAGGGGATGACCTGATCGAGATATTTATTATAAAGGTC 
TAATGCTCCATCTGCGGTTTCGATTGCGTTTTTAACTACCTCTACCGTTTTATCTGCAACGATTTCAGTC 
AT 
>pet FN554767.1 
ATGAATAAAATATACTCCATTAAATATAGTGCTGCCACTGGCGGACTCATTGCTGTTTCTGAATTAGCGA 
AAAAAGTCATATGTAAAACAAACCGAAAAATTTCTGCTGCATTATTATCTCTGGCAGTTATTAGTTATAC 
TAATATAATATATGCCGCCAATATGGATATATCTAAAGCATGGGCCCGGGATTATCTCGATCTGGCACAG 
AATAAAGGGGTGTTTCAACCAGGTTCAACACATGTAAAAATAAAACTGAAAGACGGGACTGATTTTTCAT 
TTCCAGCACTTCCTGTTCCTGACTTTTCATCTGCAACCGCAAATGGAGCTGCAACAAGTATTGGTGGTGC 
CTATGCCGTAACCGTTGCACACAATGCAAAAAATAAGTCATCAGCTAATTATCAAACATACGGTTCTACG 
CAATATACTCAAATAAACAGAATGACAACTGGAAACGATTTTTCCATTCAGCGATTAAACAAGTATGTCG 
TGGAAACAAGAGGGGCTGATACATCATTTAATTATAATGAGAACAACCAAAATATTATTGACAGATATGG 
CGTAGACGTTGGAAATGGAAAAAAAGAAATCATTGGTTTTCGTGTTGGTTCAGGAAACACCACTTTTTCC 
GGAATAAAAACATCCCAAACATATCAGGCTGACCTGTTAAGTGCATCACTATTCCATATAACAAATTTAC 
GAGCAAATACTGTCGGAGGTAACAAAGTGGAATATGAAAATGACTCATATTTCACTAACTTAACCACTAA 
TGGTGACAGTGGATCAGGCGTGTATGTATTTGATAACAAAGAAGATAAATGGGTTCTACTTGGAACAACC 
CATGGAATAATAGGGAACGGAAAAACGCAAAAAACATATGTAACACCATTTGACTCCAAAACCACCAATG 
AATTAAAGCAACTATTTATTCAAAATGTTAATATTGATAACAATACTGCTACCATTGGTGGTGGTAAGAT 
AACTATTGGCAATACAACTCAAGATATCGAGAAAAATAAAAATAACCAGAATAAAGACCTAGTGTTCTCT 
GGTGGTGGTAAAATCTCATTAAAAGAGAATCTTGATCTTGGATATGGTGGGTTTATTTTTGATGAAAATA 
AAAAATATACTGTTAGCGCTGAAGGGAATAATAATGTCACCTTTAAAGGTGCAGGCATTGATATAGGTAA 
AGGCAGTACTGTTGACTGGAACATCAAATATGCCTCAAATGATGCACTGCATAAAATTGGTGAAGGGAGC 
CTTAATGTCATACAGGCACAGAATACGAATCTGAAAACCGGGAACGGGACCGTCATTCTTGGCGCACAGA 
AAACGTTCAACAATATCTATGTCGCCGGTGGCCCGGGCACAGTACAACTCAATGCAGAGAACGCCCTGGG 
TGAGGGTGATTATGCTGGTATTTTTTTCACTGAAAACGGCGGAAAACTCGACCTGAATGGTCATAACCAG 
ACCTTCAAAAAAATTGCTGCAACAGATTCCGGAACCACCATCACTAACAGTAACACCACTAAAGAGAGTG 
TACTGTCGGTCAATAACCAGAATAACTATATCTATCATGGTAATGTGGACGGCAATGTACGCCTTGAACA 
TCACCTCGACACTAAGCAGGATAATGCCCGCCTGATACTGGATGGTGATATTCAGGCAAACAGTATCAGT 
ATCAAAAATGCCCCTCTGGTAATGCAGGGCCATGCGACTGATCACGCCATTTTCAGAACAACAAAAACAA 
ATAATTGTCCTGAGTTCCTCTGTGGTGTTGACTGGGTCACCAGAATCAAAAATGCTGAGAATTCAGTAAA 
TCAGAAGAATAAAACCACCTATAAATCGAATAACCAGGTTTCCGATTTGTCCCAGCCGGACTGGGAAACC 
AGAAAATTTAGATTCGACAATCTGAATATTGAAGATTCATCATTATCCATTGCCAGAAATGCAGATGTTG 
AAGGTAACATCCAGGCTAAAAACTCTGTGATAAATATCGGGGACAAAACGGCATATATTGATCTGTACTC 
AGGAAAAAATATTACCGGTGCCGGATTCACCTTTCGTCAGGACATAAAAAGCGGTGACTCCATCGGTGAA 
AGTAAATTTACCGGGGGCATTATGGCAACAGATGGCTCCATCAGCATAGGGGATAAAGCCATTGTCACGC 
TGAACACGGTCTCGTCTCTGGACAGAACAGCGCTGACTATCCACAAGGGGGCGAATGTTACGGCCAGCAG 
TTCCCTTTTCACCACCAGTAACATCAAATCCGGAGGCGACCTGACCCTGACTGGCGCAACAGAATCGACC 
GGGGAAATCACTCCGTCGATGTTCTATGCTGCAGGAGGATATGAACTGACGGAAGACGGGGCTAACTTTA 
CCGCCAAAAATCAGGCCTCTGTAACCGGTGATATTAAATCCGAAAAAGCAGCAAAACTTTCATTTGGCTC 
CGCTGACAAGGATAATTCTGCCACAAGATATTCGCAGTTTGCTCTCGCGATGCTGGATGGCTTTGATACG 
TCCTATCAGGGCAGCATTAAGGCTGCACAATCCAGCCTTGCAATGAATAATGCGCTCTGGAAAGTGACCG 
GCAATTCCGAGTTGAAAAAACTGAACTCCACCGGCAGTATGGTGCTCTTCAACGGAGGGAAAAACATCTT 
CAATACACTGACTGTCGATGAACTGACAACCAGTAACAGTGCCTTTGTGATGCGAACCAATACACAACAG 
GCAGACCAGTTAATTGTTAAAAACAAACTGGAAGGTGCAAACAACCTGCTGTTAGTCGATTTTATTGAGA 
AAAAAGGAAACGACAAAAACGGTCTGAACATCGATCTGGTTAAGGCTCCTGAGAATACCAGTAAGGATGT 
CTTCAAAACTGAAACACAGACCATTGGTTTCAGTGATGTAACCCCTGAAATTAAACAGCAGGAAAAAGAT 
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GGCAAATCTGTCTGGACGCTGACCGGGTATAAAACGGTGGCAAATGCTGATGCTGCGAAAAAGGCAACAT 
CACTGATGTCAGGCGGCTATAAAGCCTTCCTTGCAGAGGTCAACAACCTCAACAAACGTATGGGTGATCT 
GCGTGACATTAACGGTGAGGCCGGTGCATGGGCCCGTATCATGAGTGGAACCGGGTCTGCCGGCGGTGGA 
TTCAGTGACAACTACACCCACGTTCAGGTCGGTGCGGATAACAAACATGAACTCGATGGCCTTGACCTCT 
TCACCGGGGTGACCATGACCTATACCGACAGCCATGCAGGCAGTGATGCCTTCAGTGGTGAAACGAAGTC 
TGTGGGTGCCGGTCTCTATGCCTCTGCCATGTTTGAGTCCGGAGCATATATCGACCTCATCGGTAAGTAC 
GTTCACCATGACAACGAGTATACCGCAACTTTCGCCGGCCTTGGCACCAGAGACTACAGCTCCCACTCCT 
GGTATGCCGGTGCGGAAGTCGGTTACCGTTACCATGTAACTGACTCTGCATGGATTGAGCCGCAGGCGGA 
ACTTGTTTACGGTGCTGTATCCGGGAAACAGTTCTCCTGGAAGGACCAGGGAATGAACCTCACCATGAAG 
GATAAGGACTTTAATCCGCTGATTGGGCGTACCGGTGTTGATGTGGGTAAATCCTTCTCCGGTAAGGACT 
GGAAAGTCACAGCCCGCGCCGGCCTTGGCTACCAGTTTGACCTGTTTGCCAACGGTGAAACTGTACTGCG 
TGATGCGTCCGGTGAAAAACGTATCAAAGGTGAAAAAGACGGCCGTATGCTCATGAATGTTGGTCTGAAT 
GCTGAGATTCGTGACAACGTACGCTTTGGTCTTGAGTTTGAGAAATCGGCATTTGGTAAGTACAACGTGG 
ATAACGCCATCAACGCCAACTTCCGTTACTCCTTCTGA 
>ecpA FN554766.1 
TTAACTGGTCCAGGTCGCGTCGAACTGTACGCTAACGTCGCCGCTCCAGATGCCTTCCGGTAGAGTGCTG 
TAATCGGTTACTGCGGTGGTACCATTGGTGGTGCCGCTGATGATGGAGAAAGTGAAACCATCCTGTGCGG 
TGGTACGATTGCTGGCATTGTAACCGTTAGCCAGTGGGCTAAGGTTGCCGCCCAGTACGCCGTTGGCGGT 
ATCGATCATCACGGTATCGCCAGTTTTTTCGACTGCCGCGCCGTTATAATCCACGCCCACATTCAGTGTG 
GAACCTGAGGTATCCAACTGGGTTAAGGTGTTGGTGATAAGACGTGAGGTCAGTTTAAAGGCGGTAGCCG 
TTGAGTCACCCTCGATAGCTACGTCAAATAGACCTTTCTGTGAGTTAAAACCTTTAATGCCTTCGGCATA 
CTGGAACGCCAGGCTACCGAGTGGCGTCACAACCAGTTTACTGGTGGTGTCTTTTTTGGCTGTTGCCGAC 
CAGGTCGCTACAGCCTGAGCCGTTACGTCAGCAGCCTGCGCCACACCCATGCCGGTAAACACCGTTACCA 
GAGCTATTGCCAGAACCTTTTTTTTCAT 
>aggA U12894.1 
ATGAAAACATTAAAAAATATGAGAAGAAAGAATTTATGCATTACTTTGGGTTTAGTTAGTCTTCTATCTA 
GGGGGGCTAACGCTGCGTTAGAAAGACCTCCAATAAAAGCAACTGAGACAATCCGCCTCACCGTTACAAA 
TGATTGTCCTGTTACTATAGCTACAAATAGTCCACCAAATGTTGGTGTATCGTCAACAACACCAATAATA 
TTTAACGCAACAGTAACGACGACAGAGCAATGTGCTAAAAGCGGTGCAAGGGTCTGGTTATGGGGAACAG 
GTGCCGCTAATAAGTGGGTCCTAGAGCATACTACAAATACAAAACAAAAATACACATTAAATCCATCTAT 
AGATGGAAATTCATATTTCCAGACTCCAGGAACTAATGCAGCAATTTATAAAAATGTGACAACCAGAGAC 
AGAGTTCTGAAGGCAAGTGTCAAGGTTGACCCTAAAATTCAAGTATTAATACCAGGCGAATATAGAATGA 
TACTCCATGCCGGAATTAATTTTTAA 
>aafA FN554767.1 
ATGAAAAAAATCAGAATGTTTGTTATTGCTACTTTATTATCAAGTGGAGCCGCTATTAATGCAACTGCGG 
TAGCAAAAACTGCGACCAGTACTATCACTGTAGTGAATAATTGTGATATAACGATAACACCGGCTACAAA 
TCGTGATGTCAACGTTGACAGGAGCGCAAATATCGACCTGAGTTTTACTATTAGACAACCGCAACGCTGC 
GCTGATGCTGGTATGCGAATAAAAGCTTGGGGGGAAGGCAATCACGGTCAATTACTGATAAAACCTCAAG 
GAGGAAATAAATCAGCAGGATTCACTCTGGCCTCTCCTAGGTTTTCTTACATTCCGAATAATCCAACAAA 
CATTATGAATGGATTTGTTCTTACGAATCCTGGTGTTTATCAATTAGGAATGCAGGGCTCAATTACACCG 
GCTATGCCACTACGACCAGGAATATATGAAGTAGTATTAAATGCTGAGCTTGTGACAAATTAA 
>agg3A AF411067.1 
ATGAAAAAGATAAGTATCATTGCGAGTCTGGTATTCAGCTTGTACAGTGGGTTATCTATAGCAGCGGGAT 
CCAGTTATTACAGGGTAACAAGGGAAATATTAGCTAGTGCTACTGCAAAATTAAAGTTTGTAAACAAATG 
TAGCTTAAATCTTTCAATAAGTGGTATAAACGATGAATATCAGGCTCAGCCAGGACGAGGAGCATTAAGA 
GTAACGTTCACCCCAACGTTTGATAACAATTGCAAGAATATAAATGCTAAGTATCATATTGGGGGGATGG 
GAAAAAAAAATCAATTAATTAATGAGCGGGGAGATAAATATACTCTTAGCGAGTATTTTGTTGGGGGTAA 
CTTGGACCGCGTGGGAACAAATACTGGACATTTTTCGGGCACAGTGACAAGAAGCGGTAATTACAACGTT 
CAAGTTGTTATTCCAGACCAATATATTAAACCTGGAAGTTACTCTATAACAGCCCATGGTGTTATGGTTT 
TACCATAA 
>hdaA EU637023.1 
ATGAAAATTAAGAATATAGTGATTATTGGCGGTCTTATTTCTGGCATGTCGATAATTCCATTATGTCAGG 
CTGCAACAATAACAGCTCAACACACAGTTGAATCAGATGTTGAATTCACTATGAATTGGGTTGATTCAGG 
GCCAACAAAAACCACAGCAAAAAATAATGAGTTGTGGGGCTACCTGGATTTAACTCAAACCAGTGGTACT 
CCGACCTATGGAAAACTCAGTAACCCAAATGGTGGAAATTCCCCGGGGCCAATGAAAGTTGTTTTTGATT 
TCATTGGCCCTAATGGCAGCAAGGCAAATGCTTATTTGGCGGCTTATGGTGCTCCTATCGATCATAAGAC 
TGGGGATAGCTTTGTTAGTGGAGTTAAAGTAGGTAGTGGGAATGGATATAAACCGTTTGTTGTTGGCGCG 
GTTTCAAGAATAGCTGTAAAACTAAATGGAGATCAGACGTTAACGCCTGGAGTTTATCGAACGACATTCA 
ACTTGACCACTTGGAGTAATTAA 
>aaf5A AB571097.1 
ATGAAAAAGATAAGTATCATTGCGAGTCTGGTATTCAGCTTGTACAGTGGGTTATCTATAGCAGCAAATC 
CAACACCTAGTTCTTTAACTAGTATAGCCACAGGTAAAAGTATTGTTTCATCAACTGGAACTATTACTAT 
TTCTAATTCATGTTCATTATCTATTAGTTCGCCTAACCCTGTAACATATACTATTCCAACTGATAAAGCA 
GATAAATATATAAATTTCCAGTTAGATGTTCCTGACCCTAGATGTAAAGCGTTAGGAGGAACTGTTTATT 
TTTGGGGGGCAGATGCTAAAGATGGAAAGCTTGTCATGGTAAAGGGCAATGATAGATATACTTTAATGAC 
GACGTACGGTGGAAGTGTACAGCAAAAACTAGGAGCTGGTTACGGATATTATCATGTATCTAAAAACACT 
ACCCCACAAACTCTTTCTGGTGTAGTATCTAAAAACGGTCCTTACAAACCCGGACAATATACCGTAGAAT 
TGACTGGATTCTTCAGCTTAAATTAA 
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Appendix 1.2: Supplementary figures 
 
Figure A1.1 The scoring scale for EAEC colony size on human colonic biopsies. 
Representative images showing colonisation scale for each score. 0 = no bacteria; 1 = 
isolated bacteria or very small aggregates, < 10 bacteria; 2 = small defined colonies, 
approximately 10-100 bacteria; 3 = medium to large defined colonies, approximately 100-
1000 bacteria; 4 = very large colonies, approximately >1000 bacteria. Images obtained by 
scanning electron microscopy of sigmoidal colonic biopsies incubated with EAEC for 7 
hours. 
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Figure A1.2 Virulence gene profiles identified by alternative tools. BLAST alignment was 
performed for all ST40 and ST31 strains using the query virulence gene sequences in 
Appendix 1.1. In silico PCR was performed using primer sequences obtained from Marie 
Chattaway (GBRU at PHE) 
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Figure A1.3 Induction of IL-8 secretion from T84 cells by EAEC. Confluent T84 cells were 
incubated with EAEC for 3 hours (MOI = 7.5 bacteria/cell). Bacteria were killed with 
gentamicin (50 µg/mL), and IL-8 concentrations in supernatants were determined by ELISA 
after 24 hours. Data is shown for three independent experiments, in duplicate. *** P < 
0.001. Th work was performed by Leah Bundy and Stephanie Schüller (Bundy, 2018). 
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Appendix 2 Norwich Biorepository patient consent form 
 
APPENDIX TWO 
NORWICH BIOREPOSITORY 
PATIENT CONSENT FORM 
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Appendix 3 Cell culture media product information sheets 
APPENDIX THREE 
CELL CULTURE MEDIA PRODUCT 
INFORMATION  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study used DMEM D5671 and DMEM/F12 D6421 throughout 
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